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Human brain structure can be measured across the lifecourse (“in vivo”) with 
magnetic resonance imaging (MRI). MRI data are often used to create “atlases” and 
statistical models of brain structure across the lifecourse. These methods may define 
how brain structure changes through life and support diagnoses of increasingly 
common, yet still fatal, age-related neurodegenerative diseases. As diseases such as 
Alzheimer’s (AD) cast an ever growing shadow over our ageing population, it is 
vitally important to robustly define changes which are normal for age and those which 
are pathological. This work therefore assessed existing MR brain image data, atlases, 
and statistical models. These assessments led me to propose novel methods for 
accurately defining the distributions and boundaries of normal ageing and 
pathological brain structure. 
 A systematic review found that there were fewer than 100 appropriately tested 
normal subjects aged ≥60 years openly available worldwide. These subjects did not 
have the range of MRI sequences required to effectively characterise the features of 
brain ageing. The majority of brain image atlases identified in this review were found 
to contain data from few or no subjects aged ≥60 years and were in a limited range of 
MRI sequences. All of these atlases were created with parametric (mean-based) 
statistics that require the assumptions of equal variance and Gaussian distributions. 
When these assumptions are not met, mean-based atlases and models may not well 
represent the distributions and boundaries of brain structure. 
I tested these assumptions and found that they were not met in whole brain, 
subregional, and voxel-based models of ~580 subjects from across the lifecourse (0-
90 years). I then implemented novel whole brain, subregional, and voxel-based 
statistics, e.g. percentile rank atlases and nonparametric effect size estimates. The 
equivalent parametric statistics led to errors in classification and inflated effects by up 
to 45% in normal ageingAD comparisons. I conclude that more MR brain image 
data, age appropriate atlases, and nonparametric statistical models are needed to 
define the true limits of normal brain structure. Accurate definition of these limits will 
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 1 
1. Introduction and motivation 
 
With 100 billion neuronal cells and up to 1000 trillion synaptic connections between 
cells, the human brain is the most complex structure in the known Universe (Koch, 
2004, Pakkenberg and Gundersen, 1997, Williams and Herrup, 1988). This number of 
component parts (1026) is approximately the number of stars in the entire observable 
Universe and 10 times the number of grains of sand on planet Earth (Derbyshire, 
2003; van Dokkum and Conroy, 2010; European Space Agency, 2013). It is this great 
complexity that most differentiates humans from other animals and is the source of 
our unique intellectual ability (Jones, 2012). This intellectual ability has driven over 
5000 years of neuroscientific study, allowing us to somewhat understand and react to 
changes and diseases that occur in the brain during the human lifecourse (Adelman 
and Smith, 1987; Job et al., 2002; Fox and Schott, 2004; Wardlaw et al., 2009).  
For example, as our population ages the growing incidence of 
neurodegenerative diseases such as Alzheimer’s (AD) may be stemmed if subtle 
pathological changes in the brain are noticed early enough (Brody, 1985; Selkoe, 
2001; Selkoe, 2013). However, not all changes in brain structure indicate 
neurodegenerative disease. We still do not fully understand the pathological changes 
that lead to these increasingly common, yet still fatal, diseases (Shenton et al., 2001; 
Farrell et al., 2009; Ferguson et al., 2010; Davenport, 2013). If pathological changes 
are not accurately identified in the incipient stages then treatments can do little more 
than preserve an already diminished state of being (Selkoe, 2001; Fox and Schott, 
2004; Selkoe, 2013). Although diseases like AD are currently incurable, if these 
changes are identified in the incipient stages then their symptoms may be slowed or 
even stopped (Selkoe, 2013). 
The present work therefore aims to contribute to better understanding of 
changes that occur in the human brain across the lifecourse. This is in turn may 
circumvent the shadow of neurological disease that looms over our ageing population 
(Brody, 1985; Wardlaw et al., 2009; Selkoe, 2013). As was noted in 3000 B.C. 
(Adelman and Smith, 1987), the first step to providing this understanding is to 
accurately measure the structure of the brain. The first sections of this thesis describe 




1.1 Methods for assessing brain structure 
 
The gyral and sulcal pattern of the human brain was first described in 3000 B.C. 
(Adelman and Smith, 1987). Although study of the structure of the brain continued for 
more than 4500 years, it was not until 1664 when Thomas Willis published Cerebri 
Anatome (“Anatomy of the Brain”) that robust methods for measuring brain structure 
were developed (O'Connor, 2003). Willis directed novel autopsies of the brain in 
which it was first removed from the skull, in contrast to the traditional in situ 
dissections of the time, and then sliced from the base upwards. These slices were then 
viewed with a microscope and drawn by Christopher Wren (O'Connor, 2003). This 
method, inherent in modern “in vivo” imaging (section 1.1.1), led to the discovery of 
the “circle of Willis”, the joining area of several arteries that collectively supply 
oxygenated blood to over 80% of the brain (Jasmin and Zieve, 2012). 
Following Willis and Wren, the first major study of the brains’ gyral and 
sulcal pattern (“cranio–cerebral topography”) was undertaken in 1876 by Paul Broca. 
By drilling metal pins between them, Broca identified spatial relationships between 
sulci and cranial (skull) sutures (Broca and Brabrook, 1881; Anderson and Makins, 
1889). These early brain “atlases” were later advanced by Korbinian Brodmann in 
1909. Brodmann used microscopy to define 43 distinct brain regions (now known as 
“Brodmann’s areas”) based on their cellular organisation (Brodmann, 1994; Zilles and 
Amunts, 2010).  
The “circle of Willis”, “Broca’s area”, and all 43 of “Brodmann’s areas” form 
part of the lexicon of modern neuroscience. The methods used to derive them (e.g., 
dissection, drilling, and microscopy) are, however, not entirely suitable for modern 
day in vivo (“in the living”) studies. To better understand how the brain changes 
during life and the effects these changes have on function and health, less archaic 
methods of studying the brain were required. It was the accidental discovery of the 
ionizing radiation (X)–ray in 1895 by Wilhelm Conrad Röntgen that led to the 
development of these methods (Bull, 1961). 
 
1.1.1 In Vivo brain imaging 
Following the discovery of the X–ray in 1895 by Wilhelm Conrad Röntgen, the first 
radiological diagnosis of a pituitary tumour was made in 1897 (Bull, 1970). For the 
next 70 years X–ray brain imaging became very useful in diagnosing most types of 
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hematomas (bleeding) and hemangiomas (tumours). However, the contrast in “whole 
head” X–ray imaging meant that pathology could not always be differentiated from 
normal tissue and the macro brain structures identified in Wren and Brodmann’s post 
mortem drawings were not yet distinguishable in vivo.  
It was the development of “planar” X–ray imaging, or X–ray computed 
tomography (CT), in 1972 by Sir Godfrey N. Hounsfield that provided the means for 
reliable differentiation between normal and pathological brain tissue (Hounsfield, 
1973; Isherwood, 2005). Just as Willis was able to accrue more detail about the brain 
by slicing it in sections with a blade, CT directed X–rays in cross-sectional “slices” of 
the brain to provide more detail (than the previous whole head X–rays). The varying 
rates of absorption (“Hounsfield units”) of X-rays in different structures (e.g. tissue, 
fat, fluid …) produced high contrast, cross-sectional images. These two dimensional 
(2D) images were then reconstructed to create equally high contrast three dimensional 
(3D) images of the whole head (Hounsfield, 1973). 
Despite this great advance, the contrast between tissues in brain CT images 
was sometimes limited. Moreover, by exposing patients to ionizing radiation, the 72 
million CT scans performed in the United States in 2007 may contribute to up to 
45,000 future cancer cases (Berrington de Gonzalez et al., 2009). Further 
developments were then clearly required to safely capture the detail of Wren, Broca, 
and Brodmann in vivo. This method arrived through observation of nuclear magnetic 
resonance (NMR) in 1946 (Bloch, 1946). NMR was the basis for what became 
magnetic resonance imaging (MRI). 
 
1.1.2 Magnetic resonance brain imaging 
In 1946, Felix Bloch and Edward Purcell used magnetic fields and radiofrequency to 
observe the composition of molecular structures (Bloch, 1946; Hofstadter, 1994). But 
it was not until 1973 that Paul Lauterbur used NMR to image chemical compounds by 
exploiting the tiny electrical current given off water when it is placed within a magnet 
and exposed to a radio wave (Lauterbur, 1973). Lauterbur’s “zeugmatogram” (internal 
image) of a glass capillary of water was followed by a zeugmatogram of a human 
finger in 1976 by Peter Mansfield (Mansfield and Maudsley, 1977). Although the 
term is no longer widely used, the principles of zeugmatography form the basis for all 
modern brain MRI (Figure 1).  
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Figure 1. A modern longitudinal relaxation time (T1)–weighted MR brain 
image 
This shows coronal (top left), sagittal (top right), axial (bottom left), and 3D 
rendering (bottom right) views. The lattice structure in the 3D rendering is an 
exaggerated illustration of the numerical voxel matrix that the image consists of 
(the actual voxel size is 1mm3). Although there is no standard meaning on MRI 
intensities, the values 87 and 209 provide an example of the ratio between 
cerebrospinal fluid and grey matter values. 
 
 
The potential of zeugmatography to provide detailed images of the brain in vivo was 
described in 1978 by Mansfield (Mansfield and Pykett, 1978) and the first MR brain 
images, derived in a magnet of 0.1 tesla (T; which is still some 15,000 times the 
strength of the Earth’s magnetic field), were published in 1980 (Holland et al., 1980; 
Hoeffner et al., 2012). These images are essentially matrices of numbers (intensities) 
and individual elements within these matrices are known as “voxels”, i.e. 3D pixels 
(Figure 1). Unlike CT images (that are based on the standard Hounsfield scale), there 
is not a standard MR intensity scale. 
Despite the lack of a universal intensity scale, many research centres started to 
invest in MRI scanners and produce high resolution images of the brain. Although 
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many features, such as such as the ventricular system, Sylvian fissure, 
interhemispheric fissure and tissue boundaries, were visible in CT, the clarity of detail 
previously drawn ex vivo by Wren and Brodmann, was now provided in vivo with 
MRI (Figure 1) (Hawkes et al., 1980). During the thirty years following 1980, MRI 
was developed to produce high resolution images of the brain that clearly defined 
subregional structures as small as the hippocampus (~7ml), amygdala (~5ml), and 
third ventricle (~1ml) (Filipek et al., 1994). The human brain has now been imaged 
with a magnet of up to 9.4 T and in–plane resolution (voxel size) of in vivo images 
may now be as low 0.5mm2 (Vaughan et al., 2006). With these parameters the fibres 
of the white matter and subfields of subregional structures may now be clearly 
defined, e.g. hippocampal subfields, that could only previously be viewed in histology 
(Mueller et al., 2007).  
This range of detail is provided by the array of MRI “sequences” (timings and 
directions of radio frequency pulses and signal capture) that have been developed. A 
non-exhaustive, but commonly used list is given in Table 1. 
 
 
Table 1. Structural MRI sequences 
MR sequence name Example brain features 
Diffusion tensor imaging (DTI) White matter fibre tracks 
Diffusion weighted imaging (DWI) Ischaemic parenchyma 
Fluid attenuated inversion recovery 
(FLAIR) 
Periventricular white matter and hyperintensities 
MR angiogram Blood vessels, e.g. “circle of Willis” 
Longitudinal relaxation time (T1) Cortical and subcortical volumes, e.g. post central 
gyrus, hippocampus 
T1 gradient echo (GRE) Cortical and subcortical volumes with reduced 
scan time and noise 
Transverse relaxation time (T2) White matter hyperintensities 
T2* GRE Brain boundary (mask), haemorrhage 
Note: This table was derived from Farrall (2006), McRobbie et al. (2006), and Pooley (2005). 
 
 
These technological developments and subsequent potential to better understand how 
brain structure changes during life (discussed further in section 1.2) led to a dramatic 
increase in brain MRI studies with more than 144,000 research subjects scanned 
between the early 1990s and October 2011 (Poline et al., 2012). In the earliest of these 
years, and even more recently, most of these data were analysed and then archived 
 6 
after their primary purpose was served. This may seem like a reasonable thing to do 
and not at all wasteful, but this is unfortunately not the case. For example, if no 
further uses of petroleum were sought beyond its’ primary product (motor gasoline), it 
would cost the oil industry US$1,150,000,000,000 (US$1.15 trillion) per year (Ross, 
2012).  
Although they may not directly provide financial profit, brain MRI data are 
very valuable and have the potential to answer unforeseen questions beyond those 
originally posed (Koslow, 2000; Toga, 2002). This has been recognised by research 
funding organisations such as the Medical Research Council (MRC) who now require 
scientific data to be openly shared where possible after their initial purpose has been 
served (Arzberger et al., 2004). Therefore, to exploit their full value and potential to 
provide a deeper understanding of the brain, databanks (rather than inaccessible 
archives) of MR brain images were established. 
 
1.1.3 Magnetic resonance brain image databanks 
MR brain image databanks are structured and accessible collections of the primary 
image data as well as the associated metadata, e.g. patient characteristics and 
sequence parameters. The metadata are essentially held in spreadsheets (tables) and 
each subject record (spreadsheet row) is linked to their corresponding images that are 
independently held on a computer drive or server. This linkage allows users to search 
for images by the characteristics (spreadsheet columns) that makeup each subject 
record, e.g. if such metadata are provided by the databank, a list of subjects and their 
corresponding images may be generated by entering the search: MRI sequence=T1; 
age=60 years; gender=female; systolic blood pressure=150 (Marcus et al., 2007c). 
 When MR brain image data are made accessible to others in this manner, it 
allows them to validate results obtained from their own data, perform pilot studies, 
develop standardised procedures, produce realistic teaching material, and potentially 
provide a more integrated view of brain structure, function, and health (Koslow, 2000; 
Toga, 2002). More specifically, if these databanks are made available to others they 
will provide a source of images to “atlas” the brain which, as demonstrated by Willis, 




1.1.4 Magnetic resonance brain image atlases 
Brain atlases, through the work of Willis, Broca, Brodmann and more recently, 
Duvernoy, Ono, and Talairach, have been in development for hundreds of years 
(Broca and Brabrook, 1881; Talairach and Tournoux, 1988; Ono et al., 1990; 
Brodmann, 1994; Duvernoy, 1999; O'Connor, 2003). The earliest atlases were based 
on drawings and later film photographs of one or few brain specimens. They were 
created to map the structure of the brain, correlate these structures with specific 
functions, and guide cranial surgeries (Broca and Brabrook, 1881; Anderson and 
Makins, 1889; Talairach and Tournoux, 1988). But, as their creators themselves noted 
(Talairach and Tournoux, 1988), these atlases were not able to adequately describe the 
high variance in brain structure between individuals, even those of the same gender 
and age (Farrell et al., 2009). The advent of MR imaging and later brain MRI 
databanks allowed the relatively quick acquisition and storage of a mass of brain 
images (relative to the painstaking patience and physical storage required for 
drawings and film photographs). Furthermore, MR brain images could be much more 
easily combined, i.e. the mean of all subject intensities in each voxel (Figure 2), to 
create composite images that better reflected the variance in brain structure (Evans et 
al., 1993; Evans et al., 2012). 
 The first MR brain image atlases1 were derived from the Talairach and 
Tournoux specimen atlas and this is still the basis for many modern atlases (Figure 2). 
The Talairach and Tournoux atlas itself was derived from the brain in a 60 year old 
female cadaver (Talairach and Tournoux, 1988). One hemisphere was sectioned in the 
sagittal plane and the other in the coronal plane and from these sections the axial 
images were derived, ignoring hemispheric asymmetry (Talairach and Tournoux, 
1988; Evans et al., 2012). These images were digitised to generate the electronic, 
“Talairach space”.  
In an attempt to further knowledge derived from atlases based on one or few 
individuals, the Montreal Neurological Institute (MNI) calculated the mean intensity 
                                                 
1 Note that the term “brain image atlas” is sometimes distinguished from the term “brain image 
template” in the literature. That is, where a “template” may consist of brain structure derived from one 
or many individuals in a standard framework; an atlas, while still consisting of brain structure derived 
from one or many individuals in a standard framework, also consists of labels that have been added to 
specific regions to identify them as, for example, hippocampal grey matter or lateral ventricle 
cerebrospinal fluid. However, others do not make this distinction between the terms and use them 
interchangeably. In this work we too use these terms interchangeably, generally preferring the term 
“atlas”. 
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image from 305 MRI subjects that had been “registered”, i.e. overlaid, into Talairach 
space (Evans et al., 1993). This “MNI305” atlas was the basis for the “MNI152” atlas 
which was the mean of 152 young adult MRI subjects in MNI305 space (Figure 2). 
These modern atlases are mainly used in functional brain imaging studies 
where the mean blood flow of several subjects in the atlas space is correlated with 
specific functions. This, for example, is done to validate the structure–function 
relationships that were first identified with saws and drills by Broca and Brodmann 
(Hinke et al., 1993; Buccino et al., 2001). In order to achieve these results in a 
functional brain imaging study, each subject must be overlaid (“registered”) to the 
space defined by the atlas. That is, the angle, position, size, and shape of each subject 
brain are deformed to those of the atlas (Figure 2). This is also done in structural brain 
image studies but this degree of registration may not be appropriate for studies that 
are concerned with defining the variation in brain structure between individuals. As 
shown in Figure 2, each subject’s brain structure is warped to the structure of the 
atlas, removing almost all of the structural variance between subjects.  
 Some of the variance between subjects, e.g. head size, is not strongly 
associated with age (after childhood) or dementia (although it is moderately 
associated with intelligence; Courchesne et al., 2000; Good et al., 2001; Edland et al., 
2002; MacLullich et al., 2002). For this reason, relative measurements of brain 
structure, e.g. head size normalised tissue volumes, are calculated when attempting to 
explain variation between age or disease groups (Fotenos et al., 2005). Relative 
measurements are calculated by matching only the angle, position, and size of subject 
brains, i.e. maintaining inter–subject shape differences (in voxel–based studies), or by 
calculating subject volumes of interest, e.g. hippocampus volume, as a proportion of 
their total intracranial volume (Walhovd et al., 2005a). Following these image 
processing steps, the associations between brain structure and variables of interest, 








Figure 2. Brain atlases and subject registration 
The Talairach brain specimen atlas (top left*), Montreal Neurological Institute (MNI) 152 
brain image atlas (top right), an original individual subject (bottom left), and the same subject 
registered to the MNI152 atlas. The registration has altered the morphology of the original 
subject to that of the template, e.g. the sulcal spaces and lateral ventricles have been reduced. 
*Copyright © 2003-2013 Research Imaging Institute, University of Texas Health Science 
Center at San Antonio. 
 
 
1.1.5 Statistical models of magnetic resonance brain images 
Statistical modelling is used to determine relationships between dependent variables, 
e.g. brain tissue volume, and independent variables, e.g. age, cognitive state. There 
are a number of approaches to statistical modelling, e.g. graphical modelling, 
parametric modelling, nonparametric modelling, hierarchical Bayesian modelling 
(Freedman, 2010). The list is extensive but the most common approach in structural 
brain image analysis is parametric modelling.  
Parametric modelling itself has a number of subcategories, e.g. tests of group 
means (z– and t–testing) versus tests of variances (Hogg and Tanis, 2010). The most 
commonly used parametric approach is the general linear model (GLM; which often 
encompasses the t– and F–tests of means, e.g. Good et al., 2001). The GLM (the basis 
for linear regression and analysis of variance; ANOVA) has been used to infer general 
relationships between brain structure and independent variables, e.g. age/ gender, for 
over twenty years and is still commonly used at present (Gur et al., 1991; Good et al., 
2001; Ziegler et al., 2011; Li et al., 2012; Long et al., 2012; Peelle et al., 2012).  
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 where m is the slope of the regression line (also known as the beta (β) 
coefficient, e.g. mean brain tissue loss per year), r is the correlation between the 
variables x (e.g. age) and y (e.g. brain size), SDy is the standard deviation of y, SDx is 
the standard deviation of x, y

 is the GLM predicted value of brain size, x is the actual 
value of age, and c is the intercept of the regression line (the predicted value for y 
when x is 0) (Freedman et al., 2007).  
The main outputs from GLM studies are the parameters derived from equation 
1 (m/β and c), the “test statistic” from the hypothesis test that the equation was 
produced by chance (i.e. rather than the alternative hypothesis that there is actually an 
effect of x on y), and the resultant probability that the equation was produced by 
chance (the so called “P–value”). The m/β coefficient of the GLM is essentially the 
estimated mean difference in a dependent variable across the independent variable, 
e.g. the mean difference in brain tissue volume across age. 
It has been recommended by several prominent statisticians that the GLM 
should only be used when the data meet a number of assumptions about their 
generation and distribution (Meehl, 1978; Cohen, 1994; Freedman et al., 2007; 
Freedman, 2010). Firstly, the subjects should be generated from a statistically random 
sample of the larger population of interest. A statistically random sample is equivalent 
to “blindly drawing tickets from a box” where the entire contents of the box, that each 
have an equal probability of selection, are the population and the tickets drawn are the 
sample (Freedman et al., 2007). It is very difficult to generate a statistically random 
sample of human subjects; the use of advertisements in hospitals to recruit subjects 
does not replicate a statistically random process. For example, people who do not see 
the advert have a zero probability for selection, there are non-random reasons why the 
eventual subjects were in the hospital to see the advertisement, and these subjects also 
had the choice whether or not to respond to the advertisement (Meehl, 1978). To 
reliably validate results when data are not random (i.e., recruited with selection bias), 
statistical models should be repeated in other samples and the primary measures of 
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differences, e.g. m/β coefficients (not P–values), obtained in the separate studies 
should be compared (Meehl, 1978; Cohen, 1994; Freedman, 2010). 
 Further to being derived randomly, data are also assumed to be distributed 
“equally Gaussian” (statistically normal) between each value of the independent 
variable. That is, the values of the dependent variable, e.g. y, within each value of the 
independent variable, e.g. x, should be distributed approximately equally to the 
Gaussian distribution and the variance between values of x should be equal 
(homoscedastic – literally translated as “of the same spread”) (Freedman et al., 2007). 
An annotated illustration of the Gaussian distribution is shown in Figure 3 and 
examples of homoscedastic and heteroscedastic (unequal variance) data are shown in 
Figure 4. “Random effects” (controlling variables with various levels that are not all 
included in the model, e.g., only “low” or “high” blood pressure) may adjust for lack 
of homoscedasticity. That is, brain tissue volume distributions of subjects with only 
high or low blood pressure may be less skewed (den Heijer et al., 2005). 
Percentile ranks are levels that represent percentages of subjects within a 
distribution, e.g. the bottom 5% of subjects in a distribution have a value equal to or 
less than the 5th percentile rank value (Freedman et al., 2007). Figure 3 shows that in 
Gaussian distributed data, the mean minus 2 standard deviations (SD) is 
approximately equal to the 2.5th percentile rank; the mean minus 1 SD is 
approximately equal to the 16th percentile rank; the mean is equal to the 50th 
percentile rank (median); the mean plus 1 SD is approximately equal to the 84th 
percentile rank; and the mean plus 2 SD is approximately equal to the 97.5th percentile 
rank (Freedman et al., 2007). The exact values for the 2.5th and 97.5th percentiles are  
±1.96 σ (from the Gaussian distribution lookup table). 
 When data are distributed as in the top panel of Figure 4 the m/β coefficient is 
generalisable across the distribution of data, i.e. subjects that are far from the mean 
differ between groups as much as subjects that are close to the mean. Brain image 
data, however, are often not distributed in this manner (Rorden et al., 2007). In 
particular, there are often skewed distributions of imaging data (bottom panel in 
Figure 4) in diseased and disordered populations such as AD and schizophrenia 
(Shenton et al., 2001; Barkhof et al., 2011). This means that, while it has successfully 
defined mean changes in brain structure, the GLM and other parametric methods may 
not be the most appropriate method for defining the other levels and limits of brain 
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structure (Freedman et al., 2007). True definitions of the limits of brain structure are 
very important to obtain since people at these limits may be at increased risk of 
developing overt neurodegenerative disease. Further, subjects who later developed 
neurodegenerative disease could be retrospectively removed from models to 
determine whether they were responsible for skewed distributions and limits. 
As data accumulate, these levels and limits may be better defined with 
nonparametric statistics. However, the mean estimates, i.e. m/β coefficients, derived 
from the GLM still provide general definitions of how the brain changes across the 




Figure 3. The Gaussian distribution 






Figure 4. Example of equally Gaussian and unequally distributed (heteroscedastic) data with similar 
general linear model results (both m/β0.05) 
In the equally Gaussian data (top panel) the values of y in each value of x (individual subjects are 
shown by the dots) are distributed approximately Gaussian and the variances between values of x are 
equal (homoscedastic). Equality of variance between values of x is shown by the equally sized box 
plots. The superimposed outline of the Gaussian distribution on the data histograms in middle panel 
show the conformance of the data to the Gaussian distribution. In contrast, the varying sizes of the box 








1.2 General patterns of brain structure development, ageing, and disease 
 
Through post–mortem brain measurements, in vivo imaging techniques, databanks, 
atlases, and statistical models of these data we have developed a reasonable 
understanding of how the brain, in general, changes across the lifecourse and disease. 
The size and shape of the brain changes from gestation until death, with the 
greatest changes occurring in early and late life (Scahill et al., 2003; Sowell et al., 
2004; Fotenos et al., 2005; Prayer et al., 2006). These longitudinal changes are often 
inferred from cross–sectional differences between ages and, despite potentially 
confounding factors, e.g. technological developments and differences in nutrition 
across generations, these two types of study generally agree (Fotenos et al., 2005). 
From cross–sectional studies of whole brain volumes, brain tissue volume is said to 
increase rapidly after birth until adolescence and then decline steadily until old age, 
when it then declines more rapidly (Courchesne et al., 2000). The greatest tissue 
volume change is said to be in the grey matter whereas white matter volume is 
generally more constant across the lifecourse (Good et al., 2001). In region of interest 
(ROI) studies, age–related changes in volume and voxel tissue proportions are said to 
be more pronounced in the lower part of the brain, e.g. medial temporal lobe, than in 
the upper part of the brain, e.g. parietal lobe (Allen et al., 2005).  
These age–related changes were calculated with subjects from across the 
lifecourse however, despite an ageing population (Brody, 1985), there was often a 
limited number (<100) of older subjects (>60 years) in these studies (Courchesne et 
al., 2000; Good et al., 2001; Sowell et al., 2003; Walhovd et al., 2005a; Giorgio et al., 
2010; Li et al., 2012; Long et al., 2012). The variance in brain structure between older 
subjects has often been shown to be greater than in younger subjects (Manolio et al., 
1994; Ge et al., 2002; Resnick et al., 2003; Kruggel, 2006; Farrell et al., 2009). This 
means that these general changes may not be applicable to the limits of normal ageing 
brain structure. In other words, those at the clinical limits may change at a different 
rate to those close to the mean (Elveback et al., 1970; Freedman et al., 2007), and 
therefore may be more susceptible to age–related cognitive decline and 
neurodegenerative disease. 
Diseases such as Alzheimer’s are thought to have a devastating but focused 
effect on brain structure. Through histological and imaging studies, a general pattern 
of brain structure changes has been shown to differentiate AD from normal ageing 
 15 
(Braak and Braak, 1997; Jack Jr et al., 1997; Thompson et al., 2003; Fox and Schott, 
2004). At disease onset there is thought to be accelerated loss of neurons (and 
subsequently tissue) in the hippocampus which is then focused throughout the medial 
temporal lobe (MTL). However, there is a wide range of hippocampus tissue loss in 
normal ageing and, although certainly a reasonably strong indicator, hippocampal 
atrophy alone may not be pathological (Ferguson et al., 2010). There is also a general 
trend for lateral ventricle expansion in AD (Thompson et al., 2003; Thompson et al., 
2004). Relative to the strong (mean-based) association between AD and hippocampal 
atrophy/ ventricular expansion, frontal lobe atrophy is not thought to be greater in AD 
until the late stages of disease (Geroldi et al., 1999; Thompson et al., 2003). Further, 
many of the superior structures, e.g. sensory motor cortex, are thought to be spared in 
AD (Braak and Braak, 1997; Thompson et al., 2003).  
This pattern of brain structure changes provides a general description of 
pathology progression however, it is not always replicated clinically where a range of 
atrophy is found across normal ageing and disease (Farrell et al., 2009), e.g. frontal 
atrophy is often seen in AD patients. The lack of research-based evidence for these 
common clinical findings suggests that alternative statistical models may be required 
to support diagnoses of increasingly common diseases such as Alzheimer’s. 
 
 
1.3 The growing shadow of neurodegenerative disease 
 
Our population is ageing and this is causing a rapid increase in the rates of cognitive 
decline and subsequent neurodegenerative disease such as AD and other dementias 
(Brody, 1985; Wardlaw et al., 2009; Luengo-Fernandez et al., 2010; Selkoe, 2013). 
AD is characterised clinically by progressive cognitive and physical decline which 
eventually may require fulltime and prolonged nursing care (Blennow et al., 2006). 
Although only mild at first, by the time of even the earliest clinical symptoms there 
has already been silent but irreversible damage done to the brain (Selkoe, 2001; 
Blennow et al., 2006; Tondelli et al., 2012). Once initiated this brain damage causes a 
devastating cascade of tissue loss and degrading physical and cognitive abilities. 
From the first diagnosis to the final mental and physical incapacity, these 
diseases are emotionally and financially devastating to patients, families, and carers. 
People cannot cope with this on their own and require help from their governments 
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but the growing incidence of cases means that, if methods for earlier diagnoses are not 
found, the United Kingdom government (and those across the world) will be crippled 
by nursing care costs running into hundreds of billions (Luengo-Fernandez et al., 
2010). The estimated worldwide cost of dementia in 2010 was US$604 billion 
(Alzheimer's Disease International, 2013). This is almost twice the amount of market 
capital of the world’s largest public limited company (Telegraph Media Group 
Limited, 2013). These overwhelming human and economic costs have made research 
into brain ageing, and methods for better diagnoses of age–related neurological 
disorders, a UK government and worldwide priority (Luengo-Fernandez et al., 2010; 
Collins and Prabhakar, 2013; Schwartz, 2013). 
One way to meet this priority is to define changes in the brain that are normal 
for age and those that are indicative of cognitive decline and neurological disease. It is 
therefore the aim of this thesis to contribute to a better understanding of normal and 
pathological brain structure changes. 
 
 
1.4 Aims of thesis 
 
To better understand normal and pathological brain structure changes it is apparent 
that large volumes of data, representative and robust atlases, and generalisable 
statistical models are required. I therefore investigated these existing methods and set 
the following hypotheses and sub aims: 
 
A1. Determine whether there are sufficient brain MRI data available to 
understand ageing brain structure adequately 
 
H1. Parametric atlases adequately describe the distribution of brain structure 
across the lifecourse: 
A2. Provide representative and robust atlases of the distribution of brain 





H2. Parametric statistical models adequately describe the distributions and 
boundaries of brain structure in normal ageing and disease: 
A3. Provide generalisable statistical models of the distributions and 
boundaries of brain structure for assessments of groups and individuals 
 
My contribution to meeting these aims is summarised in section 10.1, “Contribution”. 
 
 
1.4.1 Determine whether there are sufficient brain MRI data available to understand 
ageing brain structure adequately 
 
“Data! data! data!” he cried impatiently. “I can’t make bricks without clay.” 
–Sherlock Homes (Doyle, 1892) 
 
As noted in section 1.1.3, the need for data to fully understand brain structure was 
well known (Koslow, 2000; Toga, 2002). However, it was not known whether 
sufficient normal ageing brain image data were currently available. Therefore, the first 
aim of this thesis was to determine whether or not there were sufficient data available 
to define changes in the brain that are normal for age and those that are indicative of 
cognitive decline and neurological diseases such as AD. 
 
 
1.4.2 Provide representative and robust atlases of the distribution of brain structure 
across the lifecourse 
 
“If our brains were so simple that I could understand them, I would be so simple 
that I could not.” 
       –Anonymous (Lezak et al., 2004) 
 
The complexity of the human brain means that atlases based on few individuals or the 
averages of even large amounts of MRI data may not adequately describe its structure 
(Rorden et al., 2007; Evans et al., 2012). Therefore, my second aim was to test 
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existing methods for creating atlases and then to create an atlas that was representative 
and robust to the complex and variable distributions of brain structure. 
 
 
1.4.3 Provide generalisable statistical models of the distributions and boundaries of 
brain structure for assessments of groups and individuals 
 
“It is difficult to understand why statisticians commonly limit their enquiries to 
Averages, and do not revel in more comprehensive views. Their souls seem as 
dull to the charm of variety as that of the native of one of our flat English 
counties, whose retrospect of Switzerland was that, if its mountains could be 
thrown into its lakes, two nuisances would be got rid of at once.” 
    –Sir Francis Galton, 1889 (Freedman et al., 2007) 
 
The GLM and other parametric methods have successfully defined general (mean) 
brain structure changes across the lifecourse. However, if the assumptions of 
parametric statistical models are not met, their results will likely not be generalisable 
to subjects that are far from the mean value, i.e. at clinical limits (Elveback et al., 
1970; Freedman et al., 2007). And, as discussed above, the assumptions of parametric 
statistical models may not always be met in MR brain structure data. Therefore, my 
final aim was to develop statistical models that were generalisable to subjects across 
the distributions of normal and pathological MR brain structure. 
 
 
1.5 Summary of chapters 
 
In this thesis I will first summarise each of the following nine chapters. 
 
1.5.1 Chapter 2 
Chapter 2 is a systematic review of structural brain MRI databanks with normal aged 
(≥60 years) subjects. Despite initially appearing to be several hundred, there were 
only 98 (appropriately determined) normal aged subjects openly accessible worldwide 
and these only had T1–weighted images.  
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1.5.2 Chapter 3 
Chapter 3 is a formal review of structural brain MRI atlases. Most atlases were 
originally derived from the Talairach and Tournoux brain specimen atlas and 
consisted of mainly young adult subjects. All but one atlas was based on the mean of 
subject values, and there was no electronic atlas of the normal range of brain structure 
for any age. There were three atlases that spanned the adult lifecourse, e.g. ~18–90 
years, of which the largest had 40 subjects. There were no electronic atlases for 
focused, e.g. <5 year interval, age ranges in older subjects. 
 
1.5.3 Chapter 4 
Chapter 4 is a formal review of statistical models of normal brain volumes across the 
lifecourse. I found one previous statistical model of brain structure that attempted to 
define differences in the limits of brain structure between ages. These limits were 
based on the equally Gaussian assumption of mean-based (parametric) models. All 
other studies provided mean only estimates of brain structure changes through life. 
 
1.5.4 Chapter 5 
Chapter 5 describes the image processing methods I chose to employ and the 
assessments I conducted to inform these choices. I developed and validated image 
processing pipelines for infants, young to middle (25–60 year) adults, and aged (60–
90 year) adults. This included implementation and validation of a novel registration 
method, “nonlinear surface” registration to fully account for head size differences and 
maintain within brain variance of interest; and MR intensity normalisation for 
combining data from multiple scanners and acquisition parameters.  
 
1.5.5 Chapter 6 
Chapter 6 presents a novel statistical method for definition of the levels and limits of 
normal ageing whole brain volume changes. Mean differences across age, commonly 
computed in neuroimaging studies, did not well represent differences at the limits of 





1.5.6 Chapter 7 
Chapter 7 assesses the ability of the Gaussian distribution to adequately model 
volumes from regions across the brain. The limits of brain structure and effect sizes of 
age were often vastly different between parametric and nonparametric methods. The 
assumptions of parametric methods were not met in these data which suggests that 
nonparametric methods are required to adequately define the normal limits of regional 
brain volumes. 
 
1.5.7 Chapter 8 
Chapter 8 presents novel voxel–based statistics for quantifying brain structure 
changes in individuals and groups. I developed software to compute voxel–wise 
kurtosis, skewness, and parametric and nonparametric effect sizes. Voxel values were 
often not distributed as assumed by parametric tests. This meant that these tests often 
overestimated some and underestimated other differences between normal and AD 
subjects. Further, I developed voxel–based brain ranking that can be used to transform 
voxel–values so that they are more amenable to subsequent nonparametric testing. 
This may also be used in the future to support diagnoses of neurological disorders 
such as AD and schizophrenia. 
 
1.5.8 Chapter 9 
Chapter 9 describes the development and potential uses of the Brain Images of 
Normal Subjects (BRAINS) databank and atlases. The BRAINS bank is a unique 
collection of cross-sectional and longitudinal brain images from across the lifecourse 
with extensive demographic, medical, and cognitive data. The BRAINS atlases were 
developed using novel nonparametric methods and may be used to indicate pathology 
in groups and individuals with diseases such as Alzheimer’s. 
 
1.5.9 Chapter 10 
Chapter 10 summaries and discusses the main findings from this work. The 
limitations and potential future directions are also discussed.  
These conclusions were drawn from interpretation of my own findings in view of 
existing literature. This literature is reviewed in the following three chapters. 
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With large volumes of data, brain MRI databanks may facilitate a better 
understanding of the variation in the normal ageing brain (Meehl, 1978; Cohen, 1994; 
Mazziotta et al., 2001; Toga, 2002; Insel et al., 2004; Toga et al., 2006; Van Horn and 
Toga, 2009; Freedman, 2010). For example, results from statistical models may be 
stored and validated with analyses of further data. These databanks and models 
require image data in an array range of MR sequences, such as T1, T2, T2*, and 
FLAIR, so to effectively describe the range of brain features in normal ageing, e.g. 
atrophy and white matter lesions (Wardlaw et al., 2011).  
Brain MRI databanks should also address the issue of, “what is normal” 
(Mazziotta et al., 2009). Many older people (aged ≥60 years) without neurological 
disorder have clinical characteristics that may affect brain structure, e.g. hypertension, 
diabetes, and medication use (Jernigan et al., 2001; DeCarli et al., 2005; Grady et al., 
2006; Marcus et al., 2007c; Ellis et al., 2009; Farrell et al., 2009; Mazziotta et al., 
2009; Marcus et al., 2010). This suggests that these clinical characteristics should 
therefore be considered as part of “effects of normal ageing”. Subjects with them, if 
otherwise cognitively normal, should probably not be excluded from normal ageing 
brain image studies and databanks. Instead, it should be possible to say in which way 
subjects are normal, i.e. whether they are ageing “successfully” (without these clinical 
characteristics) or “usually” (with these characteristics) (Barkhof et al., 2011). The 
inclusion of subjects in brain MRI studies and databanks should therefore be 
supported by thorough cognitive and medical test results (metadata) (Mazziotta et al., 
2009). This is particularly true if these subjects are to be used as controls in studies of 
dementia and related disorders where cognitive state greatly influences diagnoses 
(Folstein et al., 1975; Morris, 1993). 
If brain MRI databanks meet these prerequisites then they have the potential to 
support better understanding of normal ageing brain structure and diagnoses of age-
                                                 
2 Some of the work described in this chapter was published as follows: 
Dickie, D.A., Job, D.E., Poole, I., Ahearn, T.S., Staff, R.T., Murray, A.D., Wardlaw, J.M. (2012). Do 
brain image databanks support understanding of normal ageing brain structure? A systematic review. 
Eur. Radiol. 22, 1385–1394. 
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related neurological disorders (Van Horn and Toga, 2009). A systematic review may 






The Preferred Reporting Items for Systematic Reviews and Meta–Analyses 
(PRISMA) statement (Moher et al., 2009a, b), a checklist for preparing clear and 
transparent accounts of systematic reviews (EQUATOR Network, 2011), was used to 
conduct the systematic review.  
Between October 2010 and October 2011, a literature search was performed 
using PubMed (http://www.ncbi.nlm.nih.gov/pubmed/) and the internet using Google 
(http://www.google.co.uk/) and Google Scholar (http://scholar.google.co.uk/) with the 
terms: “Magnetic Resonance Imaging” or “MRI” or “MR” and “brain” and 
“databank” or “database” or “data set” or “atlas” or “template” and “human”. The 
internet search ended after two consecutive result pages provided no reference to 
brain image databanks.  
The search was supplemented by consulting the Biomedical Informatics 
Research Network (BIRN; http://www.birncommunity.org/resources/data/), 
repositories of neuroimaging resources (http://neuinfo.org/; http://www.nitrc.org/) and 
reference lists in previous commentaries of brain image databanks (Mazziotta et al., 
2001; Toga, 2002; Toga et al., 2006; Van Horn and Toga, 2009).  
First, the abstracts and/or titles produced from the search were read to select 
publications potentially describing a human brain image databank. Databanks 
described in these selected publications were included for review if they: 1) provided 
publicly accessible and downloadable brain images, 2) included people aged 60 years 
and over, 3) described some or all of their subjects as “normal”, 4) stored structural 
brain images of individual subjects. But not if they stored only brain atlases or 
templates, i.e. averaged or combined brain images from multiple subjects, without the 
underlying individual subjects’ images. While the latter three criteria are self–
explanatory, public accessibility may lead to better understanding of normal brain 
ageing because it allows for the sharing of data and results derived from these data 
(Van Horn and Toga, 2009; Freedman, 2010). 
 23 
Where available, each databank was described by its: 1) purpose, 2) number of 
subjects, 3) number of “normal” subjects aged 60 years and over, 4) criteria for 
normality, 5) MR image sequences, 6) image (subject) retrieval parameters and 7) 
results from statistical analyses, e.g. the mean and variance of brain volumes by age, 
on the data contained. Missing values were estimated where possible; the bases for 
estimates are noted in the results tables. Finally, databanks were accessed first hand 
and/or their manuals and publications consulted to determine how data were accessed 
and searched. Tables summarising these results and individual descriptions of each 





2.3.1 Systematic search results 
The literature search produced 591 publications and a further 31 items were found 
through internet and supplementary searches. Seven records were duplicates therefore 
the search produced 615 individual records. These were screened to identify 144 that 
potentially described a databank of human brain images. Based on criteria given in the 
methods section, 135 of these were excluded (Figure 5).   
Particular records that did not meet inclusion criteria and the main reasons for 
exclusion, included: 
 the Cardiovascular Health Study (CHS) database: as data were only accessible 
to investigators associated with the CHS study (The Cardiovascular Health Study, 
2010) 
 the AddNeuroMed Study database: as data were not yet publicly accessible 
(Simmons et al., 2011; The AddNeuroMed Study, 2011) 
 the BrainSCAPE database: as it was offline at the time of this review 
(Neuroinformatics Research Group, 2011) 
 the Whole Brain Atlas (Johnson and Becker, 1999) and Neuroanatomical 
Database of Normal Japanese Brains (Sato et al., 2003a, b): as images were not 
downloadable 
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 the Allen Human Brain Atlas (Allen Institute for Brain Science, 2011), NIH 
MRI Study of Normal Brain Development database (Evans, 2006a, b), BrainWeb: 
Simulated MRI Volumes for Normal Brain Database (Cocosco et al., 1997; 
McConnell Brain Imaging Centre of the Montreal Neurological Institute, 2004), 
IMAGEN project (The IMAGEN Consortium, 2011), Morphometry BIRN 
database (Biomedical Informatics Research Network (BIRN), 2009), and Surface 
Management System Database (SumsDB) (Dickson et al., 2001; Van Essen Lab, 
2001): as they did not include subjects aged 60 years and over 
 the International Stroke Database (Sorensen and Wu, 2010), the 
Neuropsychiatric Imaging Research Laboratory (NIRL) Imaging Database 
(Neuropsychiatric Imaging Research Laboratory, 2009), 1000 Functional 
Connectomes Project/ International Neuroimaging Data–sharing Initiative (INDI) 
database (Milham et al., 2011), Function BIRN Data Repository (Biomedical 
Informatics Research Network (BIRN), 2011) and Brain Image Database 
(BRAID) (Letovsky et al., 1998; Department of Radiology University of 
Pennsylvania, 2008): as they did not describe any of their subjects as “normal” 
 the BrainMap database (Fox and Lancaster, 2002; Research Imaging Institute 
UTHSCSA, 2010), BRAINnet Database (BRAINnet Foundation, 2009), Brede 
Database (Technical University of Denmark Informatics, 2009), and Internet 
Brain Volume Database (IBVD) (The Center for Morphometric Analysis MGH 
HMS, 2002): as they did not contain structural brain images 
 and the Montreal Neurological Institute (MNI) 152 atlas (McConnell Brain 
Imaging Centre of the Montreal Neurological Institute, 2010): as it did not provide 









2.3.2 Included normal ageing brain structure MRI databanks 
This left nine MR brain image databanks and 944 subjects (mean 118, SD 74 subjects 
per databank) that apparently met the inclusion criteria (Table 2 and Table 3). 
Although all of these databanks reported to include “normal” subjects aged 60 years 
and over, five (ADNI, fMRIDC, OASIS cross–sectional, OASIS longitudinal and 
XNAT Central) included subjects fully representative of the normal ageing 
population, according to cognitive and medical test results. Further, information on 
the total number of normal subjects aged ≥60 years and the criteria for normality for 
all subjects was not accessible in the XNAT Central databank. Furthermore, there 
were many subjects in more than one databank (fMRIDC, OASIS longitudinal, 
OASIS cross–sectional, and XNAT Central databanks) (Marcus et al., 2007c; Marcus 




Table 2. “Normal” ageing brain structure MRI databanks 
1. The Alzheimer's Disease Neuroimaging Initiative (ADNI) databank (Mueller et 
al., 2005; Jack Jr et al., 2008; Toga, 2009; Petersen et al., 2010; Laboratory of 
Neuro Imaging, 2011a, b) 
2. Australian Imaging Biomarkers & Lifestyle Flagship Study of Ageing (AIBL) 
databank (Ellis et al., 2009; Toga, 2009; Ellis et al., 2010; Laboratory of Neuro 
Imaging, 2011b) 
3. Designed Database of MR Brain Images of Healthy Volunteers (Mortamet et al., 
2005; Bullitt et al., 2010) 
4. The fMRI Data Center (fMRIDC) (Van Horn et al., 2001, 2007) 
5. Information eXtraction from Images (IXI) dataset (Rowland et al., 2004; 
Biomedical Image Analysis Group Imperial College London, 2010; Hill et al., 
2010) 
6. International Consortium for Brain Mapping (ICBM) databank (Mazziotta et al., 
2001; Mazziotta et al., 2009; Toga, 2009; Laboratory of Neuro Imaging, 2011b) 
7. Open Access Structural Imaging Series (OASIS): Cross–sectional MRI Data in 
Young, Middle Aged, Nondemented, and Demented Older Adults (Marcus et al., 
2007c, b) 
8. OASIS: Longitudinal MRI Data in Nondemented and Demented Older Adults 
(Marcus et al., 2007b; Marcus et al., 2010)[23, 76] 




Therefore in total, according to closer inspection of available information, there were 
approximately 343 different individual, representative normal subjects aged ≥60 years 
(from the ADNI, fMRIDC and OASIS Cross–sectional databanks; Table 3). This is 
approximately one third of the apparent 944 subjects available on initial inspection. 
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Table 3. Description of “normal” ageing brain structure MRI databanks 
 
No. of “normal” subjects  Age range; mean, 
SD in yearsa 
Representative cognitive 
and medical test resultsb Accessibility 60–69  70–79   ≥80 years (Total) 
ADNI databank 0         166 63 (229) 60–90;   75.8, 5.0 Yes By application 
AIBL databank 85         69        23             (177)c       60–100; 70.0, 7.0 No By application 
Designed Databank of MR Brain 
Images of Healthy Volunteers 
14         1 0 (15) 60–72;   64.9, 3.1  No Open 
The fMRIDC .             . . (66)d 60–93;   75.6, 6.7e Yes By application 
IXI dataset 129       58        10             (197) 60–86;   68.1, 6.0 No Open 
ICBM databank 47         19        10             (76)f 60–90;   .,       . No By application 
OASIS Cross–sectional databank 25         35        38             (98)d 60–94;   75.9, 9.0 Yes Open 
OASIS Longitudinal databank 23 35 28 (86)d 60–93;   75.8, 8.2 Yes Open 
XNAT Central . . . (.)d 60–94g;  .,       . Yes Open/ by 
applicationh 
Note: .=missing value; aThis column shows the age range; mean, and standard deviation (SD) of “normal” subjects aged ≥60 years; bThis shows whether or not I found 
cognitive and medical test results, representative of the entire normal ageing population, in the databank/ criteria for normality; cEstimated from age frequency distribution 
graph (Ellis et al., 2009); dMany of these subjects were part of the fMRIDC, OASIS Cross–sectional, OASIS Longitudinal and XNAT Central databanks (Marcus et al., 
2007c; Marcus et al., 2010); eEstimated from ages and sample sizes in original studies (Head et al., 2005; Grady et al., 2006); fEstimated from exclusion by age group graph 










Of the 343 different individual, representative normal subjects, approximately 25 
were aged 60–69, 201 aged 70–79, and 101 aged ≥80 years (I did not find the age 
distribution of the different individual subjects in the fMRIDC, n=16). The mean age 
of the 343 different individual, representative normal subjects was 75.78, standard 
deviation (SD) 6.49 years.  
Many subjects were not accessible without application; only 98 different 
individual, representative normal older subjects were openly accessible. Databanks 
that were not openly accessible (Table 3) had reasonable application procedures. 
Applications required a description of the intended analysis and the investigators 
involved. This is not overly restrictive but anonymous review (similar to publication 
peer-review) was not adopted by any databank. 
The 98 openly accessible subjects represented approximately 10% of the 
apparent 944 subjects available on initial inspection. The mean age of the openly 
accessible subjects was 75.92, SD 8.99 years. Discounting whether representative 
metadata were available and subject overlap, the apparent 944 subjects available (in 
the seven databanks where age could be found or estimated) had a mean age of 72.31, 
SD 6.36 years. 
 
2.3.3 Image retrieval and acquisition parameters 
Table 4 shows the subject (image) retrieval parameters and Table 5 the image 
acquisition parameters in the nine eligible databanks. 
 Subjects were retrievable by measures of whole brain and regional structures 
in OASIS and XNAT. No databank supported subject retrieval by more subtle 
confounding factors, such as Fazekas rating or quantitative volume of white matter 
lesions. No databank supported random or stratified random, i.e. random within 
specified constraints such as age, subject retrieval. Finally, no databank stored results 
from statistical models of the data it contained. 
Detailed descriptions of each databank included in the review are in Appendix 



















ADNI 1 1 1 1 
AIBL 1 1 1 1 
Designed Database of 
MR Brain Images of 
Healthy Volunteers 
1 0 1 0 
The fMRIDC 0 0 0 0 
IXI dataset 1 0 1 0 
ICBM 1 1 1 1 
OASIS Cross–sectional 1 1 1 1 
OASIS Longitudinal 1 1 1 1 
XNAT Central 1 1 1 1 






















T1 T2 PD FLAIR T2* SWI Tesla T1 voxel size 
ADNI databank 58 1 1 1 0 0 0 1.5, 3 1×1×1.2 mm 
AIBL databank 2 1 1 1 1 0 0 3 1×1×1.2 mm 
Designed Databank of MR Brain  
Images of Healthy Volunteers 
1 1 1 0 0 0 0 3 1×1×1 mm 
The fMRIDC 2 1 0 0 0 0 0 1.5 . × . ×1.4 mm 
IXI dataset 3 1 1 1 0 0 0 1.5, 3 0.94×0.94×1.2 mm 
ICBM databank 8 1 1 1 0 0 0 1.5, 2, 3 1×1×1 mm 
OASIS Cross–sectional databank 1 1 0 0 0 0 0 1.5 1×1×1.25 and 1×1×1   mm 
OASIS Longitudinal databank 1 1 0 0 0 0 0 1.5 1×1×1.25 and 1×1×1   mm 
XNAT Central 1 1 0 0 0 0 0 1.5 1×1×1.25 and 1×1×1   mm 
Note: these parameters are for normal ageing subjects that I could access; No.=number; PD=Proton Density; FLAIR=Fluid Attenuated Inversion Recovery;  





A systemic review found 9 databanks with structural MR brain images of “normal” 
older people (aged ≥60 years). Amongst these databanks there appeared to be 944 
normal subjects aged 60 years and over. However, many subjects were in more than 
one databank or did not have metadata (cognitive and medical test results) 
representative of the entire normal ageing population. When adjusting for these 
subjects, there were approximately 25 normal subjects aged 60–69, 201 aged 70–79, 
and 101 aged ≥80 years (I did not find the age distribution of the different individual 
subjects in the fMRIDC, n=16). In all, brain MRI from only 98 normal subjects ≥60 
years were openly accessible worldwide.  
There is high variation in structure of the normal ageing brain (Manolio et al., 
1994; Resnick et al., 2003; Farrell et al., 2009) and inconsistency of causal inferences 
between studies (Good et al., 2001; Sowell et al., 2003; Fotenos et al., 2005; 
Salthouse, 2011). These studies had upwards of 400 subjects and their inconsistencies 
would suggest that 343 subjects (most of which some investigators may not be able to 
access) may be too few to effectively characterise normal brain structure within and 
between older age ranges. 
The criteria for normality in many of these databanks may not have fully 
represented the clinical characteristics of normal ageing. For example, the Designed 
Database of MR Brain Images of Healthy Volunteers and ICBM criteria for normality 
were the same across the lifespan (Mazziotta et al., 2009; Bullitt et al., 2010). These 
criteria excluded the increasing proportion of prescription medications and 
hypertension in cognitively normal old age. When a population has a mean of 
approximately three prescriptions and ~50% have medically diagnosed hypertension 
(DeCarli et al., 2005; Marcus et al., 2007c; Ellis et al., 2009; Farrell et al., 2009; 
Mazziotta et al., 2009; Marcus et al., 2010), it would be reasonable to conclude that 
subjects with these characteristics are at least equally “normal” to subjects without. It 
is arguable then that both could be included in normal ageing brain image databanks. 
The entire normal ageing population that includes “successful” and “usual” ageing 
individuals would then be represented (Barkhof et al., 2011). This is particularly 
important when considering that these subjects may be used as controls for study 




Brain MRI databanks with representative normal older subjects have led to many 
publications: over 200 publications from the ADNI databank and the OASIS cross–
sectional databank has been cited over 100 times (ADNI, 2011; Google Scholar, 
2011). These databanks provided a limited range of image sequences (Jack Jr et al., 
2008); the openly accessible images from representative normal older subjects were 
only T1–weighted (Marcus et al., 2007c). To support better understanding of normal 
ageing brain structure, databanks should include, for example, T2* and FLAIR 
images as well as the commonly used T1 and T2 images (Marcus et al., 2007c; Jack Jr 
et al., 2008; Wardlaw et al., 2011). These extra image sequences will allow for 
reliable identification of common brain ageing features, e.g. white matter lesions 
(Wardlaw et al., 2011). 
Almost all databanks supported image (subject) retrieval by clinico–
demographic and scanning acquisition parameters. Few (LONI IDA, OASIS, and 
XNAT Central) supported subject retrieval directly by medical and cognitive test 
results and parameters derived from image analyses e.g. brain volumes. In particular, I 
did not find any databank to support subject retrieval by white matter changes that, if 
prevalent in a normal ageing control group, could skew cognitive measures (Breteler 
et al., 1994). It may then be difficult to match or differentiate databank subjects (to 
study groups) on potentially confounding variables, e.g. cognitive scores, head size, 
blood pressure. Moreover, no databank supported random subject retrieval and so 
manual selection bias errors may occur in studies that use these databank subjects as 
controls.  
Databanks that store results from statistical models of normal brain images and 
metadata may facilitate better understanding of normal ageing brain structure (Meehl, 
1978; Cohen, 1994; Farrell et al., 2009; Van Horn and Toga, 2009; Freedman, 2010). 
For example, results from statistical models can be stored, tested, and validated with 
analyses of further data. The storage of statistical models is required due to the 
unreliability of causal inferences from single studies (Meehl, 1978; Cohen, 1994; 
Freedman, 2010). This is particularly true in brain imaging, given the inconsistencies 
in reports of normal ageing brain atrophy progression and cognition (Good et al., 
2001; Sowell et al., 2003; Fotenos et al., 2005; Salthouse, 2011). Despite their need, I 
found no databank that had results from statistical models.  
Although not yet included, the ICBM databank plans to include probabilistic 
atlases of the variation of normal brain structures from 7000 subjects throughout the 
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adult lifespan (Mazziotta et al., 2001). According to a more recent progress report of 
this work (Mazziotta et al., 2009), the number of subjects aged ≥60 years will be 
limited. From subject proportions in the progress report, I estimated 581 older 
subjects, if the 7000 subject target is reached. The Internet Brain Volume Database 
(IBVD) (The Center for Morphometric Analysis MGH HMS, 2002), excluded from 
my review as it did not contain structural brain images, contained brain volume 
measurements from different studies. These studies had different normality criteria 
and other parameters so may not effectively describe normal ageing brain structure 
variation.  
This shows that there is a current lack of easily accessible, and reliable statistical 
models and atlases of the normal ageing brain, e.g. distributions of normal ageing 
brain volumes. These methods may support better understanding of normal ageing 
brain structure and diagnoses/ treatment of dementia (Meehl, 1978; Cohen, 1994; 
Selkoe, 2001; Farrell et al., 2009; Freedman, 2010). For example, dementia may be 
predicted and treatments dosed according to patient positions in the distribution of 
normal ageing brain volumes. 
To have such a great effect, these models and atlases should be openly available 
to others (Van Horn and Toga, 2009).  I conducted a formal review to determine what 
brain image atlases were openly available. 
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The basic concept of brain atlases is to create image-based models of the brain and 
quantify relationships between these models and a large number of variables of 
interest, e.g. skull structures, age, functional response. Large amounts of data now 
storable in brain MRI banks mean that, although even in relatively modern times they 
were derived from one or few subjects (Talairach and Tournoux, 1988; Ono et al., 
1990; Duvernoy, 1999), brain atlases may now be derived computationally from many 
subjects (Evans et al., 1993). While these computational methods have significantly 
advanced in the last fifteen years, the brain atlas concept has been around for several 
hundred years (Broca and Brabrook, 1881; Anderson and Makins, 1889; Brodmann, 
1994; O'Connor, 2003; Toga et al., 2006).  
Modern (MRI) brain atlases3 not only allow the mapping of various structures 
and quantification of relationships but also provide a standard framework, known as 
“stereotactic space”, in which to compare subjects at the voxel level (Talairach and 
Tournoux, 1988; Evans et al., 1993; Evans et al., 2012). Standard stereotactic space is 
basically a set of 3D axes (X, Y, and Z) that, at the very least, allow brain MRI to be 
overlaid at their centres. The development of a standard space was required to 
sensibly compare subject voxels because head size, position, and angle vary 
dramatically between brain MRI subjects. In general, these variables are not known to 
be a direct consequence of age (after full development) or disease (Courchesne et al., 
2000; Good et al., 2001; Ge et al., 2002; Buckner et al., 2004; Kruggel, 2006) and so 
must be controlled for in subsequent analyses. For example, without controlling for 
these it would be difficult to determine if reduced grey matter volume was due to age 
and/or disease or simply due to a person being smaller. 
One of the first stereotactic atlases was developed by Talairach and Tournoux 
in 1988. This was derived from the brain in a 60 year old female cadaver. One 
                                                 
3Note that “MRI brain atlases” are sometimes distinguished from “MRI brain templates” in the 
literature. That is, where a “template” may consist of brain structure derived from one or many 
individuals in a standard framework; an atlas, while still consisting of brain structure derived from one 
or many individuals in a standard framework, also consists of labels that have been added to specific 
regions to identify them as, for example, hippocampal grey matter or lateral ventricle cerebrospinal 
fluid. However, others do not make this distinction between the terms and use them interchangeably. In 
this work we too use these terms interchangeably, generally preferring the term “atlas”. 
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hemisphere of the brain was sectioned in the sagittal plane and the other in the coronal 
plane and from these the axial images were derived, ignoring hemispheric asymmetry 
(Talairach and Tournoux, 1988; Evans et al., 2012). These images were digitised to 
generate the electronic, “Talairach space”. Although initially used as a standard 
framework in which to register brain MRI, several limitations of Talairach space were 
apparent. Ignored in the Talairach space, brains normally exhibit hemispheric 
asymmetry and as it was only based on one subject, the Talairach brain did not 
represent the great variance in brain structure among individuals. These limitations 
are clear, have been discussed extensively (Mazziotta et al., 2001), and have been well 
known since the atlases’ inception (Evans et al., 1993). Indeed, they were noted in the 
original author’s foreword, “this method is valid with precision only for the brain 
under consideration” (Talairach and Tournoux, 1988).  
Given the limitations inherent in single subject atlases, the MNI created an 
atlas from 305 brain MRI subjects in the early 1990s (Evans et al., 1993). These 305 
subjects were initially registered to the Talairach space by aligning their manually 
identified anterior–posterior commissure (AC–PC) line to the Talairach AC–PC line 
and adjusting the extent of their XYZ axes to the extent of the Talairach XYZ axes 
(Figure 6). The average voxel–wise MRI intensity of the subjects was then derived in 
Talairach space to create “initial MNI space”. The subjects were then all re–registered 
to initial MNI space and a final average was taken to create “final MNI space”, or just 
“MNI space” as it is known in the literature. 
The MNI305 atlas circumvented the single subject bias inherent in the 
Talairach atlas and, through its apparent loss of resolution (it was rather blurry in 
some regions), somewhat reflected the variance in brain structure between a large 
number of subjects (Evans et al., 1993). However, it did not actually define any 
measures of voxel variance, e.g. SD or interquartile range (IQR), therefore reflected 
the central tendency but not the range of normal brain structure. Further, the lack of 
complete agreement between the shape of each of the 305 subjects and the shape of 
the Talairach brain (bottom panel in Figure 6) led to the MNI atlas being markedly 
larger than the brain of an average person (although this is potentially no worse than 
perfectly matching the size of the Talairach brain which was smaller than average). 
Furthermore, while not based on the symmetrical sulci pattern of Talairach, the MNI 
atlas was derived in the same general (symmetrical) space therefore could lead to bias 
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towards symmetrical hemispheric width – something that does not often occur 




Figure 6. Schematic of "9pt" registration from a subjects’ 
native space (brain size and position) into the size and position 
of the Talairach brain 
This method was used to derive the first generation MNI atlas, 
“MNI305”. “9pt” refers to the overlay, alignment, and 




Despite these potential issues, it was apparent from a brief review that the MNI atlas 
(also referred to as the International Consortium for Brain Mapping (ICBM) atlas) 
was one of only a few atlases in wide use (Ashburner and Friston, 2000; Good et al., 
2001; Mazziotta et al., 2001; Evans et al., 2012). Although later generations of the 
MNI atlas were released, e.g. MNI152, these were all derived from mainly young 
adult subjects. Brain structure in old age is different to brain structure in younger and 
middle–aged adults (Gur et al., 1991; Courchesne et al., 2000; Good et al., 2001; 
Sowell et al., 2003). For example, the lateral ventricles and sulci spaces are generally 
larger in subjects over 60 years (Lemaitre et al., 2005). Because of these differences in 
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brain structure the use of an atlas based on only younger subjects can create a bias in 
lifecourse studies, e.g. systematic overexpansion of older brains (Buckner et al., 
2004). An atlas based on only aged subjects would be appropriate for a study 
involving only aged subjects but if implementing two atlases (one for younger 
subjects and another for older subjects) in a lifecourse study, differences between ages 
could be attributed to differences between the atlases. 
There is therefore a need for a range of brain atlases for different age ranges 





I conducted a brain MRI atlas search concurrently with the systematic review of brain 
MRI databanks (chapter 2). However, the atlas review described in this chapter was 
not systematic and did not follow PRISMA guidelines due to a lack of time. 
Between October 2010 and October 2011 I searched PubMed 
(http://www.ncbi.nlm.nih.gov/pubmed/) and the internet using Google 
(http://www.google.co.uk/) and Google Scholar (http://scholar.google.co.uk/) with the 
terms: “Magnetic Resonance Imaging” or “MRI” or “MR” and “brain” and “atlas” or 
“template” and “human”. As noted in the introduction to this chapter and section 
1.1.4, the term “atlas” is sometimes distinguished from the term “template” in the 
literature. That is, where a “template” may consist of brain structure derived from one 
or many individuals in a standard framework; an atlas, while still consisting of brain 
structure derived from one or many individuals in a standard framework, also consists 
of labels that have been added to specific regions to identify them as, for example, 
hippocampal grey matter or lateral ventricle cerebrospinal fluid. However, others do 
not make this distinction between the terms and use them interchangeably. Not to 
exclude records simply due to personal nomenclature preference, I searched for both 
“atlases” and “templates” (and use these terms interchangeably, preferring the term, 
“atlas”). 
I supplemented this search until August 2013 by periodically searching 
Google with a subset of these terms and by reviewing content alerts distributed by 
relevant journal articles, e.g. NeuroImage (http://www.journals.elsevier.com/ 
neuroimage/) and Human Brain Mapping (http://onlinelibrary.wiley.com/journal/ 
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10.1002/(ISSN)1097–0193). I also reviewed the references in previous brain atlas 
commentaries (e.g. Mazziotta et al., 2001; Toga et al., 2006; Evans et al., 2012). 
I did not have a systematic exclusion process in this review, rather, I only excluded 
atlases that were apparently not publicly available, e.g. the elderly and demented sub–
volume probabilistic brain atlas (that consisted of 20 subjects; Mega et al., 2005), 
animal brain atlases, functional brain MRI image atlases, and those that did not have 
adult (>18 year old) subjects (I did not maintain a record of all the atlases I excluded). 
The next section therefore describes all structural brain MRI atlases that I found to be 





3.3.1 Structural brain MRI atlases 
The 31 structural brain MRI atlases that I found to be publicly available and include 
adult subjects are listed in Table 6. These atlases are described in more detail in 
section 3.3.3; the subjects used to create each of them are described in Table 7. 
 
3.3.2 Subjects in structural brain MRI atlases 
The subjects used to create each of the structural brain MRI atlases are described in 
Table 7. The “Digital Anatomist: Interactive Brain Atlas” and “Whole Brain Atlas” 
are not listed because they did not provide individual subject information (Sundsten, 
1994; Johnson and Becker, 1999). The 30 atlases (including the two parts of “Normal 
reference MR images for the brain” separately) that provided individual subject 
information had between 1 and 662 subjects (median 27, IQR 44.5). With the 
exception of the “Alzheimer’s Disease Template”, “Normal reference MR images for 
the brain”, “Brain atlas for healthy elderly”, “Symmetric atlas in normal older adults” 
and “Clinical toolbox”, most atlases were derived from mainly young to middle aged 
adults. Three atlases spanned the majority of adult life (18–90 years), both 
“FreeSurfer” atlases and the “SRI24” atlas, of which the largest had 40 subjects. 
There were three atlases for focused age ranges, both “Normal reference MR images 




Table 6. Structural brain MRI atlases 
1. Allen Human Brain Atlas (Allen Institute for Brain Science, 2011) 
2. Alzheimer's Disease Template (Thompson et al., 2000; Thompson et al., 2001) 
3. Brain atlas for healthy elderly (Lemaitre et al., 2005) 
4. Chinese_56 (Tang et al., 2010) 
5. Clinical toolbox (Rorden et al., 2012) 
6. Digital Anatomist: Interactive Brain Atlas (Sundsten, 1994) 
7. FreeSurfer ‘Desikan–Killiany’ cortical atlas (Desikan et al., 2006; Schmansky, 2010) 
8. FreeSurfer ‘Destrieux’ cortical atlas (Fischl et al., 2002; Fischl et al., 2004; Schmansky, 
2010) 
9. Harvard brain atlas (Shenton et al., 1995) 
10. Harvard–Oxford cortical and subcortical structural atlases (FMRIB, 2008) 
11. MNI/ ICBM 152 (Mazziotta et al., 2001) 
12. MNI/ ICBM 452 (Mazziotta et al., 2001) 
13. JHU ICBM–DTI–81 white–matter labels atlas (Mori et al., 2005; FMRIB, 2008) 
14. JHU white–matter tractography atlas (FMRIB, 2008; Hua et al., 2008) 
15. Jülich histological atlas(Eickhoff et al., 2005; FMRIB, 2008) 
16. LPBA40 (Shattuck et al., 2008) 
17. MNI single–subject brain (“colin27”)(Collins et al., 1998; Holmes et al., 1998)  
18. MNI structural atlas (Collins et al., 1995; Mazziotta et al., 2001; FMRIB, 2008) 
19. MNI305 (Evans et al., 1993) 
20. Normal reference MR images for the brain (Farrell et al., 2009) 
21. Oxford thalamic connectivity atlas (Johansen-Berg et al., 2005; FMRIB, 2008) 
22. Population–average, landmark–and surface–based (PALS) atlas (Van Essen, 2005) 
23. Parcellated MNI single–subject brain (Tzourio-Mazoyer et al., 2002) 
24. SRI24 (Rohlfing et al., 2010) 
25. Symmetric atlas in normal older adults (Grabner et al., 2006; Zamboni et al., 2013) 
26. Talairach Daemon (Lancaster et al., 1997; Lancaster et al., 2000) 
27. Talairach and Tournoux (Talairach and Tournoux, 1988; Brett et al., 2001; Brett et al., 
2002) 
28. The Cerefy clinical brain atlas (Nowinski and Belov, 2003) 
29. The Whole Brain Atlas (Johnson and Becker, 1999) 
30. Washington University 711 target atlases (Buckner et al., 2004) 
31. WFU_PickAtlas (Maldjian et al., 2003; Maldjian et al., 2010) 
Note: ICBM=International Consortium for Brain Mapping; JHU=Johns Hopkins University; DTI=Diffusion 
tensor imaging; LPBA= LONI Probabilistic Brain Atlas; MNI=Montreal Neurological Institute; SRI=Stanford 
Research Institute; WFU=Wake Forest University. 
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Table 7. Subjects used to create structural brain MRI atlases 
Atlas Age in years1 n Gender2 
Allen Human Brain Atlas 24–57; 43,   12P 2 F,   6 M       (8) 
Alzheimer's Disease TemplateT .–.;       75,   2 14 F, 12 M     (26) 
Brain atlas for healthy elderlyT 63–75; 70,   3 331 F 331 M  (662) 
Chinese_56T 21–29; 24,   2 0 F,    56 M    (56) 
Clinical toolboxT .–.;       73,   8 32 F,  18 M    (50) 
FreeSurfer ‘Desikan–Killiany’ cortical atlas 19–86; 56,   . 26 F,  14 M    (40) 
FreeSurfer ‘Destrieux’ cortical atlas 23–68; .,      . . F,     . M       (12)  
Harvard brain atlas 25 0 F,    1 M      (1) 
Harvard–Oxford cortical and subcortical 
structural 
18–50; .,      . 16 F,  21 M    (37) 
MNI/ ICBM 152T 18–44; 24*, 7 66 F,  86 M    (152) 
MNI/ ICBM 452T “young adults” . F,     . M       (452) 
JHU ICBM–DTI–81 white–matter labels 
atlas 
18–59; 39,   . 39 F,  42 M    (81) 
JHU white–matter tractography atlas .–.;       29,   8 11 F,  17 M    (28) 
Jülich histological atlas “post–mortem brains” . F,      . M      (10) 
LPBA40T 19–39; 29,   6 20 F,   20 M   (40) 
MNI single–subject brain (“colin27”) T ~35 0 F,     1 M     (1) 
MNI structural atlasT .–.;       29,   3 . F,      . M      (>50) 
MNI305T .–.;       23,   4 66 F,   239 M (305) 
Normal reference MR images for the 
brainI/II 
65–70; 67,   . 0 F,     54 M   (54) 
 75–80; 77,   . 7 M,   18 F     (25) 
Oxford thalamic connectivity atlas .–.;       35,   11 4 F,     7 M     (11) 
PALS 18–24; .,       . 6 F,     6 M     (12) 
Parcellated MNI single–subject brainT ~35 0 F,     1 M     (1) 
SRI24 19–84; 52,    5 12 F,   12 M   (24) 
Symmetric atlas in normal older adultsT .–.;       75,    6 . F,      . M      (153) 
Talairach DaemonT 60 1 F,    0 M      (1) 
Talairach and Tournoux 60 1 F,    0 M      (1) 
The Cerefy clinical brain atlasT 60 1 F,    0 M      (1) 
Washington University 711 target atlasesT .–.;       49,    . 15 F,  9 M      (24) 
WFU_PickAtlasT/MNI 18–44; 24*,  7 66 F, 86 M     (153) 
Note: 1age is displayed “range; central tendency (median/ mean), variance (standard deviation/ interquartile range)” when I was 
able to obtain it (and when there was more than one subject); 2number of females, number of males (total); P=postmortem; 
T=descended from the Talairach and Tournoux atlas; .=I was unable to obtain this information; *=Median; #Subjects may have been 
schizophrenic or normal, authors “were blind to diagnosis” (Fischl et al., 2004); I/II=this consisted of two separate atlases one for 
each of the age groups shown; T/MNI=this atlas had two versions, one in Talairach space and the other in MNI space.
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The methods used to construct these atlases and their potential uses (according to and 
if given by the authors) are described in the following sections.  
 
3.3.3 Methods and uses of structural brain MRI atlases 
The technical methods used in development of the atlases I found are described in the 
following sections. Many atlases are first based on registration of subjects into a 
common space. Registration, or “spatial normalisation”, is the process of overlaying 
subjects on top of one another. It may also involve altering their brain size and shape. 
There are two main types of registration: linear and nonlinear. Linear registration 
aligns the axes of individual brains and nonlinear registration attempts to match voxel 
values between brains. Linear registration has between 3 and 12 parameters: 3 and 6 
parameter registrations align the axes of brains and 7, 9, and 12 parameter 
registrations alter the axis dimensions (where the higher the number of parameters 
produces higher alterations compared to the original brain structure). Registration is 
discussed further in chapter 5 and the following sections describe the registration 
method (if any) used in the development of each atlas I found. 
 
3.3.3.1 ALLEN Human Brain Atlas 
Post–mortem scans were obtained from eight subjects with no brain disorder, cancer, 
infectious disease, or substance dependency related death. Brain images were 
manually labelled in their native space (i.e., substructures such as the hippocampus 
were delineated). Each subject contributed at least two acquisition sequences, T1 and 
T2, four subjects also had DTI, to provide 20 separate, structurally labelled, atlas 
images. 
 
3.3.3.2 Alzheimer's Disease Template 
All 26 subjects were initially registered into Talairach space before being re–
registered to the sample average MRI intensity image by continuum–mechanical 







3.3.3.3 Brain atlas for healthy elderly 
One–hundred and twenty of the 662 subjects were randomly selected and nonlinearly 
registered to the MNI152 template. The average tissue proportion in each voxel was 
then computed from these 120 subjects (in the MNI152 template space). All subjects 
were then nonlinearly registered to this newly created average of 120 subjects, 
referred to as the “Epidemiology of Vascular Aging” (EVA) prior space. The final 
atlas (consisting of four components) was created by averaging the smoothed T1 
intensity, GM, WM, and CSF proportion images of all 662 subjects in the EVA prior 




A randomly selected image from the sample was used as the space to which all 
remaining 55 subjects were registered via a 12 parameter linear registration. An 
intensity average image was then derived before all images were realigned to this 
average by a 6 parameter linear registration. Another average image was then derived 
as the linear atlas. A nonlinear atlas was also created by nonlinearly registering 
individual images to the linear atlas and subsequently deriving the average of these 
voxel intensities. 
 
3.3.3.5 Clinical toolbox 
The clinical toolbox contained a CT and MRI brain atlas from 50 subjects. The MRI 
images were manually trimmed to remove excess signal from the neck and around the 
head and then linearly registered with the position and angle of MNI space. In this 
space, grey matter, white matter, and cerebrospinal fluid were segmented from each 
individual and an average atlas of each tissue was created with Diffeomorphic 
Anatomical Registration using Exponentiated Lie algebra (DARTEL – a function 
included in Statistical Parametric Mapping; Ashburner, 2007; Ashburner and Friston, 
2009). These atlases and the original T1 images were then registered into MNI space 
with SPM’s linear registration. Finally, to make the atlases symmetrical, the 
hemispheres within each atlas were averaged. The clinical toolbox was intended to 




3.3.3.6 Digital Anatomist: Interactive Brain Atlas 
This atlas appeared to be an online teaching tool that consisted of several parts: (1) a 
cadaver brain surface; (2) cadaver brain dissections; (3, 4) cadaver brain axial and 
coronal slices; (5, 6, 7) brain MRI axial, coronal, and sagittal slices; (8, 9) cadaver 
brainstem and sections; (10) cadaver spinal cord slices; (11) sectioned blood vessels; 
and (12–16) a series of 2D and 3D animations. 
 
3.3.3.7 FreeSurfer ‘Desikan–Killiany’ cortical atlas 
Thirty–four gyral based structures were manually delineated in 40 subjects and 
integrated using the FreeSurfer ‘Destrieux’ cortical atlas method described below. 
Like the ‘Destrieux’ atlas, the ‘Desikan–Killiany’ atlas was proposed for automatic 
labelling of brain structures in new subjects. 
 
3.3.3.8 FreeSurfer ‘Destrieux’ cortical atlas 
Two images for each of the 12 subjects were averaged and manually segmented to 
label each voxel as belonging to one of 85 brain structures. Individual cortical 
surfaces were then reconstructed and combined into a spherical cortical atlas by 
landmark driven registration (manually determined points in the brain were matched 
between subjects rather than axis or voxels). This provided an image with 
probabilities of all anatomical labels at every point in the cortex given constraints of 
anatomical arrangement, e.g. the amygdala generally resides anterior and superior to 
the hippocampus but never inferiorly.  
This atlas parcellates new images by assigning the highest probability label to 
individual voxels based on their coordinate in the atlas space and the labelling of 6 
neighbouring voxels in all of the cardinal directions. The algorithm is iterated to 
maximise the label probability at each voxel and ends when no voxel probabilities 
change through an iteration. Finally, voxels are transferred from the spherical atlas 
space back to their native space with the label they received in spherical atlas space. 
 
3.3.3.9 Harvard brain atlas 
The single subject used in this atlas was selected from 15 others due to it showing the 
best tissue contrast and least artefact. The image was segmented into different tissue 
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classes and ROI (i.e., substructures such as the hippocampus) were drawn. Volumes 
and surface models were computed for each structure. 
 
3.3.3.10 Harvard–Oxford cortical and subcortical structural atlases 
Using locally sourced semi–automatic tools, each of the 37 subjects were individually 
segmented into 48 cortical and 21 subcortical structures. All images were then linear 
registered to MNI152 space before the transforms were applied to the individual 
labels. Finally, all images were overlaid in this space to form probability maps for 
each structure. 
 
3.3.3.11 MNI/ ICBM152 
All 152 subject images were individually registered to the MNI305 template using a 9 
parameter linear transformation. The average intensity image of these 152 subjects 
was then derived in MNI305 space so to create MNI152 space. 
 
3.3.3.12 MNI/ ICBM452 
The 452 subject images were individually registered to the MNI305 template using a 
12 parameter linear registration. An average image was then derived from the images 
in this space to create the linear atlas. To create a nonlinear atlas, the 452 subjects 
were individually registered to the MNI305 template using a 5 order polynomial 
nonlinear registration. The voxel–wise average of these nonlinearly registered images 
was then derived. 
 
3.3.3.13 JHU ICBM–DTI–81 white–matter labels atlas 
The 81 subjects used to create this atlas were provided by the ICBM DTI workgroup 
and each subject was hand segmented into 50 white matter tract labels. The result was 
an ICBM space average of diffusion MRI tensor maps from 81 subjects. 
 
3.3.3.14 JHU white–matter tractography atlas 
Eleven white matter structures were probabilistically defined by overlaying the fibre 




3.3.3.15 Jülich histological (cyto– and myelo–architectonic) atlas 
The histological volumes of these 10 brains were digitally reconstructed and spatially 
normalised to the MNI single subject atlas to create a probabilistic map of 52 grey 




Each of the 40 subjects were first aligned to the MNI305 atlas by a 6 parameter 
registration that accounted for head tilt and alignment. Fifty–six ROI structures were 
then manually delineated in each of the images before three versions of the atlas were 
created by registering the delineated brains to three different targets. LPBA40/AIR 
was created by nonlinear registration and intensity averaging in the ICBM452 space; 
LPBA40/FLIRT by linear registration and intensity averaging in the skull–stripped 
ICBM152 space; and LPBA40/SPM5 by nonlinear registration and intensity 
averaging in the whole head ICBM152 space.  
Every voxel, within each atlas version, was assigned a probability for 
belonging to each of the delineated structures. Maximum probabilities from every 
voxel generated three maximum likelihood segmented atlases. Tissue maps were 
generated by automatically segmenting GM, WM, and CSF in each subject’s native 
space before registering each image to atlas space. Voxels in each tissue atlas were 
displayed in a gradient according to the probability that they belonged to the 
corresponding tissue. A maximum probability map of GM was created by calculating 
voxels that most frequently (among all subjects) belonged to GM. ROI probability 
maps were created by calculating the maximum probability label in each voxel. 
 
3.3.3.17 MNI single–subject brain (“colin27”) 
A single subject was scanned 27 times with each image linearly registered to MNI305 
space before an average intensity image was derived. 
 
3.3.3.18 MNI structural atlas 
A single subject image was hand segmented into 9 anatomical structural regions 
before the labels were propagated to more than 50 subject images using nonlinear 
registration. Each resulting labelled brain was then transformed into MNI152 space 
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using linear registration. Finally, all segmented images were overlaid in this space to 
produce the final probabilistic atlas. 
 
3.3.3.19 MNI305 
Each of the 305 subjects were oriented to Talairach space by manually identifying 
their AC–PC line and overlaying it with the Talairach AC–PC line. The extent of each 
subject’s brain was then scaled to the extent of the Talairach brain in the XYZ axes. 
The oriented subjects were then averaged before being individually reoriented and 
scaled to this average. A final average was then derived. 
 
3.3.3.20 Normal reference MR images for the brain 
A radiologist rated all subjects individually by ventricular and cortical atrophy to 
designate five subjects as quartile ranks in each sample (n=54, 65-70 years; n=25, 75-
80 years). This inferred the distribution of atrophy within the two subject samples. 
This distributional atlas consists of 4 axial image slices per quartile for each subject 
group and was printable from: http://www.sbirc.ed.ac.uk/documents/ageing-brain-
template.pdf. 
 
3.3.3.21 Oxford thalamic connectivity atlas 
Using probabilistic diffusion tractography, the probability of anatomical connection 
between points in the thalamus and seven cortical zones was defined in each subject. 
Atlas probabilities were derived from a combination of all 11 subjects. 
 
3.3.3.22 PALS 
All 12 subjects were first registered to the Washington University 711–2C atlas 
(section 3.3.3.30) by a 12 parameter linear registration and averaged to create the atlas 
volume. The fiducial surface of each hemisphere from individual images was then 
registered to the atlas volume by landmark constrained registration. The average 







3.3.3.23 Parcellated MNI single–subject brain 
Global sulcal topography was delineated in the MNI single–subject brain before 31 
sulci was identified. These sulci was used to delineate 45 volumes of interest. Voxels 
were then labelled by the volume in which they resided. Points of functional 
activation in new subjects, registered to this map, may be attributed to the volume in 
which they reside, to the volume which they are nearest to, or to volumes in which a 
10 mm radius around the point of activation encompasses. 
 
3.3.3.24 SRI24 
The anatomical and diffusion MR images for all 24 subjects were first brought into 
alignment. Subjects were then all registered to an empty grid of pixels, with the same 
characteristics as the T1 images, by non–linear registration to the group wise 
configuration in this space. Tissue maps were created by extracting tissue volumes 
separately from individual images before averaging them in the atlas space. A 
consolidated tissue map was created by overlaying all tissue segmented images into 
the atlas space and labelling voxels as per the tissue that fell most frequently within 
them. In the native space of subjects diffusion tensor fields were reconstructed before 
they were reformatted into the atlas space by a cubic interpolation kernel and 
averaged. Finally, two cortical parcellation maps were constructed by transferring 
anatomical labels, manually delineated elsewhere (Tzourio-Mazoyer et al., 2002; 
Shattuck et al., 2008), to the atlas space. The manually delineated images were 
individually registered to SRI24 space before being combined by label fusion to 
create the final parcellation maps. 
 
3.3.3.25 Symmetric atlas in normal older adults 
Each of the 153 subjects were initially linear registered to the MNI152 symmetric 
atlas. The left and right hemispheres of each subject were averaged to make each 
subject symmetrical. All symmetric subjects were then averaged in this space. Each 
subject was then re–registered to this new average, again with linear registration, and 
another average was derived. This process was then repeated 9 times but with 
nonlinear registration before a final highly symmetrical average was derived. This 
atlas was designed to automatically extract subcortical structures and allow left–right 
comparison of the volumes of these structures without bias or subjective error. 
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3.3.3.26 Talairach Daemon 
The (single subject) Talairach atlas was digitised into a lookup table; each voxel 
(coordinate) was assigned a tissue type and Brodmann area. 
 
3.3.3.27 Talairach and Tournoux 
One hemisphere of a cadaver brain was sliced in the sagittal plane and the other 
hemisphere was sliced in the coronal plane to create symmetrical drawings of the 
axial sections. The brain was orientated so that a line between the AC and PC was 
horizontal. When new brains are registered to Talairach space their AC–PC line is 
oriented to the Talairach AC–PC line. The AC is the centre of the Talairach 
coordinate system where 3 dimensional (XYZ) axes begin. The extent of the Talairach 
brain on each of these axes provides the dimensions to which new brains are scaled 
when registered to Talairach space. 
 
3.3.3.28 The Cerefy clinical brain atlas 
The Talairach atlas was digitised; cortical and subcortical structures were segmented 
and labelled. 
 
3.3.3.29 The Whole Brain Atlas 
Images from various clinical and normal cases were collected and brain structures 
annotated. Although there were a large number of annotated images, I was unable to 
obtain further provenance of the images. 
 
3.3.3.30 Washington University 711 target atlases 
Four images from each of the 24 subjects were aligned and averaged to create a 
single, high signal-to-noise ratio (SNR) image for each subject. Minimum mismatch 
averages were then separately derived for each age group by first registering images 
to Talairach space and then generating a new target space by the average of the 
registered images. Images were then re-registered to the new target space and an 
updated target space created by further averaging. Five iterations of this process were 
completed in each group before all of the fifth iteration averages (the averages from 




Using the Talairach Daemon, voxels (coordinates) in Talairach and MNI space were 
filled with Brodmann, lobular, hemispheric, anatomic, and tissue type labels. Once 
registered to either space voxels of subject images are labelled corresponding to the 
label in the coordinate at which they lie. As suggested by the information held at each 
coordinate in the tables, brain images that have been registered to the WFU_PickAtlas 
can be segmented by Brodmann areas, the major lobes, hemispheres, anatomic 
structures, and/or tissue types. 
 
3.3.4 Summary of structural brain MRI atlas methods 
The overwhelming majority of atlases were created via voxel-wise averaging of 
original MRI intensity or tissue proportion images from a group of subjects. These 
atlases are valuable for image processing, i.e. segmenting tissues in new subjects, and 
for aligning functional imaging subjects into a common space. I only found one atlas 
that defined the distribution of brain structure in a subject group (“Normal reference 
MR images for the brain”). This was not the voxel-wise distribution but the 
distribution of whole brain volumes as determined by qualitative radiological 
assessment. There was apparently no atlas that could be used to assess new subjects at 





I found 31 publicly available structural brain image atlases that were designed for a 
wide range of purposes, e.g. to provide a standard analysis space or reference for 
correlating brain structure and function. These were mainly derived from the mean 
brain structure of young to middle aged subjects. The number of subjects was 
generally rather small (median 27, IQR 44.5) given that several hundreds or even 
thousands of subjects are required to adequately represent population brain structure 
(Toga, 2002; Toga et al., 2006; Evans et al., 2012). Further, many were descended 
from a single subject atlas, the Talairach atlas. 
 The Talairach brain atlas has a number of limitations that were noted in its 
publication (Talairach and Tournoux, 1988). Most relevant to modern atlases derived 
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in this space, the Talairach atlas is based on symmetrical hemispheric volumes. This 
means that, while their sulcal pattern may be accurately asymmetric, the widths of 
many modern atlases’ hemispheres may be inaccurately the same. The use of a 
consistent standard framework, e.g. a Talairach-based coordinate system, was well 
founded and conceptually appropriate. However, to accurately represent brain 
structure in a given group, it may be more appropriate to use only the standard 
“skeleton”, i.e. axes, of Talairach space and fill that space with the asymmetric, or 
otherwise distinctive, structure of that group. 
Specific groups should be analysed using an atlas derived from other subjects 
in that population, otherwise systematic errors may be introduced, e.g. the 
overexpansion of atrophied brains registered to younger subject atlases (such as the 
MNI series of atlases; Buckner et al., 2004). I found five atlases derived from ageing 
(≥60 year old) subjects and only three of these (“Clinical toolbox”, “Symmetric atlas 
in normal older adults”, and “Brain atlas for healthy elderly”) were designed for 
quantitative image processing of normal subjects, each of which were derived or 
mapped into Talairach/ MNI space. Three atlases were derived from subjects across 
the adult lifecourse (both “FreeSurfer” atlases and the “SRI24” atlas) of which the 
largest had 40 subjects. Given the wide variation in brain structure across the 
lifecourse (Good et al., 2001; Sowell et al., 2003; Allen et al., 2005; Raz et al., 2010), 
these studies may require atlases with many more subjects. Equally, studies of 
focused age groups (≤5 years) require atlases specific to them. However, I found only 
one atlas, “PALS” (18-24 years), for image processing in such focused studies. 
All but one of the atlases (“Normal reference MR images for the brain”) were 
primarily designed for image processing that would produce data for subsequent 
statistical analyses. That is, they were designed to provide a standard space for voxel-
wise analyses or support tissue/ subregional, e.g. hippocampus, volume extraction. 
The “Normal reference MR images for the brain” atlas was based on qualitatively 
determined percentile ranks of normal ageing brain volumes and designed to support 
clinical diagnoses of whole brain volume in ageing (65-70 and 75-80 year old) 
patients. Given that neurological diseases may lead to only subtle changes (Shenton et 
al., 2001; Farrell et al., 2009; Ferguson et al., 2010), it may be useful to derive a 
voxel-based atlas of the clinically normal distribution of brain structure. All voxel-
based atlases that I found used mean-based measures of brain structure and I found 
none that used nonparametric, e.g. median or percentile rank, distributional measures. 
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The atlases in this review were found through a formal, but not systematic search, and 
were openly accessible. This suggests that I may not have reviewed all relevant 
atlases, i.e. those described as part of larger studies (and therefore potentially only 
visible through a full systematic search) or those not openly accessible. Further, I did 
not investigate potential uses for atlases beyond those described in the original 
manuscripts/ sources. It could be that any one of these atlases may be modified to 
serve additional purposes. Related to this, I described the methods and uses of each 
atlas according to my own interpretation of the source manuscripts/ reference 
manuals, which (much like a “Chinese whisper”) may have altered the meaning 
intended by the original authors. Notwithstanding these limitations, I have compiled a 
comprehensive review that assessed the methods and uses of the most commonly 
applied atlases in brain imaging analyses. 
I have reviewed and described openly accessible structural brain image atlases 
and found that, in general, they were primarily designed to serve image processing 
tasks in young to middle-aged adults. I found no atlas to quantify the range 
(distribution) of voxel-wise brain structure. In other words, there was no atlas that 
calculated the distribution (rather than mean) of voxel values in a group of normal 
subjects to determine “how normal” each voxel value was in a new subject. Rather 
than this atlas-based assessment, MRI brain structure was previously assessed using 
statistical models and these are described in the next chapter. 
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Statistical models aim to describe the association between two or more variables, e.g. 
age and brain tissue volume. Traditionally, there were two major schools of thought in 
statistical modelling; there were the “frequentists” and the “Bayesians”. The 
frequentists took the conventional view of probability, i.e. there are two sides of a 
coin therefore the probability of it landing on one side, say heads, is always 0.5. While 
the Bayesians took the view that probabilities are not constant but change given 
acquired data, i.e. if a coin is tossed ten times and lands on heads 6 times, then the 
Bayesian probability for heads on the 11th toss is somewhere between 0.5 and 0.6. 
These were once competing views but now statisticians are generally open to using 
either method or a combination of both methods, depending on the situation. In brain 
image analyses, the frequentist approach is the most commonly applied (Ashburner 
and Friston, 2007; Freedman et al., 2007).  
Even within the frequentist approach there are varying methods. That is, there 
are “parametric” or “Gaussian” (mean–based) models versus “nonparametric” or 
“distribution–free” (rank–based) models (Hogg and Tanis, 2010). Many datasets from 
a broad range of fields, e.g. the physical and life sciences, are analysed with 
parametric models (Freedman et al., 2007; Freedman, 2010; Hogg and Tanis, 2010). 
This is appropriate because these data are often distributed similarly to the Gaussian 
distribution (Freedman et al., 2007; Hogg and Tanis, 2010). However, many other 
types of data, including brain image data (Rorden et al., 2007), are not always 
distributed Gaussian; in which case nonparametric models may be more appropriate 
(Hogg and Tanis, 2010). 
Although they do not assume that data are distributed Gaussian, many 
nonparametric methods still make assumptions about data distributions between 
groups. That is, frequently applied methods such as the Wilcoxon–Mann–Whitney 
test and “nonparametric regression” assume that distributions between groups have 
similar shapes and approximately equal variance (Hollander and Wolfe, 1973; Cliff, 
1993; Zimmerman, 1998). When their respective assumptions are not met, the results 
from parametric and nonparametric tests may be unreliable and difficult to interpret 
(Meehl, 1978; Cliff, 1993; Cohen, 1994; Zimmerman, 1998; Freedman et al., 2007; 
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Freedman, 2010). In these cases, rather than comparing central tendency (mean or 
median) values between groups, it may be better to model the entire distributions of 
data between groups, e.g. values that define where a given percentage of subjects lie 
within a group (percentile rank values). 
Further to the distributions of data, statistical models make the assumption that 
data were generated via a statistically random sample from a population where each 
individual had an equal chance of selection (Meehl, 1978; Cohen, 1994; Freedman et 
al., 2007; Freedman, 2010; Hogg and Tanis, 2010). A statistically random sample is 
equivalent to “blindly drawing tickets from a box” where the entire contents of the 
box are the population and the tickets drawn are the sample (Freedman et al., 2007). 
These samples are often difficult to generate in social and epidemiological science 
studies; in which case “effect sizes” should be computed and compared across all 
available data (Meehl, 1978; Cohen, 1994; Freedman et al., 2007).  
One of the most widely used measures of effect size is “Cohen’s d”; this is 
essentially the mean difference between groups normalised by their pooled SD 
(Cohen, 1988; Coe, 2002). As it is based on the standardised mean difference, this 
statistic still relies on the data being equally Gaussian between groups. Even small 
departures from these assumptions may lead to uninterpretable and/or unreliable 
results (Cliff, 1993; Coe, 2002). Thankfully, there is a nonparametric measure of 
effect size that does not require data to be Gaussian, equally shaped, or have 
approximately equal variance - the so called, “d statistic” 
The “d statistic” is a type of nonparametric statistic that provides a direct 
measure of the overlap between two distributions, while not making any assumptions 
about data distributions (Siegel and Castellan, 1988; Cliff, 1993; Coe, 2002). Given 
that it does not make these assumptions, a measure of overlap is all that it provides, 
i.e. it does not say anything about the central tendencies (means/ medians) of groups 
(Cliff, 1993). The measure of overlap is a clinically relevant and useful measure in 
itself. This is because, despite being commonly used (Ashburner and Friston, 2000; 
Good et al., 2001; Freedman et al., 2007), central tendency measures may not 
adequately describe the differences between two clinical groups (Elveback et al., 
1970). Although the overlap statistic is referred to as “d” in the literature, I use the 
Greek equivalent “delta” (δ) to avoid confusion with “Cohen’s d”. This clashing of 
terms serves to further illustrate the myriad of statistical approaches available (there 
are so many they cannot have entirely unique names!) 
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The complexity of the brain described in chapter 1 and the large number of statistical 
modelling approaches available (that I have only briefly summarised), led me to 
conduct the following review. In this review I describe the data, methods, and results 





I conducted a review of brain structure models concurrently with the reviews of brain 
MRI databanks (chapter 2) and atlases (chapter 3). A full systematic search of 
statistical models was not undertaken due to time constraints. Between October 2010 
and October 2011, I searched PubMed (http://www.ncbi.nlm.nih.gov/pubmed/) and 
the internet using Google (http://www.google.co.uk/) and Google Scholar 
(http://scholar.google.co.uk/) with the terms: “Magnetic Resonance Imaging” or 
“MRI” or “MR” and “brain” and “normal” and “ageing” and “human”. I 
supplemented this search until August 2013 by periodically searching Google with a 
subset of these terms and by reviewing content alerts distributed by relevant journal 
articles, e.g. NeuroImage (http://www.journals.elsevier.com/neuroimage/) and Human 
Brain Mapping (http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1097–0193). 
I did not have a formal exclusion process, i.e. I did not keep track of excluded 
articles, but included all articles I found to model the effects of age on structural brain 
volumes. That is, whole brain, regional, and voxel volume models across the 
lifecourse, i.e. I did not include models of diffusion, cortical thickness, or connectivity 
parameters. As I was interested in assessing brain changes in life, I excluded post–
mortem studies. I excluded longitudinal studies as the parameters they assess are 
inherently different to cross–sectional studies, e.g. within–subject changes from 
baseline (rather than differences between subjects at different ages) are calculated 
(Holland et al., 2012). I included baseline cross–sectional analyses from longitudinal 
studies where available, e.g., Fotenos et al. (2005). Longitudinal data are more robust 
for defining individual changes in brain structure with time (rather than cross-
sectional data that define differences between ages). However, the data to be used in 
this thesis are cross-sectional (chapter 5); therefore I cannot investigate and/or 
comment on the best method for longitudinal studies. Given that my interest was in 
assessing brain structure across the whole lifecourse, I excluded studies that did not 
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have subjects aged over 60 years. I did not include comparisons between normal and 
diseased groups, e.g. Alzheimer’s diseases, unless there was a specific component that 





Seventeen studies were included for review from 591 publications found during the 
search. The subjects, criteria for normality, image processing, statistical methods, and 
results from the included studies are described in the following sections. 
 
4.3.1 Subjects 
The subjects assessed in the included statistical models of brain structure are 
described in Table 8. 
 Ten studies did not report the sampling method used, five reported the use of 
advertisements, and only two reported that their sample was randomly derived. There 
was generally an equal representation of gender in all studies. Only three studies had 
subjects less than 10 years and, in general, most subjects were young to middle aged 
adults; with the exception of the DeCarli et al. (2005), Jernigan et al. (2001), Peelle et 
al. (2012), and Ziegler et al. (2011) studies that had larger proportions of subjects 
aged over 60 years. There were three studies across the majority of the lifespan, 
Fotenos et al. (2005), Peelle et al. (2012), and Ziegler et al. (2011), that had over one 
hundred subjects distributed somewhat evenly across ages. All of these subjects were 
reported to be “normal” and the following sections describe the criteria for normality 
in each study. 
 
4.3.2 Subject criteria for normality 
The criteria for normality provided in each study are described fully in Appendix 
AI.2, “Criteria for normality in each normal ageing brain volume statistical model”. 
The definition of normality, and the methods used to define it (e.g. questionnaire, 
physical tests), were different between studies. However, most studies reported that 
the images of each subject were reviewed by a radiologist or neuroradiologist and 
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found to contain no overt abnormalities. Following this, each study processed their 
images as described in the next section. 
 
 
Table 8. Studies that reported brain volume models across the lifecourse 
Author Sampling method n Gender1 Age2 
Allen et al. (2005) Advertisements 44 F, 43 M (87) 22–88; 48,  19 
Blatter et al. (1995) Advertisements 105 F, 89 M (194) 16–65; .,     . 
Courchesne et al. (2000) Advertisements 37 F, 79 M (116) 1–80;   21,  20  
DeCarli et al. (2005) Random3 1133 F, 948 M (2081) 34–96; 62,  10 
Fotenos et al. (2005) . 160 F, 112 M (272) 18–95; 50,  7 
Ge et al. (2002) . 32 F, 22 M (54) 20–86; 47,  19 
Giorgio et al. (2010) . 35 F, 31 M (66) 23–81; 37c, . 
Good et al. (2001) Advertisements 200 F, 265 M (465) 17–79; 30c, . 
Gur et al. (1991) . 35 F, 34 M (69) 18–80; 41,  20 
Jernigan et al. (2001) . 41 F, 37 M (78) 30–99; 64,  17 
Kruggel (2006) . 248 F, 254 M (502) 16–70; 30,  10 
Li et al. (2012) . 38F 38 M (76) 19–70; 43,  16 
Long et al. (2012) . 38 F, 39 M (77) 22–89; .,     . 
Peelle et al. (2012) . 206 F, 214 M (420) 18–77; .,     . 
Sowell et al. (2003) Random5 86 F, 90 M (176) 7–87;   30,  22 
Walhovd et al. (2005) Advertisements 40 F, 33 M (73) 20–88; 52,  .  
Ziegler et al. (2011) . 305 F, 242 M (547) 19–86; 48,  17 
Note: .=I was not able to obtain this information; 1number of females, males (total); 2Range; mean, 
standard deviation (SD); 3The census of people aged over 20 years in Framingham, Massachusetts, 
USA was stratified by family size and precinct of residence and then ordered by address; subjects were 
then systematically drawn from this list (Dawber et al., 1951). 4Median; 5Subjects were randomly 
selected from a telemarketing list of families in the local community. 
 
 
4.3.3 Image acquisition and processing methods 
The image processing methods varied considerably between studies (Table 9). 
Automated and semi–automated image processing methods have been shown to be in 
general agreement (Lehmann et al., 2010) and most studies reported some kind of 
validation or reference to validation. However, because a method has worked well in 
one group of subjects, it does not mean that it will work well in another group. Each 
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step of processing (whether automatic or manual) should be thoroughly checked in all 
new studies, otherwise bias may be introduced (Nordenskjöld et al., 2013).  
 But perhaps the biggest confounding measure between studies is the choice of 
registration space and points. Both of these have been shown to significantly affect 
results (Buckner et al., 2004; Peelle et al., 2012). Different studies have different aims 
and their own reasons for using one processing method or another but, given the effect 
these choices have on results, it would be preferable to have a standard protocol to 
sensibly collate results and reliably define how the brain changes with age. The results 
from studies that reported models of whole brain tissue volumes across the lifecourse 
are collated in the next section. 
 
4.3.4 Statistical methods used in brain volume models 
The statistical methods used in models of grey matter (Table 10), white matter (Table 
11), and cerebrospinal fluid (Table 12) volumes across the lifecourse, and the results 
from these models, are described here. 
From Table 10 there was relative agreement between studies that grey matter 
volume generally decreases with age. However, the general rate and pattern, i.e. 
linearly or nonlinearly, at which it decreases did not appear consistent between 
studies. There was a similar pattern in white matter between studies, it is apparent that 
white matter generally decreases with age but the rate and pattern was again not 
apparently consistent (Table 11). 
The results in Table 12 are in concordance with a general increase in 
cerebrospinal fluid with age. Again, some studies report a more dramatic difference 
between ages than others. The confidence intervals of coefficients were not given in 
all studies and so tests of heterogeneity, e.g. forest plots and chi-square tests, were not 
possible for tissue or CSF statistics. 
These results (Table 10, Table 11, and Table 12) are all general (mean) 
differences. Values at other distributional locations, e.g. 5th/ 95th percentile ranks, 
were only reported in one study. Kruggel (2006) provided the 5th and 95th percentile 
rank values of normalised brain volumes for males and females aged 16–70 years. 
These percentile ranks corresponded to the whole age range, i.e. not for each decade 
or year. The distributions of brain image data may be visualised in “Q-Q” plots and if 
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the data do not lie on a straight diagonal line they may be transformed (as in Kruggel, 
2006) to appear Gaussian.  
 
 
Table 9. Image acquisition and processing methods in statistical models of brain 
structure across the lifecourse 
Author Tesla Sequence Processing tool Registration space Registration points 





Blatter et al. 1.5 T1, T2 ANALYZE Native N/A 
Courchesne et al. 1.5 T2 SEGMENT 
(semi–automated) 
Native N/A 





Fotenos et al. 1.5 T1 FSL Study specific 
Talairach 
12 
Ge et al. 1.5 PD, T2 3DVIEWNIX Native N/A 
Giorgio et al. 1.5 T1 FSL Study specific 
MNI152 
Nonlinear 
Good et al. 2 T1 SPM 99 Study specific 
MNI152 
12 and nonlinear 
Gur et al. 1.5 T2 In–house (semi–
automated) 
Native N/A 




“Resectioned in a 
standard coronal 
plane” 
Kruggel 3 T1 In–house 
(automated) 
Talairach 12 
Li et al. 1.5 T1 FreeSurfer Native N/A 
Long et al. 3 T1 FreeSurfer FreeSurfer brain 
atlas 
“aligned” 
Peelle et al. 3 T1, T2 SPM Native, custom 
MNI152 atlas 
Nonlinear 
Sowell et al. 1.5 T1 AIR, in–house 
(semi–automated) 
ICBM1 12 
Walhovd et al. 1.5 T1 FreeSurfer Aseg Atlas “Optimal linear and 
nonlinear 
transforms” 
Ziegler et al. 1.5, 3 T1 SPM MNI152 12 and nonlinear 
Note: SPM=Statistical Parametric Mapping; FSL=(University of Oxford Centre for) Functional MRI of 
the Brain Software Library; .=I was unable to obtain this information; PD=proton density; 1Tissue 
segmentation was conducted in ICBM space but volumes were calculated in subject’s native space; 














Linear regression  
(Good et al., 2001) 
β=–0.0039L (ρ=–0.699), P<0.0001 
 Linear regression 
(Courchesne et al., 2000) 
ρ=–0.75        (β=.),           P<0.001 
 Linear regression  
(Kruggel, 2006) 
β=–1.562mL,                   P<0.001 
 Linear regression  
(Giorgio et al., 2010) 
ρ=–0.84        (β=.),           P<0.001 
 Nonlinear regression  
(Sowell et al., 2003) 
β=0.60mL*,                     P=0.01 
 Correlation  
(Ge et al., 2002) 
ρ=–0.48,                           P=0.0004 
 Correlation  
(Li et al., 2012) 
ρ=–0.55, (males)              P<0.001  




(Ge et al., 2002) 
717.8mL–626.1mL,         P=0.001 
Normalised grey 
matter volume2 
Linear regression  
(Good et al., 2001) 
β=.,                                   P<0.001 
 Linear regression 
(Kruggel, 2006) 
β=–0.008,                         P<0.001 
 Linear regression 
(Fotenos et al., 2005) 
ρ=–0.91        (β=.),           P<0.001 
 Linear, nonlinear linear 
regression  
(Walhovd et al., 2005) 
ρ=–0.78,                           P=0.000                                        
Nonlinear β=.,                  P>0.05 
 Correlation 
(Ge et al., 2002) 
ρ=–0.57,                           P=0.0002 
 Spearman’s correlation 
(Jernigan et al., 2001) 
ρ=–0.53,                           P<0.001C,TSV 
 t–test 
(Ge et al., 2002) 
52.5%–47.6%,                 P<0.0001 
Note: 1results from regressions are shown, “beta (β), P–value”; correlations are shown, “rho (ρ), P–
value; and t–tests are shown, “mean difference (between young and old adults), P–value” where 
obtainable; .=unobtainable by me; L=litres, mL=millilitres; *=in a nonlinear model this corresponds to 
a decrease until mid to late adulthood before levelling off; 2unless otherwise stated volumes were 



















(Good et al., 2001) 
ρ=–0.571 (β=.),         P>0.30 
 Linear regression 
(Kruggel, 2006) 
β=–0.706 mL,           P>0.05 
 Linear, nonlinear 
regression 
(Courchesne et al., 2000) 
ρ=–0.39  (β=.),          P>0.05   
Nonlinear –β=.,         P<0.01 
 Nonlinear regression 
(Sowell et al., 2003) 
β=–1.94 mL*,           P<0.000001 
 Correlation 
(Ge et al., 2002) 




(Ge et al., 2002) 
499.9mL–445.3mL,  P=0.003 
Normalised white 
matter volume2 
Linear regression  
(Kruggel, 2006) 
β=–0.0002,                P>0.05 
 Linear regression 
(Fotenos et al., 2005) 
ρ=–0.25 (β=.),           P<0.001 
 Linear, nonlinear 
regression 
(Walhovd et al., 2005) 
ρ=–0.51,                    P=0.000                                       
Nonlinear β=.,           P<0.003 
 Correlation 
(Ge et al., 2002) 
ρ=–0.35,                    P=0.009 
 Spearman’s correlation 
(Jernigan et al., 2001) 
ρ=–0.63,                    P<0.001TSV 
 t–test 
(Ge et al., 2002) 
36.6%–34.0%,           P<0.02 
Note: 1results from regressions are shown, “beta (β), P–value”; correlations are shown, “rho (ρ), P–
value; and t–tests are shown, “mean difference (between young and old adults), P–value” where 
obtainable; .=unobtainable by me; L=litres, mL=millilitres; *=in a nonlinear model this β corresponds 
to an increase in childhood that levels off in middle age and decreases after middle age (inverted U 
shape); 2unless otherwise stated volumes were normalised by total intracranial volume; 












Table 12. Models of cerebrospinal fluid volume by age: statistical methods and results 




(Good et al., 2001) 
β=0.0019L (ρ=0.614),   P<0.001 
 Linear regression 
(Courchesne et al., 2000) 
ρ=0.84 (β=.), (males)     P<0.001            
ρ=0.88 (β=.), (females)  P<0.001  
 Linear regression 
(Kruggel, 2006) 
 
β=1.54 mL,                    P<0.001 
 Linear, nonlinear 
regression 
(Sowell et al., 2003) 
β=0.49 mL,                    P<0.01 




(Gur et al., 1991) 





(Good et al., 2001)  
β=.,                                  P<0.001 
 Linear regression 
(Courchesne et al., 2000) 
ρ=0.81 (β=.),                   P<0.001 
 Linear regression 
(Kruggel, 2006) 
β=0.001,                          P<0.001 
 Linear, nonlinear 
regression 
(Walhovd et al., 2005) 
ρ=0.69,                            P=0.000V                                   
Nonlinear β=.,                 P<0.003V 
 Correlation 
(Gur et al., 1991) 
ρ=0.76,                            P<0.001 
 Spearman’s correlation  
(Jernigan et al., 2001) 
ρ=0.83,                            P<0.001S, TSV 
 Spearman’s correlation  
(Jernigan et al., 2001) 
ρ=0.74,                            P<0.001V, TSV 
Note: 1results from regressions are shown, “beta (β), P–value”; correlations are shown, “rho (ρ), P–
value; and t–tests are shown, “mean difference (between young and old adults), P–value” where 
obtainable; 2unless otherwise stated volumes were normalised by total intracranial volume; V=ventricle 
cerebrospinal fluid; S=sulcal cerebrospinal fluid; TSV=normalised by total supratentorial volume. 
 
 
As well as whole and regional brain volumes, several studies reported voxel–based 
statistics; these are described in the next section. 
 
4.3.5 Voxel–based statistical methods 





Table 13. Voxel–based statistics reported in brain structure models across the lifespan 
Author Voxel–based statistics 
Good et al. t–values, ρ 
Giorgio et al. t–values, ρ 
Long et al. P–values 
Peelle et al. Means, t–values, β/m  
Sowell et al. β/m, peak ages* 
Ziegler et al. t–values, β/m, percent reductions 
Note: *of nonlinear regression curves. 
 
 
All of the statistics listed in Table 13 are derived from central tendency measures, e.g. 
mean/ median. All but ρ (“rho”, a measure of correlation) require the parametric 





According to this review, the most commonly applied statistical models in 
structural brain imaging are from the parametric-frequentist family of methods. That 
is, I found the overwhelming majority of studies to calculate mean differences in brain 
structure across the lifecourse. Nonparametric-frequentist methods were reported in 
one study (Jernigan et al., 2001). All but one of the studies I found reported measures 
other than central tendencies, i.e. other than means and medians (Kruggel, 2006). 
Central tendency models are useful for indicating general trends in brain structure 
across life but if their assumptions, e.g. random samples/ equally distributed data, are 
not met these may not well describe changes at the extremes of normal ageing. In 
order to provide useful clinical metrics for diagnoses of pathology, the extremes of 
brain structure need to be adequately defined (Farrell et al., 2009). While earlier 
studies could only reliably define central tendencies of brain structure due to the 
limited amount of data available, there is an increasing amount of brain image data 
becoming available so that extremes may also be defined (Poline and Poldrack, 2013). 
I found one study that attempted to define the extremes of brain structure with 
statistical modelling (Kruggel, 2006). In that study the limits of normal brain structure 
were estimated by artificially transforming the data to be distributed approximately 
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Gaussian and then calculating the mean values minus two SD. By transforming data 
to the Gaussian distribution the true limits of brain structure may be misrepresented, 
e.g. increased variance at older ages means that the limits of brain structure are likely 
greater here than at younger ages (Elveback et al., 1970; Farrell et al., 2009). In this 
instance, nonparametric methods may be more appropriate for defining the limits of 
brain structure. 
Nonparametric methods have been proposed and widely adopted in functional 
imaging (Nichols and Holmes, 2002) however they have been implemented far less 
frequently in structural imaging (Rorden et al., 2007; Yang et al., 2011). This may be 
because of the perceived decrease in “power” in nonparametric models (Hogg and 
Tanis, 2010). However, if parametric methods are applied in situations where their 
assumptions are not met they may provide unreliable results, e.g. if data are not 
distributed Gaussian their “power” may actually overinflate results (Elveback et al., 
1970). I found few studies to report whether their data met the assumptions of the 
models they used and so, at least according to this review, the robustness of these 
assumptions and their effects in lifecourse structural brain image data are largely 
unknown. 
Prior to constructing these models, each study defined a set of characteristics 
by which to classify their subjects as “normal”. While the statistical methods for 
modelling data were generally consistent across studies, methods for determining 
subject normality differed greatly. Although this is a tricky definition to make, others 
have noted the adverse effects of differing criteria for normality, e.g. unrepresentative 
effects of age from “super-healthy” older subjects, and attempted to create standard 
definitions that may reduce inconsistency of results between studies (Mazziotta et al., 
2009). Further to differing criteria for subject normality, there were a range of 
different image processing tools and methods employed across studies. In conjunction 
with the varying criteria for normality and robustness of parametric methods (given 
the underlying data generation and distribution), these differences in image processing 
methods may explain why this review did not find the effect size of age on brain 
structure to be consistent across studies. 
This review used formal search criteria, however, I did not maintain a record 
of all excluded studies nor did I perform extensive manual searching throughout the 
search period. This was therefore not a systematic review so there is a reasonable 
chance that I did not include all relevant studies. I did check another recent review 
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(Peelle et al., 2012), and this reported only a couple of additional studies. The 
majority of cross-sectional studies reported in that review were also found to use the 
parametric-frequentist methods. In the present review I did not assess longitudinal 
studies and so, although collated from a number of different sources, these results may 
not indicate actual changes in brain structure through time but only normal differences 
between age groups. 
  These mean differences were defined with the aim of highlighting 
pathological changes in brain volume (Courchesne et al., 2000). If data are, as 
expected by parametric methods, distributed equally Gaussian then mean differences 
will generally be replicated across the spectrum of ageing, e.g. at the clinical limits 
(Farrell et al., 2009). According to this review it was unclear whether these 
assumptions were robust across ageing. It was therefore not known if mean-based 
(parametric) models were applicable at the limits of brain structure.  
I proposed to test these assumptions in statistical models of whole brain, 
regional, and voxel-wise volumes across the lifecourse. Further, given the previous 
focus on central tendency measures, I sought to determine whether these apply at the 
extremes of normal brain structure or whether alternative, percentile rank methods are 
required. Before I did this I assessed various methods of preparing brain MRI data for 








Given the age-related changes in brain structure that I described in previous chapters, 
specific MRI processing methods are required at different stages of the lifecourse. But 
regardless of the age of a subject and even within a single sequence, MR images 
contain a large amount of data about the brain. For example, T1–weighted images 
contain whole brain grey matter, white matter, and cerebrospinal fluid volumes, as 
well as ventricular, cerebellar, lobular, and regional, e.g. hippocampus, volumes. 
However, these data are not available immediately after scanning; several 
mathematical operations are required even before the widely recognisable MR image 
in Figure 1 (page 4) is formed. 
 The signal detected by a MRI scanner is termed “free induction decay” (FID) 
and this contains information about frequency and phase, i.e. the strength of a 
magnetisation signal over time. After receiving a MR “pulse”, different tissues emit 
different signal strengths and lose magnetisation at different rates and it these 
properties that generate the contrast seen in images such as Figure 1. The location and 
intensity (brightness) of a voxel in a MR image are obtained from the FID signal via a 
pair of “Fourier Transforms”. The mathematics of Fourier Transforms are beyond the 
scope of this thesis however they, and a wide range of MR physics, are discussed in 
great detail elsewhere (McRobbie et al., 2007). For present purposes, the point is that 
different structures in the brain, e.g. grey and white matter, have different magnetic 
properties and these signals can be mathematically transformed to form grey scale 
(MR intensity) images such as Figure 1. 
 Once the MR intensity image has been formed there are several further steps 
required to obtain tissue and substructure volumes of interest. The first of these steps 
is generally “brain extraction”, also known as “skull stripping” or “scalping”. This is 
basically the removal of all structures in an image, e.g. skull, neck muscles, that do 
not form part of the brain. Several methods have been proposed to do this manually 
(Woods, 2005), semi–automatically (Shattuck and Leahy, 2002), and fully–
automatically (Smith, 2002; Avants et al., 2008).  
Modern brain images may have upwards of 218 acquisition slices and 
manually drawing around the cortical boundary in each of these slices can take 
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upwards of an hour and a half per subject (1st year of PhD, David Alexander Dickie). 
This is clearly not an efficient use of time. At the opposite end of the spectrum is fully 
automatic brain extraction. Although these methods take almost no human time (they 
take computational time) and have been validated in some cohorts (Smith et al., 
2002), there are concerns that they may not always be reliable (Nordenskjöld et al., 
2013). I therefore tested several brain extraction methods in the subjects here to get 
the best balance between accuracy and efficiency.  
 Brain extraction is employed for various reasons, the most relevant to the 
present work being for easier/ optimal extraction of the cortex and subregional 
volumes, tissue classification and spatial normalisation (“registration”). Tissue 
classification, based on the intensities and locations of voxels (explaining the need for 
the removal of skull that has similar intensities to white matter), has been fairly 
successfully automated across adulthood, including in old age (Zhang et al., 2001; 
Fotenos et al., 2005). This replaces MR intensities with a standard range representing 
proportion of a particular tissue within each voxel, i.e. 0 for no grey matter, 1 for 
entirely grey matter. One reason for doing this is to allow sensible comparison of 
subjects between scanners and acquisition parameters (that, even for the same tissues, 
lead to different MR intensity ranges). Standardised voxel values mean that subjects 
acquired from different scanners, or even on the same scanner but with slightly 
different acquisition parameters, can be sensibly compared. However, given that 
tissue classification is partially based on MR intensities, there is the potential for 
inaccuracies in older subjects with white matter hypointensities (hyperintensities on 
T2 images that are potentially lesions) that are a similar intensity to grey matter. I 
therefore assessed another image standardisation method that does not classify voxels 
but match their range with that of an atlas (intensity range standardisation). 
 The vast amounts of data needed to effectively understand the brain are 
unfeasible to collect in one scanner/ centre. However, MR signal intensities, unlike 
CT Hounsfield units, do not have a universal meaning and so it is difficult to combine 
data from one scanner that may have a grey matter value range of 3000 to 4000 with 
another scanner that has a range of 500 to 1500. Given the potential issues with tissue 
classification I assess another approach which is to normalise the entire range of 
individual subject voxel values into a reference or template range. This method was 
previously validated to provide more consistent reporting rating between MR brain 
images from multiple sclerosis (MS) and tumour patients (Nyúl and Udupa, 1999). I 
  
 67 
implemented this method to determine whether it could provide a standard scale of 
values for the subjects here (who came from multiple scanners) while not unduly 
altering brain structure. 
 As well as providing a standard intensity scale, atlases may also provide a 
standardised spatial framework for images. As discussed in chapter 3, a standard 
space is required for voxel–based image analyses and there are a variety of 
registration methods for transforming subjects to this space. Three point registration 
overlays the centres of images; 6 point transformation overlays the centres and aligns 
the X (left–right), Y (anterior–posterior), Z (inferior–superior) axes of images; 9 point 
transformation overlays the centres, aligns the XYZ axes, and rescales images along 
the XYZ axes; and 12 point transformation overlays the centres, aligns the XYZ axes, 
rescales the XYZ axes, and rescales the central axes between XYZ. These 
transformations maintain within brain structure variance, e.g. lateral ventricle 
volumes, but may not always account for head size differences that occur in axes 
other than XYZ and the three axes between XYZ, e.g. the axis at X-10 degrees/  Y+90 
degrees.  
Nonlinear registration is based on directly altering the location of individual 
voxels rather than via alterations based on their parent axes (Avants et al., 2008). This 
means that a much higher degree of similarity between a subject and atlas may be 
achieved, e.g. head size differences are fully accounted for. However, within brain 
variance of interest, e.g. lateral ventricle volumes, are also warped to be almost the 
same as the atlas. As discussed in chapter 1, this may be appropriate for functional 
imaging studies that seek to accurately overlay specific structures, e.g. the amygdala, 
and compare their functional response. Further, it is also useful for “atlas based 
segmentation”. That is, a manually labelled atlas may be nonlinearly registered to a 
subject so that these labels can be used to segment the corresponding structures in the 
subject. This is the method I used to segment regional brain volumes in the subjects 
studied here. 
Nonlinear registration may not be suitable for transforming individual subjects 
to an atlas in a structural brain image study because it may remove much of the 
variance in brain structure that the study seeks to quantify, e.g. tissue atrophy. I 
therefore assessed existing registration methods. Further, I developed my own hybrid 
linear/nonlinear method in an attempt to mitigate the limitations and exploit the 
benefits of each method. 
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The image processing methods discussed were assessed in a range of subjects aged 
from 0 to 90 years. Data from these subjects were used throughout the remaining 





During this work I acquired a number of subjects from across the lifecourse. I did not 
recruit these subjects myself but acquired them from colleagues within The University 
of Edinburgh or from publicly available repositories. Starting with infants (0 years) 
and through to aged adults (60–90 years), these subjects are described in the following 
sections. 
 
5.2.1 Infant subjects 
The infant study was approved by NHS Lothian and National Research Ethics 
Service, South East Scotland Research Ethics Committee 02 reference: 11/SS/0061 
(PI: Dr James Boardman, The University of Edinburgh / MRC Centre for 
Reproductive Health). Forty–three preterm infant subjects were recruited from the 
Royal Infirmary of Edinburgh. They were delivered before 36 weeks of gestation and 
had a birth weight of <1500 grams. Twelve subjects had considerable motion artefact 
(it is difficult to keep babies still in the scanner) and so were excluded from 
subsequent image processing and analysis. This meant that I analysed 31 preterm 
infant subjects. At the time of writing, recruitment was not complete and term 
equivalent control subjects (delivered after 36 weeks of gestation) were not available. 
Once recruited, T1–weighted magnetization prepared rapid gradient–echo (MP–
RAGE) brain MR were acquired in the sagittal place at 3 T and 1x1x1mm resolution.  
To illustrate my intended analysis in the preterm subjects (chapter 9), I used 
the Montreal Neurological Institute (MNI) 36–44 weeks postmenstrual age normal 
infant atlas (Fonov et al., 2009) as an intermediary reference. This atlas is a mean 
image of 36 normal infant subjects; for future analyses I will create a percentile rank 
atlas of the normal subjects recruited in Edinburgh (target ~15 subjects). Recruitment 
of the normal young to middle adult sample was complete and these subjects are 




5.2.2 Young to middle adult subjects 
Eighty normal subjects (40 males, 40 females) aged 25–64 (median 43, IQR 17) years 
were recruited from advertisements in the Western General Hospital and Royal 
Infirmary, Edinburgh. National Institutes of Health (NIH) grant R01 EB004155-03 
(PI: Dr. Mark E. Bastin, Neuroimaging Sciences, The University of Edinburgh). All 
subjects gave written informed consent to be assessed and were determined to be 




Table 14. Ages of young to middle adult sample 








Each subject completed a battery of cognitive tests that were taken from the Wechsler 
Adult Intelligence Scale III (WAIS-III; Wechsler, 1997a), Wechsler Memory Scale III 
(WMS-III; Wechsler, 1997b), National Adult Reading Test (NART; Nelson and 
Willison, 1991), verbal fluency (Lezak et al., 2004), and simple and four–choice 
reaction time (Deary et al., 2001) tasks. The cognitive domains tested in these tasks 
are listed in section 7.2.2. The mean NART score was 38 ± 5.6. After determining that 
they were cognitively normal, brain MRI was acquired from these subjects. 
Brain MRI data were acquired with a GE Signa Horizon HDxt 1.5T clinical 
scanner (General Electric, Milwaukee, WI, USA). The imaging protocol consisted of: 
axial T2–, T2*–, and FLAIR–weighted sequences, a coronal T1–weighted volume 
sequence, an axial T1–weighted fast–spoiled gradient echo (FSPGR) sequence, a 
magnetization transfer (MT–MRI) pulse sequence, and a diffusion MRI protocol, all 
acquired in Digital Imaging and Communications in Medicine (DICOM). I converted 
the T1–weighted volume DICOM to NIFTI–1 (http://nifti.nimh.nih.gov 




5.2.3 Aged adult subjects 
Brain MRI from 236 normal subjects and 224 subjects diagnosed with AD (all aged 
between 55 and 90 years) were acquired from the Alzheimer’s Disease Neuroimaging 
Initiative (ADNI; adni.loni.ucla.edu) and the Open Access Series of Imaging Studies 
(OASIS; http://www.oasis–brains.org/). The normal subjects did not have dementia, 
but potentially had non–debilitating conditions common in ageing, e.g. hypertension. 
At the time of the present study, ADNI and OASIS were the only public sources of 
structural MRI brain scans with clinical metadata that fully represented normal older 
people (≥60 years) (Dickie et al., 2012). Their demographics are described in Table 
15. 
Both ADNI and OASIS provided 1.5 T MP–RAGE T1–weighted MR brain 
images that were acquired in the sagittal plane at approximately 1x1x1mm resolution. 
Both studies also acquired a range of other MRI sequences, e.g. T2–weighted. 
However, while theses sequences were available to me from ADNI, they were not 
available to me from OASIS. OASIS data were acquired in one site whereas the 
ADNI data were acquired from 60 sites. The full image acquisition parameters are 
described in Marcus et al. (2007c – OASIS) and Jack Jr et al. (2008 – ADNI). 
 
 
5.3 Image processing methods 
 
I performed various processing steps for each subject group, some of which were 
specific and others were applied to all groups. These processing steps are described in 
the following sections. Brain extraction, which I performed in all subject groups but 
with varying methods, is described first. 
 
5.3.1 Brain extraction 
Brain extraction, sometimes referred to as “skull–stripping”, is often the first step in 
obtaining quantitative data from MR brain images. The complex and variable shape of 
the human brain means that this task is neither trivial nor amenable to unsupervised, 
mass computer processing. However, the need for mass amounts of data to effectively 
understand the brain (Koslow, 2000; Toga, 2002) has led several groups to attempt to 
partially or fully automate brain extraction (Shattuck and Leahy, 2002; Smith, 2002; 
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Avants et al., 2008). Since I sought to obtain such a large amount of data, I tested 
whether these methods were suitable, or could be developed, for the broad subject 




Table 15. Demographics of the ADNI and OASIS subjects 
Sample Age in years Number of M:F (total) 
ADNI    
Controls <70 0  :0 (0) 
 70–74 35 :28 (63) 
 75–79 25 :22 (47) 
 80–84 9 :8 (17) 
 85–89 8 :2 (10) 
 ≥90 0 :1 (1) 
 Overall 77 :61 (138) 
AD <70 16  :12 (28) 
 70–74 14  :17 (31) 
 75–79 12  :14 (26) 
 80–84 16  :8    (24) 
 85–89 8  :7      (15) 
 ≥90 0  :0      (0) 
 Overall 66  :58 (124) 
OASIS    
Controls <70 7 :18 (25) 
 70–74 7 :19 (26) 
 75–79 3 :6 (9) 
 80–84 4 :13 (17) 
 85–89 4 :9 (13) 
 ≥90 1 :7 (8) 
 Overall 26 :72 (98) 
AD <70 6 :9 (15) 
 70–74 10 :15 (25) 
 75–79 10 :13 (23) 
 80–84 10 :15 (25) 
 85–89 3 :4 (7) 
 ≥90 2 :3 (5) 
 Overall 41 :59 (100) 







The Brain Extraction Tool (BET; Smith, 2002) is one of the most commonly used 
fully automated skull-stripping method. BrainSuite is a semi-automated skull-
stripping method. Atlas based segmentation is also regularly used and may be 
implemented with Advanced Normalization Tools (ANTS) registration (Avants et al., 
2008). Registration is discussed in detail in section 5.3.5, “Spatial normalisation 
(registration)”. 
Since there is less variability among young to middle aged subjects than at the 
extremes of life, I considered that the ANTS method would perform very well in these 
subjects. I selected the Montreal Neurological Institute (MNI) 152 brain mask atlas as 
the reference to register to all subjects. When I acquired this atlas I noted that it was 
provided in resolutions of 0.5, 1.0, and 2.0mm3. Although the subject images that I 
studied here were in approximately 1.0mm3, I speculated that by downsampling these 
images to the 2.0mm3 atlas, I could reduce the manual editing time by half. Notably, 
this would not unduly alter subjects as I intended to resample the masks back to 
1.0mm3 resolution and apply these masks to the original images. Following brain 
extraction, regional structures were extracted using atlas-based segmentation. 
 
5.3.2 Regional brain volume extraction: atlas based segmentation 
The SRI24–TZO atlas (Rohlfing et al., 2010) consists of a large number of manually 
delineated subregional brain volumes, e.g. lateral ventricles, supplementary motor 
area. There are over 100 gyral and subcortical brain regions in this atlas but, given 
their associations with ageing and disease (Jack Jr et al., 1997; Job et al., 2002), I only 
used the subcortical grey matter regions in my analysis. That is, the left and right 
hippocampus, amygdala, parahippocampal gyrus, caudate, putamen, and thalamus. 
Atlas–based segmentation is the process of registering (reshaping) these labels to 
match the anatomy in new subjects and using the transferred labels to extract regional 
brain volumes from these subjects. It is a relatively simple process where the 
structural (T1–weighted) atlas image is registered to the subject’s T1–weighted image. 
This produces a “transformation matrix” (the series of calculations required to reshape 
the atlas into the shape of the subject) that may be applied to any image, i.e. label 
image, in the atlas space so that it is then in the subject space (Figure 7).  
I used ANTS to reshape (nonlinearly register) the SRI24 structural and label images to 
each subject. Registration methods are described in detail in section 5.3.5. For now, it 
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is important to note that the subject was not registered (deformed) to the atlas, but that 
the atlas was deformed to the subject. If subjects were deformed to the atlas then they 
would all have volumes biased towards those of the atlas (and not reflective of their 
own actual volumes). Volumes are calculated by summing the proportions of grey 
matter in each voxel in the region. Proportions of grey matter are calculated with 




Figure 7. Atlas based segmentation with the SRI24 atlas 
The structural atlas image (coloured pink on the left) is nonlinearly registered to the subject's 
structural image (right) and the resulting transformation matrix is the applied to the coloured labels 
so that they are also in the shape of the subject’s anatomy. In this example the subjects anatomy was 
such that all regional volumes did not appear on one slice (the amygdala was calculated, it just did 
not extend to this slice for this particular subject). Green=caudate; red=thalamus; yellow=putamen; 
royal blue=amygdala; purple=hippocampus; light blue=parahippocampal gyrus. 
 
 
5.3.3 Tissue classification 
Tissue classification and bias correction was performed with the FMRIB’s Automated 
Segmentation Tool (FAST) in a number of previous studies (Zhang et al., 2001; 
Buckner et al., 2004; Fotenos et al., 2005; Marcus et al., 2007c). Since I aimed to 
evaluate the statistical methods used in previous volumetric brain studies, I choose to 
use FAST for tissue classification (limiting the potential for my results being due to 
differences in image processing). Since all tissue classification methods I could find 
were based on similar principles and produce similar results (Avants et al., 2008), I 
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did not conduct an assessment of methods. Rather, I attempted to implement another 
method for standardising data between scanners.  
 
5.3.4 MR intensity scale standardisation  
To normalise the entire range of individual subject voxel values into a reference or 
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 where jiV ,

 is the transformed value of voxel i in subject j, s is the median of 
the template, jiV , is the original value of voxel i in subject j, j is the median of subject 
j, s1 is the 1
st percentile of the template, p1j is the 1
st percentile of subject j, s99 is the 
99th percentile of the template, p99j is the 99
th percentile of subject j, m1i is the 
minimum value of subject j, and m2i is the maximum value of subject j. This is in 
effect shifting the subject’s histogram into the scale of the template histogram (Nyúl 
and Udupa, 1999). I implemented this algorithm in the Matrix Laboratory (MATLAB) 
computing language. 
 
5.3.5 Spatial normalisation (registration) 
My work on spatial normalisation (registration) began with a project in collaboration 
with an industrial partner, Toshiba Medical Visualisation Systems Europe (TMVSE). 
During this project I worked on site to assess their registration algorithms in 
comparison with the freely available and widely used FMRIB’s Linear Image 
Registration Tool (FLIRT) and ANTS algorithms. The TMVSE data are confidential 
so cannot be reported here but I do describe how the FSL and ANTS algorithms affect 
brain structure. 
Forty–nine randomly selected normal ageing subjects (aged ≥60 years) were 
taken from the OASIS databank (Marcus et al., 2007c). These 49 subjects had clinical 
characteristics associated with normal ageing, e.g. hypertension and diabetes, but not 
dementia. Their mean age was 75.92 years, standard deviation (SD) 8.98 years (range 
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60–94 years). Approximately 73% of the normal ageing subjects in OASIS were 
female. 
 
5.3.5.1 Standard space (atlas) for registration 
A random selection of half (49) of the normal OASIS subjects was used to create the 
template standard space (Figure 8): 
 
1. The brain extracted image of each randomly selected subject was linearly 
orientated (not stretched) to the MNI Colin 27 brain extracted template, i.e. a 6 
point linear transformation 
2. The mean voxel–wise intensity was calculated in this space 
3. Each subject was then oriented and linearly deformed (12 point transform) to 
this average brain 
4. The mean voxel–wise intensity was calculated in this space 
5. Each subject was then nonlinearly deformed (Avants et al., 2008) to this 
average brain 
6. The mean voxel–wise intensity was calculated in this space and this defined 
the template standard space (Figure 8) 
 
3D renderings of the aged standard space and the MNI atlas, both created with 
MRIcron (Rorden, 2010), are shown in Figure 9. This illustrates that the larger 
ventricles, sulcal spaces, and overall reduced brain tissue volume associated with 






Figure 8. Procedure to create a standard space representative of aged (≥60 years) 
subjects 
This is in the orientation of the commonly used Montreal Neurological Institute 
(MNI) atlas but was derived from half (49) of the normal OASIS subjects; 




Figure 9. The mean atlas image from 49 aged normal subjects (60–90 years) in the space of the 
Montreal Neurological Institute (MNI) Colin 27 atlas 
The aged atlas is markedly smaller and has larger ventricles and sulcal spaces than the Colin 27 atlas 
that is based on a ~35 year old subject. The blurriness of the aged atlas is due to it being the mean of 




I registered the aged subjects to aged standard space (Figure 9) by the methods 
described in the following sections. 
 
5.3.5.2 Linear registration 
I performed linear registration using FLIRT. FLIRT provides a number of linear 
registration methods with 3, 6, 9, and 12 point transformations (Jenkinson and Smith, 
2001; Jenkinson et al., 2002). I registered each subject into standard space with 
FLIRT using 6, 9, and 12 point transformations. 
 
5.3.5.3 Nonlinear registration 
I used ANTS with step–size 0.25 and 100×100×100×25 iterations to perform 
nonlinear registration. These parameters, specific to the ANTS program, were chosen 
to optimise similarity between the atlas and subject (Avants et al., 2008). 
 
5.3.5.4 Comparison of registration methods 
To compare the results of each registration method I calculated mean and standard 
deviation images of all subjects after each registration. I then used these to compute 












where CVi is the coefficient of variance in voxel i, σi is the standard deviation 
in voxel i, and i is the mean in voxel i. 
I then computed median change in CV after each registration, relative to the 6 pt 
(lowest) degree of registration. 
 
5.3.6 A novel registration method: “nonlinear surface” registration  
Linear registration maintains within brain variance of interest, e.g. ventricle size, 
between subjects but may not always adequately account for head size differences. 
Nonlinear registration generally accounts for head size differences but may remove 
within brain variance of interest, e.g. ventricle size, between subjects. Therefore, I 
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devised “nonlinear surface” registration by nonlinearly registering each subject’s 
brain mask (binary image) with ANTS to the standard space mask. The 
transformations calculated with the masks (Figure 10) were applied to the original 




Figure 10. Warps from nonlinear and "nonlinear surface" 
(Nsurf) registration 
In nonlinear registration the entire brain is warped to 
approximate the atlas brain, in nonlinear surface registration 
only the overall size and shape of the brain is warped to the 
atlas (the ratio of within brain structure, e.g. lateral ventricles, 







5.3.7 Cortical thickness 
I used BrainSuite (Shattuck and Leahy, 2002) to extract the cortex from a subset of 
the aged subjects. BrainSuite extracts the cortex by defining the grey/white (inner) 





Figure 11. BrainSuite method for measuring cortical thickness 
The inner (grey/ white matter) and outer (grey matter/cerebrospinal fluid) cortical boundaries are 
extracted and the Euclidean distance between them calculated. 
 
 
Cortical thickness is then measured by calculating the Euclidean distance between the 
inner and outer boundaries.  
 
 
5.4 Image processing assessment results 
 
The following sections describe the results from each image processing assessment 






5.4.1 Brain extraction 
Brain extraction was the first image processing step that I implemented in each 
subject group, starting with infant subjects. 
 
5.4.1.1 Infant subjects 
I first attempted brain extraction in the infant subjects with BET.  
 
5.4.1.1.1 BET 
An example of infant subject skull stripping using the default parameter settings in 
BET is shown in Figure 12. Although the top of the brain was extracted very well, a 
large amount of non–brain structure remained around and below the optic nerves. By 
adjusting BET’s default settings I was able to improve the brain extraction (lower 
panel Figure 12). Despite correcting some of the default setting errors, reasonably 
large amounts of non–brain structure remained, while a very large proportion of brain 
structure was incorrectly removed. This meant that mass unsupervised skull stripping 
using BET was not suitable for the infant subjects. Indeed, BET was not designed for 
use in these subjects. The BET process took less than 30 computer seconds and 
manual editing took between 30–60 minutes per subject. 
 
5.4.1.1.2 BrainSuite 
BrainSuite generally extracted the infant brain very well, but while there were only 
minor errors in some subjects (Figure 13i), there were more considerable errors in 
others (Figure 13ii). Further, despite the subjects being from the same scanner and 
sequence, the high variability in brain structure between subjects meant that the 
extraction parameters had to be adjusted for each individual. Therefore mass 







Figure 12. Brain extraction of an infant subject using various parameters 
in the Brain Extraction Tool (BET) 
The extracted brain is highlighted in red and overlaid on the original 
whole head image. The yellow arrow shows erroneous remaining non-





Figure 13. Automatic brain extraction in two separate infant 
subjects using BrainSuite 
The extracted brains are outlined in green and overlaid on 
the original whole head images. The centres of the 
crosshairs show where non-brain tissue remained. 
BrainSuite provided a tool to remove this manually. 
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The BrainSuite process took less than 30 computer seconds per subject and manual 
editing took between 20–45 minutes per subject. Figure 14 shows an example 




Figure 14. Brain extraction in an infant subject after manual editing in BrainSuite 
The extracted brain is highlighted in pink and overlaid on the original whole head image. 
 
 
5.4.1.1.3 Atlas based brain extraction with ANTS 
By diffeomorphically registering the (manually validated) extracted brain from Figure 
14 to all other subjects, ANTS performed brain extraction very well. Of the 31 infant 
subjects, there were two gross errors while the remaining 29 subjects had slight 
volumes of meninges and skull (Figure 15). The ANTS process took one computer 
hour and manual editing took between 10–20 minutes per subject. The requirement 
for manual editing meant that mass unsupervised skull stripping using ANTS was not 






Figure 15. Automatic atlas based brain extraction in an infant subject using ANTS 
The extracted brain is highlighted in red and overlaid on the original whole head image. The centre of 
the yellow crosshairs shows the minor errors that occurred in this method. On the far right is a brain 
extraction 3D rendering that illustrates the limited errors across the cortex. The green/blue areas are 
tissue and the red/ yellow areas are cerebrospinal fluid. 
 
 
Since the high variability between infant subjects is similar to the variability between 
aged adults, I adopted what I found to be the best method for the infant subjects (atlas 
based segmentation) for the aged adult subjects. 
 
 
5.4.1.2 Aged adult subjects 
The long computational processing time of ANTS registration (~1 hour) led me to 
attempt atlas based segmentation in the aged adult subjects with linear registration. 
Linear registration computes far less transformations (this is discussed in detail in 
section 5.3.5) and so has a much shorter computational processing time (~2 minutes). 
However, the reduced number of computations means that differences between the 




Figure 16. Automatic atlas based brain extraction in an aged subject using 12 point linear registration 
This led to several erroneous areas where skull remained, indicated by the centres of the red crosshairs. 
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These errors and doubled manual editing time (20–40 minutes per subject) determined 
that atlas based segmentation with ANTS registration was most suitable for the aged 
adult subjects (Figure 17). 
 As illustrated in Figure 17, ANTS performed very well for the majority of the 
460 aged subjects. This still required approximately 10 minutes of manual editing per 





Figure 17. Automatic atlas based brain extraction in an aged subject using 
ANTS 
The atlas in cyan was registered to the subject using ANTS for brain 
extraction. The extracted brain is highlighted in magenta and overlaid on 




Figure 18. An infrequent but gross error from atlas–based brain extraction in an aged 
subject using ANTS 
The attempted brain extraction is highlighted in red and overlaid onto the original whole 




The gross error shown in Figure 18 and the more subtle errors in Figure 17 (at the 
outer edge of the cortex) meant that mass, unsupervised skull stripping was not 
suitable for the aged adult subjects. The error rates, computational times, and manual 
editing times for each brain extraction method are given in Table 16. 
 
 
Table 16. Error rates and processing times in aged subject brain extraction 
Method Percent of subjects 
with gross errors 
Computational time Manual editing 
time 
Linear registration 75% 2 minutes 20-40 minutes 
ANTS registration 5% 1 hour 10-20 minutes 
Note: ANTS=Advanced Normalisation Tools. 
 
 
The errors in aged adult brain extraction were due in part to the high variance in 
ageing brain structure but fortunately this problem did not exist across the whole 
lifecourse. Brain structure was much more homogeneous in younger adult subjects 
and this allowed me to implement a downsampled method in these younger subjects. 
 
5.4.1.3 Young to middle adult subjects 
The downsampled method that I proposed in young to middle adults was generally 
successful. Manual editing time was reduced by approximately half, to approximately 
5 minutes per subject (from 10 minutes in original resolution).  However, despite this 
reduction, my approach did not completely negate the need for manual editing (Figure 
19). Therefore, even in these much more homogenous subjects, mass unsupervised 






Figure 19. Automatic brain extraction in a middle aged adult using a 
downsampled atlas 
The extracted brain is highlighted in red and on each whole head image. 
The downsampled mask was edited (see missing brain tissue on the left at 
the centre of the crosshairs) and then returned to its original resolution to 
provide the subsequent brain extraction in the original subject (right). 
 
 
5.4.2 Tissue segmentation 
Examples of FAST tissue classification in the aged subjects are shown in Figure 20. 
 
 
Figure 20. Misclassification of hypointense white matter in a T1 image using FAST 
Grey matter has been highlighted in blue showing that subject i was correctly classified, 
however, this also shows that the classification algorithm has incorrectly classified hypointense 
white matter as grey matter in subject ii. The misclassifications are highlighted at the 
intersection of the crosshairs (right panel). 
 
 
Although FAST differentiated brain tissue from cerebrospinal fluid very well, it 
sometimes misclassified white matter hypointensities (hyperintensities on T2–
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weighted images) as grey matter (Figure 20). Gross errors occurred in approximately 
5% of aged adult subjects and were not focused in any one age group but equally 
spread across the age range. These errors may be corrected using multimodal MR 
imaging, e.g. the combination of T1-weighted and FLAIR images differentiates white 
matter abnormalities from GM (Admiraal-Behloul et al., 2005). The use of 
multimodal MRI sequences and parallel molecular imaging has been shown to 
provide improved characterisations of brain structure (Toga et al., 2006). However, 
only T1-weighted images were available for many of the aged adult subjects used here 
(Marcus et al., 2007c). There were almost no hypointense white matter regions in the 
young to middle adult subjects. Because tissue intensities are inverted in early life, I 
did not use tissue classification in infant subjects. 
 In an attempt to mitigate errors in standardising voxel values while still being 
able to sensibly combine subjects from different acquisition parameters and scanners, 
I implemented a MR signal normalisation algorithm (Nyúl and Udupa, 1999). 
 
5.4.3 Standardising the MR intensity scale 
To illustrate the standardisation procedure and its effect on brain structure, the 
original voxel intensities of 25 normal aged subjects (different individuals) from 3 
different scanners in ADNI and those of the template are shown in Figure 22. The 
standardised intensities in Figure 23i show that this method successfully normalised 
the intensity scales from these three scanners. Figure 23ii shows that this was 
achieved without unduly altering original brain structure: median, IQR error in grey 
matter volume following intensity normalisation was 0.011, 0.019 (1.1, 1.9%). Only 
25 subjects are shown in Figure 22 to avoid clutter, the tissue segmentation was 
carried out in 49 subjects (Figure 23ii).  
The minimal error in tissue segmentation before and after SIS suggested that 
the algorithm removed only between scanner variance and not between subject 
variance (right panel Figure 23). However, as shown in Figure 21, this original 
algorithm did affect the appearance of brain structure, i.e. it increased tissue contrast. 
Although this may be aesthetically pleasing, it is an artificial effect that does not 
reflect the true brain structure (tissue contrast naturally decreases in ageing; 









After investigating this effect, I found that it was introduced by removing image 
background values before the standardisation procedure. I therefore updated the 
algorithm to include image background values during standardisation and only 
remove these for graphically visualising output (e.g. Figure 24). Tested in 460 
different subjects (NAD=224, NControl=236) from 60 different sites used in ADNI and 
OASIS, the updated SIS algorithm standardised voxel values whilst not affecting the 
original appearance of brain structure (Figure 24). 
 This validation is not absolute and applies only to the subjects that I assessed. I 
recommend that, even if already validated in one group of subjects, thorough visual 
and quantitative testing is done prior to performing subsequent analyses after SIS.  
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Original subject voxel intensities 
 
Template voxel intensities 
 
 
Figure 22. Original voxel intensities of 25 subjects from 3 different scanners and the template voxel intensities 







Standardised subject voxel intensities 
 




Figure 23. i. Standardised voxel intensities of 25 subjects from 3 different scanners and ii. The effect of standardisation on original brain structure 




Figure 24. Output from updated standardised intensity scale (SIS) algorithm 
The updated algorithm removed background voxels after standardisation, only for graphically visualising output, i.e. these histograms.
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5.4.4 Spatial normalisation (registration) 
The results from each type of registration are illustrated in Figure 25. Linear 
registration methods with a lower number of transformations (6 point, 9 point, and 12 
point) maintained original anatomical variation but did not always adequately account 
for head size differences. Nonlinear registration adequately accounted for head size 
differences however removed almost all of the within brain variance of interest, e.g. 
lateral ventricle volume. Nonlinear surface registration addressed both of these issues 
by adequately accounting for head size while still maintaining within brain variance 
of interest.  
CV was 0.45 6pt registration, 0.37 in 9pt registration, 0.36 in 12pt registration, 
0.33 in nonlinear surface registration, and 0.25 in nonlinear registration. This meant 9 
point (pt) registration reduced CV by 17.7%, 12 pt registration by 20%, nonlinear 
surface registration by 27.5%, and nonlinear registration by 44.9% (with respect to 6 
pt CV). Higher reductions in CV indicate that the registration method is removing 
more of the natural variance in brain structure between subjects, i.e., nonlinear 





Figure 25. Comparison of 
registration methods 
Methods with a low number of 
transformations (6 point, 9 
point, and 12 point) did not 
always account for head size 
differences (indicated by the 
yellow crosshairs and bright 
cyan regions in the middle 
horizontal panel). Nonlinear 
(Nonlin) removed almost all of 
the within brain variance, e.g. 
lateral ventricle volume 
indicated by the white 
horizontal line in the middle 
panel. Nonlinear surface 
(Nsurf) registration adequately 
accounted for head size and 
maintained within brain 






Figure 26. Histograms of coefficient of variance (CV) images from each registration method 
The 9pt (green line) and 12pt (red line) registration methods were almost entirely overlapping in CV, 
with 12pt registration having a slightly lower median CV than 9pt (0.36 in 12pt versus 0.37 in 9pt). 
 
 
Figure 26 shows the histograms of voxel variance (CV images) after linear, nonlinear, 
and nonlinear surface registration. It can be seen here that nonlinear registration has 
reduced the variance between subjects to almost zero in a large proportion of voxels. 
I qualitatively observed that nonlinear surface registration more adequately 
accounted for head size differences. Although it appeared within brain structure was 
also maintained, I tested this quantitatively by computing proportional lateral ventricle 
volumes before and after registration. The error in proportional lateral ventricle 
volume following registration (median=2.76%, IQR=1.89%) indicated that nonlinear 










Although the inner parts of the brain (e.g. lateral ventricles) were not unduly altered 
with nonlinear surface registration, the algorithm focused on the surface of the brain 
therefore may have been more likely to unduly affect cortical thickness. I tested this 
by computing cortical thickness before and after nonlinear surface registration in a 
group of AD subjects and a matched group of controls (the groups consisted of 89 
subjects randomly selected from the ADNI cohort described in 5.2.3). Figure 28 
shows that, while the algorithm increased cortical thickness (as expected given the 
increase in overall brain size; Figure 29), it did so to the same extent in both groups 








Figure 28. Cortical thickness before and after nonlinear surface (Nsurf) 
registration in a group of AD subjects (top panel) and a group of matched 
control subjects (bottom panel) 
Cortical thickness was increased to the same level in both groups (as 
expected given the increase in overall brain size) and therefore Nsurf did 











Figure 29. Cortical thickness before and after nonlinear surface registration 
The increase in cortical thickness (shown in figure 28) after Nsurf is consistent with the increase in overall brain size shown here. The inner cortical boundary is shown in 






Because of the brain structure changes that occur through life (chapters 1-4), I had to 
assess specific image processing methods at different stages of the lifecourse. I 
discuss the implications of these assessments under each subject group heading, 
starting with infants. 
 
5.5.1 Brain structure MRI processing in infants 
Brain extraction in infants represented a unique challenge. Infant brains are much 
smaller than adult brains and therefore methods designed for use in adults were not 
entirely suitable. In particular, BET produced gross errors (that required substantial 
manual editing) despite extensive tweaking of the algorithms’ parameters. This is not 
overly surprising and not a criticism of BET; it was simply not designed for use in 
infants. But given BETs’ widely successful application, it was sensible to perform this 
test in infants and at least rule it out for future use. The automatic sequence of the 
BrainSuite pipeline produced smaller errors in some subjects, but still led to gross 
errors in others. Again, BrainSuite was not specifically designed for the nuances of 
the infant brain but did provide an incorporated manual editing platform to speed up 
processing time (by 10-15 minutes). While BrainSuite and BET were designed for use 
in adults, ANTS atlas-based segmentation was specifically designed for brains with 
challenging features, such as infants and older adults. It was not surprising then that 
ANTS, also with the longest computational processing time, produced the smallest 
errors and required the least manual editing time. However, it did still require manual 
editing and illustrates that in brains with such distinctive features, e.g. markedly 
smaller size, fully automatic processing may not be appropriate. The general shrinking 
of the brain in ageing meant that these issues were also present in aged adult subjects. 
 
5.5.2 Brain structure MRI processing in aged adults 
Brain extraction in aged adults was equally as challenging as in infant subjects. While 
the infant brain is growing, the aged adult brain is generally shrinking and this means 
that specifically designed programs, such as ANTS, are required to successfully brain 
extract these subjects. However, ANTS took up a large amount of computational time 
(~1 hour per subject) therefore I first attempted atlas-based segmentation using linear 
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registration (which has much less transforms and so takes much less time than 
ANTS). While it took dramatically less computational time (~2 minutes vs. ~1 hour), 
the limited number of transforms in linear registration drastically reduced the 
correspondence between the reshaped atlas and each subject. This meant that, while it 
saved on computational time, manual editing time was doubled with linear atlas-based 
segmentation. I therefore proceeded to use ANTS atlas based segmentation in aged 
adult subjects. This led to a significant reduction in errors but there were still mild to 
moderate errors in many subjects and these required approximately 10 minutes 
manual editing per subject. Moreover, there were gross errors in a very small number 
of subjects and these illustrate that, as in infants, fully automatic brain extraction may 
not be appropriate in aged adults. 
 Following brain extraction I automatically extracted GM, WM, and CSF 
images that may be used to sensibly compare subjects from different scanners and 
sequences. Especially for CSF, this process could be almost entirely automated even 
in these aged subjects (save for manual double-checking). However, some of these 
aged subjects had marked white matter hypointensities (potentially lesions) on their 
T1 images and these were sometimes incorrectly classified as GM. I required MR 
sequences that were not available for all subjects, e.g. FLAIR, T2*, to reliably correct 
these errors (Wardlaw et al., 2011). I therefore sought another method to allow 
sensible comparison of subjects across scanners and sequences. 
 Since I could not adequately address the issues with tissue segmentation (due 
to time and image sequence constraints), I implemented MR signal intensity 
standardisation (SIS). After addressing the issues of contrast alteration in the first 
version of the SIS algorithm, this appeared to bring the intensities of over 400 subjects 
with and without AD into a common framework. By computing GM before and after 
SIS it was apparent that the algorithm maintained the original anatomical structure of 
subjects. However, this validation is not definitive and I recommend that the results of 
SIS are thoroughly checked, both quantitatively and qualitatively, in the specific 
group of subjects under study.  
While I recommend such meticulousness in all aspects of image processing in 
aged and infant subjects, the homogeneity of young to middle adult brains suggested a 





5.5.3 Brain structure MRI processing in young to middle adults 
The homogeneity between young to middle adult brains allowed me to test a 
downsampled brain extraction method. That is, I downsampled subjects to an atlas 
with lower resolution (number of slices) in the hope that this would negate or reduce 
manual editing time. While it did not completely negate the need, this method did 
reduce manual editing time by half (from 10 to 5 minutes). There were no gross errors 
in this method and even before implementation, manual editing in this group was the 
lowest across the lifespan. This suggests that the homogeneous anatomy of these 
subjects had a great deal to do with the success of this brain extraction method.  
Following brain extraction, I extracted several regional brain volumes 
(hippocampus, parahippocampal gyrus, amygdala, putamen, caudate, and thalamus) 
also using atlas-based segmentation. Through visual assessment I found no gross 
errors in these segmentations. The segmentations were however not perfect and (due 
to time and resource constraints), I could not correct these small errors. This is a 
limitation common to many studies and an image processing method that is 
commonly applied (Maldjian et al., 2003). Therefore, since I am interested in testing 
commonly applied brain imaging statistical methods, it is arguably only a minor 
limitation for my purposes. Future studies with manually edited regional volumes will 
assess the effect of this limitation in determining true measures across the lifecourse. 
Although extraction of brain image volumes requires specific methods given 




Linear registration only alters brains via their main axes therefore does not unduly 
alter within brain structure such as lateral ventricle volumes, i.e. lateral ventricle 
volume is scaled according to the whole brain maintaining its original ratio. This 
means that spurious differences in head size that occur in regions other than the main 
axes may remain. Conventional nonlinear registration addresses this problem however 
it does not maintain within brain structure variance, e.g. lateral ventricle volumes are 
warped to those of the atlas/ registration target. I therefore devised Nsurf registration 
to fully account for head size differences but maintain within brain structure variance 
of interest. Validation of this method in aged subjects suggested that it sufficiently 
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addressed these issues without creating systematic bias between groups, e.g. in 
cortical thickness between AD subjects and controls.  However, it should be noted 
that, as with any registration method, Nsurf does alter overall brain structure, e.g. 
Figure 29. Moreover, my validation only applies to the limited number (n=118) of 
ageing and AD subjects I assessed. Because of this I recommend that Nsurf is 
appropriately validated before it is used in subjects at other stages of the lifecourse. 
 
5.5.5 Summary 
The changing nature of the brain through life requires image processing methods that 
are specific to the age of subjects under study. Different methods may also be adopted 
depending on the purpose of a study, e.g. in a functional study investigators may wish 
to entirely remove brain structure variance between subjects by registering each 
subject to an atlas with a very high number of transforms. This work was interested in 
quantifying normal brain variance that may be implicit in subsequent neurological 
disease. I therefore devised a registration method (Nsurf) that removed spurious 
differences, e.g. head size differences, while it maintained variance that may indicate 
disease, e.g. lateral ventricle volume. 
Having extracted relevant data in a manner most suitable for my purposes, I 
proposed a novel statistical analysis method for defining the normal limits of brain 
tissue volumes; this method is described in the next chapter. 
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6. A novel statistical method for definition of the distributions and boundaries of 





Methods to define normal brain volumes across age are often based on central 
tendency, e.g. mean or median, statistics. The review in chapter 4 found that, for over 
20 years, mean-based statistical models have been used extensively to define normal 
brain volumes across age (see chapter 4 for the full review or Table 17 for a 
summary). 
Mean estimates may be extrapolated to define the distributions and clinical 
boundaries of brain volumes if the variance in brain volumes is equally Gaussian 
between ages and disease states. However, if the variance is not equally Gaussian, the 
distribution of differences in brain volumes between ages may not be well represented 
by models based on mean estimates (Elveback et al., 1970; Koenker and Bassett Jr, 
1978; Freedman et al., 2007). That is, the true range of normality and boundaries with 
pathology may be obscured if extrapolated from these models. 
Several independent studies have shown that variance in brain tissue volume is 
unequal between ages (Manolio et al., 1994; Ge et al., 2002; Resnick et al., 2003; 
Kruggel, 2006; Farrell et al., 2009), i.e. the range of volumes generally increases with 
age. However, data transformation methods were previously used in brain image 
analyses, e.g. Box-Cox (Box and Cox, 1964; Kruggel, 2006), and these removed 
much of this inequality to fit the requirements of models based on mean estimates. 
While this approach is useful in research to identify general patterns of brain ageing, it 
may mask the true boundaries of normality and the subtle early signs of disease. I 
found no other previous study that attempted to define the distribution and boundaries 
of normal brain volume differences between ages. The true distribution of differences 
in brain tissue volume between ages is therefore largely unknown.  
                                                 
4This was supported by a travel grant award from Guarantors of Brain (www.guarantorsofbrain.org.uk) 
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normality. PLoS ONE 8(12): e84093. 
Dickie, D.A., Job, D.E., Rodríguez González, D., Shenkin, S.D., Wardlaw, J.M. (2012). A databank, 
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Age rangea Mean ±SD 
Agea  Statistical Methodb 
Allen et al., 2005 87 22.0–88.0 49.4 ± 20.8 Multiple regression 
Courchesne et al., 
2000 
116 1.6–80.0 21.4 ±20.0 Regression analyses 
DeCarli et al., 2005 2081 34.0–96.0 62.4 ±10.4 Linear regression 
Fotenos et al., 2005 94 65.0–95.0 78.0 ±8.0 Hierarchical 
polynomial regression 
Ge et al., 2002 54 20.0–86.0 46.8 ±19.3 Least–squares 
regression 
Giorgio et al., 2010 66 23.0–81.6 36.7c Regression analysis 
Good et al., 2001 465 17.0–79.0 29.5d General Linear Model 
Gur et al., 1991 69 18.0–80.0  41.4 ±20.2 Multivariate analysis of 
variance 
Jernigan et al., 2001 78 30.0–99.0 64.0 ±17.4 Nonparametric monotone 
regression 
Kruggel, 2006 502 16.0–70.0 30.0 ±9.6 Linear, quadratic 
regression 
Raz et al., 2005 72 20.0–77.0 52.6 ±14.1 Latent difference model 
Sowell et al., 2003 176 7.0–87.0 32.4 ±21.8 Quadratic multiple 
regression 
Walhovd et al., 2005 25 67.0–88.0 74.3 ±4.8 Regression analyses 
Ziegler et al., 2011 547 19.0–86.0 48.1 ±16.6 General linear model 
Note: Bolded entries show methods based on means; aIn years; bThis is the statistical 
method used to provide the majority of results, recorded as stated in the corresponding 
manuscript; cMedian; dEstimated median; SD=standard deviation. 
 
 
Specifically, as they have not previously been calculated (Table 17), it is not known 
whether percentile rank differences are equal to mean (parametric) differences in 
brain volume. In parametric regression models it is implicitly assumed that mean 
differences approximate percentile rank differences (Freedman et al., 2007). 
Percentile ranks are levels that represent percentages of subjects within a distribution, 
e.g. the bottom 5% of subjects in a distribution have a value equal to or less than the 
5th percentile rank value (Freedman et al., 2007). To define these levels with mean-
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based models one must assume, for example, that the differences in brain tissue 
volume between 60 and 70 year olds at lower ranks, e.g. the 5th percentile, are the 
same as the differences between 60 and 70 year olds at higher ranks, e.g. the 95th 
percentile. It is unknown whether or not this is true. If it is not true then potentially 
important biological information may be lost by extrapolation from mean-based 
models. In particular, the limits of normality and boundaries with pathology may be 
misrepresented (Elveback et al., 1970; Freedman et al., 2007).  
In this chapter, using publicly available brain images, I attempted to determine 







MR brain images from 137 “normal” subjects (n=60, 44% female), mean age ~76 (70-
89) years, were acquired from the ADNI databank (Table 15, page 71). These subjects 
did not have dementia, but potentially had non-debilitating conditions common in 
ageing, e.g. hypertension. A further 90 subjects (n=65, 72% female) with similar 
clinical characteristics and a mean age of ~75 (60-89) years, were acquired from the 
OASIS databank (Marcus et al., 2007c) (Table 15, page 71). According to the 
systematic review in chapter 2, ADNI and OASIS were the only public sources of 
structural MR brain images that had medical and cognitive metadata representative of 
the characteristics of normal older people (≥60 years). These subjects were reported to 
be representative of normal older people through cognitive and physical tests but 
actual measures of potentially confounding variables, e.g. blood pressure, for all 
subjects were not available to me (Marcus et al., 2007c). I combined the ADNI and 
OASIS samples to create a single normal subject sample of n=227 subjects. 
A sample of MR brain images from 124 subjects diagnosed with AD (n=58, 
47% female) and a mean age of ~75 (55-89) years was also acquired from ADNI 
(Table 15, page 71). A further 95 AD subjects with similar demographics were 
acquired from OASIS (Table 15, page 71) and combined with the ADNI subjects to 




6.2.2 MR brain image processing 
Non–brain structure was removed from the images and grey matter, white matter, and 
cerebrospinal fluid volumes were calculated by the steps described in chapter 5. The 
advanced age of these subjects meant that many of them had what appeared to be WM 
lesions (hypointense WM regions on T1-wieghted images that are hyperintense on 
T2-weighted images). FAST sometimes incorrectly classified these regions as GM. I 
did not have the MRI sequences, e.g.  fluid attenuated inversion recovery (FLAIR), 
required to accurately address these errors for all subjects (Marcus et al., 2007c). 
Although incorrectly classified as GM, these regions were still correctly classified as 
tissue, i.e. not CSF. I therefore added the GM and WM volumes within each subject to 
calculate overall brain tissue volume in voxels. Brain tissue volumes were then 
normalised (divided) by total intracranial volume (TIV=tissue+CSF). I do not report 
normalised CSF regression models because they were the exact inverse of normalised 
whole brain tissue volume models. 
 
6.2.3 Calculating mean and percentile rank regression models of brain volume by age 
When age was expressed in one year intervals, there were very few subjects at some 
ages, meaning that it was not possible to calculate the values of percentile ranks at 
these ages. Therefore, I expressed age in the following intervals: <70, 70-74, 75-79, 
80-84, and 85-89 years. 
Mean differences in brain tissue volume between age groups were calculated 
in each sample with “PROC REG” in the Statistical Analysis System (SAS) v9.3 
(http://support.sas.com/documentation/cdl/en/statug/63033/HTML/default/viewer.htm
#reg_toc.htm). PROC REG produces a regression equation (y=βx1… βxn+c) to 
describe mean differences in a dependent variable (y), e.g. brain tissue volume, 
between values of an independent variable (x), e.g. age group. The beta (β) coefficient 








The 5th, 25th, 50th, 75th, and 95th percentile ranks of brain volume were directly 
calculated for each age group by equation 4, 
 
 gjnp    (4.1) 
 )(2/1 1 jj xxy  if g = 0 (4.2) 
 
1 jxy  if g > 0  
where n is the number of subjects, for the tth percentile p=t/100,  j is the 
integer part of np, g is the fractional part of np, y is the tth percentile, and x1, x2, ... 
, xn are the ordered values of brain tissue volume. Differences in volume between ages 
(regression equations) at these percentile ranks (rather than the mean) were then 
calculated with PROC QUANTREG in SAS.  
For both mean and percentile rank estimates, I initially performed linear 
regressions. These were used to produce residual plots (actual minus regression 
predicted volumes by age group). The linearity assumption is in question if these plots 
show a systematic pattern, e.g. particular age groups with skewed positive or negative 
residuals (Freedman et al., 2007). When the linearity assumption was in question, I 
performed nonlinear (cubic) regression to define differences between ages (Fotenos et 
al., 2005). Cubic regression was chosen because previous literature indicated brain 
tissue exhibits a nonlinear decline in ageing (>60 years) but not a nonlinear decline 
with subsequent regrowth (i.e., it does not exhibit a higher order polynomial pattern; 
Good et al., 2001; Fotenos et al., 2005). 
The representativeness of mean estimates was illustrated by relative 
percentage error between the expected (mean) and observed (percentile rank) 













 where ipy ,

 is the mean-based prediction of percentile rank p for age group i, 
idpy ,

is the directly calculated percentile rank prediction, and  is the overall mean 
change in brain tissue volume (mean regression predicted volume at <70 years minus 
mean regression predicted volume at 85-90 years). Due to the potential for subtle 
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differences between ages and disease (Fotenos et al., 2005; Farrell et al., 2009), 





6.3.1 Mean and variance of brain volume within the normal and AD samples 
The mean and SD of normalised brain volume in each age group in the normal and 
AD samples are shown in Table 18. Given the potential for subtle differences between 
age groups, volumes are given to four significant figures. Variance in brain tissue 
volume generally increased with age in the normal sample but decreased with age in 
the AD sample.  
 
Table 18. The mean and standard deviation of normalised brain volume in each age 
group in the normal and AD samples 
Sample Age n Mean SD 
Normal <70 25  0.7555  0.0130 
 70-74 89  0.7569  0.0196  
 75-79 56  0.7490  0.0204  
 80-84 34  0.7418  0.0193  
 85-89 23  0.7359  0.0210  
AD <70 43 0.7399 0.0236 
 70-74 56 0.7350 0.0208 
 75-79 49 0.7330 0.0209 
 80-84 49 0.7292 0.0199 
 85-89 22 0.7128 0.0187 
Note: SD=standard deviation. 
 
 
Residual plots (actual minus regression predicted volumes by age group) from the 
mean linear regressions in each sample are shown in Figure 30. The different spread 
of points at each age group further illustrates unequal variance between ages. 
Moreover, skewed residuals at 70 years in the normal sample (few positive compared 
to negative residuals) and a similar pattern at 85-90 years in the AD sample suggested 
that the linearity assumption was in question. I therefore performed nonlinear 




Figure 30. Residual plots (actual minus mean linear regression predicted brain volumes by age) in the 
normal (top panel; n=227) and AD (bottom panel; n=219) samples. 
There are skewed residuals at 70 years in the normal sample (top) and a similar pattern at 85-90 years 






6.3.2 Mean and percentile rank regression estimates of brain volume across age within 
the normal sample 
Mean and percentile rank regression estimates of brain volume across age in the 
normal sample are listed in Table 19 and illustrated in Figure 31 and Figure 32. As the 
dashed (percentile rank) lines within each graph (Figure 31) are generally not parallel, 
the distribution of differences in brain tissue volume between ages was not well 
represented by mean estimates. The diverging percentile rank lines further illustrate 
that variance in brain tissue volume increased with age in normal subjects. 
Mean estimates generally overestimated differences in brain tissue volume 
between ages at percentile ranks above the mean, i.e. in the upper percentile ranks, 
mean regression beta underestimated brain tissue volume at advanced ages. For 
example, the mean-based prediction of the 95th percentile of brain volume at 85-90 
years was short by 74% of the overall expected change between <70 and 90 years 
(Table 19). This is in contrast to percentile ranks below the mean, where mean 
estimates generally underestimated differences between ages, i.e. in the lower 
percentile ranks, mean regression beta overestimated brain tissue volume at advanced 
ages. For example, the mean-based prediction of the 5th percentile of brain volume at 
85-90 years was inflated by 66% of the overall expected change between <70 and 90 














Table 19. Mean and percentile rank regression estimates of normalised brain tissue 
volume across age in the normal sample 
Rank Age (x) c Beta_x Beta_x2 p prediction  prediction () % error 
MEAN  0.7584 0.0007  -0.0011    
5th  0.7397 -0.0089 0.0002    
 <70    (1)    0.7310 0.7393 35 
 70-74 (2)    0.7227 0.7367 59 
 75-79 (3)    0.7148 0.7319 72 
 80-84 (4)    0.7073 0.7249 75 
 85-89 (5)    0.7002 0.7157 (0.0236) 66 
25th  0.7545 -0.0049 -0.0002    
 <70    (1)    0.7494 0.7541 20 
 70-74 (2)    0.7439 0.7515 32 
 75-79 (3)    0.7380 0.7467 37 
 80-84 (4)    0.7317 0.7397 34 
 85-89 (5)    0.7250 0.7305 (0.0236) 23 
50th  0.7533 0.0036 -0.0014    
 <70    (1)    0.7555 0.7529 -11 
 70-74 (2)    0.7549 0.7503 -19 
 75-79 (3)    0.7515 0.7455 -25 
 80-84 (4)    0.7453 0.7385 -29 
 85-89 (5)    0.7363 0.7293 (0.0236) -30 
75th  0.7674 0.0038 -0.0016    
 <70    (1)    0.7696 0.7670 -11 
 70-74 (2)    0.7686 0.7644 -18 
 75-79 (3)    0.7644 0.7596 -20 
 80-84 (4)    0.7570 0.7526 -19 
 85-89 (5)    0.7464 0.7434 (0.0236) -13 
95th  0.7747 0.0067 -0.0016    
 <70    (1)    0.7798 0.7743 -23 
 70-74 (2)    0.7817 0.7717 -42 
 75-79 (3)    0.7804 0.7669 -57 
 80-84 (4)    0.7759 0.7599 -68 
 85-89 (5)    0.7682 0.7507 (0.0236) -74 
Note: This table shows the regression equations for the mean and each percentile rank. Percent errors 
between predictions are calculated for each age relative to the overall mean regression change 
(=mean regression predicted volume at <70 years minus mean regression predicted volume at 85-90 
years). Positive percent errors indicate that the mean regression underestimated differences between 
ages, i.e. overestimated brain tissue volume at advanced ages. Negative percent errors indicate that the 
mean regression overestimated differences between ages, i.e. underestimated brain tissue volume at 









Figure 31. Mean (top panel) and percentile rank (bottom panel) regression estimates of brain tissue 
volume across age in the normal sample (n=227). 
The slopes of these lines represent the beta coefficients in table 4. The mean-based model expects all 
percentile ranks to change at the same rate, i.e. be parallel. The diverging percentile ranks show that 
this is not the case and that variance in brain volume generally increased with age in the normal 




Figure 32. Illustration of the varying differences in normal ageing brain tissue volume, according to 
percentile rank. 
There were much greater differences between ages at the 5th percentile of brain tissue volume (bottom 
panel) than between ages at the 95th percentile (top panel) of normal subjects. 
  
 
6.3.3 Mean and percentile rank regression estimates of brain volume across age within 
the AD sample 
Mean and percentile rank regression estimates of brain volume across age in the AD 
sample are listed in Table 20 and illustrated in Figure 33. As in normal subjects, the 
lack of parallel lines (Figure 33) shows that the distribution of differences in brain 
tissue volume between ages in AD was not well represented by mean estimates. The 
converging percentile rank lines further illustrate that variance in brain tissue volume 
decreased with age in AD subjects. 
Opposite to the normal sample, mean estimates generally underestimated 
differences in brain tissue volume between ages at percentile ranks above the mean, 
i.e. in the upper percentile ranks, mean regression beta overestimated brain tissue 
volume at advanced ages. For example, the mean-based prediction of the 95th 
percentile of brain volume at 85-90 years was inflated by 47% of the overall expected 
change between <70 and 90 years (Table 20). This is in contrast to percentile ranks 
below the mean, where mean estimates generally overestimated differences between 
ages, i.e. in the lower percentile ranks, mean regression beta underestimated brain 
tissue volume at advanced ages. For example, the mean-based prediction of the 5th 
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percentile of brain volume at 85-90 years was short by 28% of the overall expected 
change between <70 and 90 years (Table 20). 
 
 
Table 20. Mean and percentile rank regression estimates of normalised brain tissue 
volume across age in the AD sample 
Rank Age (x) c Beta_x Beta_x2 p prediction  prediction () % error 
MEAN  0.73638 0.0035 -0.0015    
5th  0.6950 0.0072 -0.0020    
 <70    (1)    0.7002 0.6970 -14 
 70-74 (2)    0.7014 0.6960 -24 
 75-79 (3)    0.6986 0.6920 -30 
 80-84 (4)    0.6918 0.6849 -31 
 85-89 (5)    0.6810 0.6749 (0.0222) -28 
25th  0.7186 0.0062 -0.0019    
 <70    (1)    0.7229 0.7206 -10 
 70-74 (2)    0.7234 0.7196 -17 
 75-79 (3)    0.7201 0.7156 -20 
 80-84 (4)    0.7130 0.7085 -20 
 85-89 (5)    0.7021 0.6985 (0.0222) -16 
50th  0.7474 -0.0060 0.0000    
 <70    (1)    0.7414 0.7494 36 
 70-74 (2)    0.7354 0.7484 59 
 75-79 (3)    0.7294 0.7444 68 
 80-84 (4)    0.7234 0.7373 63 
 85-89 (5)    0.7174 0.7273 (0.0222) 44 
75th  0.7399 0.0098 -0.0025    
 <70    (1)    0.7472 0.7419 -24 
 70-74 (2)    0.7495 0.7409 -39 
 75-79 (3)    0.7468 0.7369 -45 
 80-84 (4)    0.7391 0.7298 -42 
 85-89 (5)    0.7264 0.7198 (0.0222) -30 
95th  0.7794 -0.0016 -0.0009    
 <70    (1)    0.7769 0.7814 20 
 70-74 (2)    0.7726 0.7804 35 
 75-79 (3)    0.7665 0.7764 45 
 80-84 (4)    0.7586 0.7693 48 
 85-89 (5)    0.7489 0.7593 (0.0222) 47 
Note: This table shows the regression equations for the mean and each percentile rank. Percent errors 
between predictions are calculated for each age relative to the overall mean regression change 
(=mean regression predicted volume at <70 years minus mean regression predicted volume at 85-90 
years). Positive percent errors indicate that the mean regression underestimated differences between 
ages, i.e. overestimated brain tissue volume at advanced ages. Negative percent errors indicate that the 
mean regression overestimated differences between ages, i.e. underestimated brain tissue volume at 





Figure 33. Mean (top panel) and percentile rank (bottom panel) regression estimates of brain 
tissue volume across age in the AD sample (n=219).  
The slopes of these lines represent the beta coefficients in table 5. The mean-based model expects all 
percentile ranks to change at the same rate, i.e. be parallel. The converging percentile ranks show that 
this is not the case and variance in brain volume generally decreased with age in the AD subjects. 
Although some may appear linear, each line is the result of nonlinear regression (table 5). 
 
 
6.3.4 Comparison of normal and AD samples 
There was increased overlap between normal and AD brain tissue volumes with 
advancing age, as illustrated by the diverging normal subject percentile ranks and 
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converging AD subject percentile ranks (Figure 31 and Figure 33). Differences 
between normal ageing subjects at lower percentile ranks were similar to, or even 
greater than mean differences between AD subjects. For example, 5th percentile rank 






I have shown in the publicly-available data that variances in brain tissue volume are 
unequal across older ages. As a result of this, the distributions and clinical limits of 
brain tissue volume may not be well represented by mean estimates. Differences in 
brain tissue volume between normal subjects at the lowest percentile ranks (below the 
mean) were considerably greater than differences at the highest percentile ranks 
(above the mean). For example, mean estimates inflated volumes by 35 to 75% at the 
5th percentile of normal subjects whereas they were short by 23 to 74% at the 95th 
percentile of normal subjects. This normal variation needs to be adequately defined so 
that it is not incorrectly attributed to neurodegenerative disease. While I had 
insufficient data to define true population variance, this proof of concept study 
suggests that percentile rank statistical models will be required to do so. 
Statistical models of the normal ageing brain may be used to support earlier 
diagnoses of AD and related disorders (Fox et al., 2001; Farrell et al., 2009; McEvoy 
et al., 2009). Models based on mean estimates found that differences in brain tissue 
volume between ages were greater in AD than in normal ageing (Fotenos et al., 2005). 
However, these models assume that the distributions of normal and abnormal brain 
volumes are equally Gaussian within age, and that the overlap between these 
distributions does not change with age (Freedman et al., 2007). I found that the 
distributions of brain volume were not equal within age and that the overlap between 
normal and AD brain volumes increased with advancing age.  
Further, I found that differences in brain tissue volume between normal ageing 
subjects at lower percentile ranks may be similar to, or even greater than differences 
between patients diagnosed with AD. Therefore, if a group of subjects acquired for 
controls in a clinical trial was unknowingly skewed to lower percentiles, true 
treatment effects in brain volume between normal ageing and AD may be obscured.  
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A percentile rank-based reference for brain volumes may then be useful to 
quantitatively rank individuals or to determine if the distribution of a control group is 
skewed. Given the wide and irregular variance in brain volume that I have identified 
in a relatively small number of apparently normal subjects, this percentile rank-based 
reference will require much more data than are publicly available at present (Dickie et 
al., 2012).  
New databanks such as Minimal Interval Resonance Imaging in Alzheimer's 
Disease (MIRIAD), which provides longitudinal data from 23 cognitively tested 
normal ageing subjects (Malone et al., 2013), may help to address this shortage. The 
Australian Imaging Biomarkers & Lifestyle Flagship Study of Ageing (AIBL) 
databank is similar to ADNI and OASIS and includes 177 control subjects aged over 
60 years. However, these subjects are not generally representative of the normal 
ageing population as they were preferentially selected as APOE ε4 allele carriers 
(Ellis et al., 2010).   
Other neuroimaging projects are ongoing or initiating that may, in due course, 
provide the required data. For example, we are building a brain image databank to 
provide a normal reference for the brain using existing data from >1000 cognitively 
tested normal older subjects aged mostly between 55 and >90 years 
(http://www.sinapse.ac.uk/research-resources/brains-project). These data are in the 
process of being collated and were not available at the time of this study. In the future, 
by iteratively adding subjects and monitoring the subsequent fluctuations in percentile 
rank values, I may determine the amount of data required to create robust models that 
represent the true distributions of brain volumes in normal ageing and disease. 
The limited number of subjects available to the present study (n=446) meant 
that I had to express age in five year rather than one year intervals. Differences 
between subjects within these intervals could not then be calculated here but could be 
calculated in future studies with larger samples. The age groups in this study did not 
have equal sample sizes and this may have contributed to the unequal variance in 
brain volumes (Freedman et al., 2007). However, a larger number of subjects 
generally leads to greater variance (Freedman et al., 2007). Therefore, since sample 
size generally decreased while variance increased with age in the normal subjects, 
future studies with more subjects may further illustrate our point that variance in the 
brain increases during normal ageing. This further suggests that percentile rank 
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models may be required to adequately describe the “true” levels and limits of normal 
brain structure. 
While I have shown that percentile rank analyses will likely be required to 
define the range of ageing brain structure, it may be that the wide variance described 
here (e.g., Figure 33) is due to the limited number of subjects currently available. 
Future work with much larger samples will be required to determine whether 
percentile ranks vary as greatly in the wider normal ageing population. 
The inclusion of “normal” subjects with and without hypertension or other risk 
factors may have also contributed to the unequal variance between ages. I could not 
specifically test this here as, although it was stated that some subjects had 
hypertension in general descriptions of the ADNI and OASIS databanks, the actual 
measures of blood pressure and individual medical diagnoses for all subjects were not 
available to me. However, as at least 50% of subjects tend to be diagnosed with 
hypertension in many “normal” older cohorts (Aribisala et al., 2012), it could be 
argued that the inclusion of subjects with and without hypertension is more 
representative of the normal ageing population.  
The incidence of normal subjects with silent AD pathology, e.g. that might be 
detected with Pittsburgh Compound-B (PIB) binding, or longitudinal cognitive 
decline that has not yet reached the point of dementia, may partially explain the 
increasing variance in brain structure with age. However, these data were not 
available for all subjects and therefore a bias would have been introduced had I 
excluded only some subjects based on these measures. Further, it was not the aim of 
this study to determine the source of brain structure variance in normal ageing but to 
demonstrate the effect of this variance. If the aim of this study had been to determine 
the source of variance then subjects with the measures could have been excluded and 
a sensitivity analysis done to detect bias. Future work with larger samples, more 
demographic and medical measures, and longitudinal data (to identify who eventually 
converts to disease) will be required to determine true population distributions and the 
sources of variance in normal ageing brain structure. 
My calculation of TIV will have underestimated true TIV because the venous 
sinuses as well as CSF expand to occupy space vacated by the shrinking brain 
(Aribisala et al., 2012). Further, FMRIB’s FAST may have incorrectly classified 
reduced signal areas of WM on MP-RAGE (potentially WM lesions) as GM. I did not 
have the MRI sequences, e.g. FLAIR, required to correct these errors for all subjects 
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(Marcus et al., 2007c). These regions were still correctly classified as tissue, i.e. not 
CSF, and so I combined GM and WM volumes to calculate whole brain tissue volume 
for each subject. Future studies and brain image databanks will need to acquire these 
additional sequences to define the true distributions of brain shrinkage and specific 
tissue, i.e. GM vs. WM, changes that occur with ageing. 
Although all subjects were scanned with the same T1 MP-RAGE sequence, 
the different scanners used in ADNI may have also affected variance in brain volumes 
(Jovicich et al., 2009). Future work may implement scanner type as a random effect.  
However, all scanner protocols were standardised (Jack Jr et al., 2008) and the 
magnitude of difference between brains that I detected is too large to be attributed 
only to differences in scanner performance. Studies using one scanner and equally 
sized age groups (Farrell et al., 2009) have shown that irregular variance in brain 
tissue volume is attributable to advancing age. 
Percentile rank models provide at least two new sources of information in 
brain image analyses. The first is that, given the general association between brain 
volume and cognitive function (Fotenos et al., 2005), percentile ranks may provide a 
measure to predict future brain loss and cognitive decline in individual patients, i.e. 
subjects at the lowest percentile ranks may be at greater risk of developing cognitive 
decline and dementia. I will test this in a planned longitudinal study. The second 
benefit is that percentile ranks may provide a deeper understanding of the differences 
between normal and diseased groups. For example, they will show whether general 
(mean) differences are due to consistent differences between subject groups or 
whether a given group of subjects has a skewed distribution of brain structure, e.g. a 
proportion of subjects with extremely low values of brain volume. These potential 
benefits, as well as the data I have presented here, suggest that percentile rank models 
may provide a deeper understanding of brain volume changes in normal ageing and, 
in future, assist diagnoses of neurodegenerative disease. 
As neurological diseases are associated with subtle changes that may occur 
earlier in life (Shenton et al., 2001; Tondelli et al., 2012), I also assessed whether 
mean differences in regional brain volumes between younger adults were 
representative of percentile rank differences. This is described in the next chapter. 
  
 119 
7. The accuracy of Gaussian distributions of regional brain volumes across early 





This work (among that of many others, e.g. Manolio et al., 1994; Good et al., 2001; 
Ge et al., 2002; Resnick et al., 2003; Sowell et al., 2003; Walhovd et al., 2005a; 
Kruggel, 2006; Farrell et al., 2009) has demonstrated that the human brain changes 
with age and disease. As I showed in the previous chapter, brain structure does not 
change uniformly between individuals. Moreover, specific regions within the brain 
have differential rates of change (Walhovd et al., 2005b; Raz et al., 2010). For 
example, some people retain their youthful brain size into old age while others lose 
brain tissue much sooner (Farrell et al., 2009). Within subjects the effect size of age 
has been shown to be smaller in superior regions, e.g. the superior motor cortex, 
relative to inferior regions such as the medial temporal lobe, where the effect size of 
age on tissue volume was greater (Sowell et al., 2003; Allen et al., 2005). 
As with whole brain volumes, differences in regional brain volumes between 
ages and states of health and disease were previously assessed with mean estimates 
and confidence intervals based on the Gaussian distribution (Allen et al., 2005; Raz et 
al., 2010). These parametric models assume that the distributions of brain volumes do 
not change with ROI, age, or disease (Meehl, 1978; Cohen, 1994; Freedman et al., 
2007). Several independent studies have shown that the distributions of brain tissue do 
change with ROI location, age, and disease (Manolio et al., 1994; Ge et al., 2002; 
Resnick et al., 2003; Sowell et al., 2003; Thompson et al., 2003; Kruggel, 2006; 
Farrell et al., 2009; Raz et al., 2010). This suggests that mean differences may not 
reflect differences between subjects that are far from the mean.  
Brain structure data are sometimes transformed, e.g. via “Box–Cox” (Box and 
Cox, 1964) or “nonparametric smoothing splines”, to make them less vulnerable to 
deviations from model assumptions (Kruggel, 2006; Ziegler et al., 2011). But this 
                                                 
5 Some of the work in this chapter was submitted for presentation as follows: 
Dickie, D.A., Job, D.E., Wardlaw, J.M., Laidlaw, D.H., Bastin, M.E. (2014). Evidence of non-normal 
distributions in brain imaging data from normal subjects: implications for diagnosis of disease. Proc. 




introduces an unnecessary layer of complexity (Freedman, 2010); may lead to 
irreproducible results depending on the transformation method used (Scott and Wild, 
1991); and makes data difficult to interpret.  
In other parametric models of regional brain volumes, the distribution of data 
and their proximity to the Gaussian distribution were not reported (Allen et al., 2005; 
Li et al., 2012). The robustness and generalisability of parametric models can vary 
dramatically when their assumptions are not met (Meehl, 1978; Cohen, 1994; 
Freedman et al., 2007). However, although applied often to model brain structure 
(Ashburner and Friston, 2000; Good et al., 2001), the effect of departures from 
parametric assumptions has not been thoroughly tested in these models. 
Specifically, the differences between models that assume Gaussian 
distributions and equal variances (i.e. parametric models) and models that do not 
make these assumptions (i.e. certain nonparametric models) are unknown. Therefore, 
in this chapter I will compare parametric and nonparametric models of whole brain 





The data described in this section were collected under NIH grant R01 EB004155-03 
(PI: Dr. Mark E. Bastin, Neuroimaging Sciences, The University of Edinburgh). 
 
7.2.1 Subjects 
Eighty normal subjects (40 males, 40 females) aged 25–64 (median 43, IQR 17) years 
were recruited from advertisements in the Western General Hospital and Royal 
Infirmary, Edinburgh. All subjects gave written informed consent to be assessed and 
were determined to be normal via medical histories and a battery of cognitive tests. 









Table 21. Demographics and age group labels of young to middle adult sample 
Age group in years Age group label1 Number 
25–34 1 21 
35–44 2 23 
45–54 3 24 
55–64 4 12 
25–64  80 
Note: 1this was the label used in statistical analyses described in 
the sections 7.2.5 and 7.2.6. 
 
 
7.2.2 Cognitive tests 
Each subject completed a battery of cognitive tests that were taken from the Wechsler 
Adult Intelligence Scale III (WAIS-III; Wechsler, 1997a), Wechsler Memory Scale III 
(WMS-III; Wechsler, 1997b), National Adult Reading Test (NART; Nelson and 
Willison, 1991), verbal fluency (Lezak et al., 2004), and simple and four–choice 
reaction time (Deary et al., 2001) tasks.  
 
7.2.3 Brain MRI acquisition 
Brain MRI data were acquired with a GE Signa Horizon HDxt 1.5T clinical scanner 
(General Electric, Milwaukee, WI, USA). The imaging protocol consisted of: axial 
T2–, T2*–, and FLAIR–weighted sequences, a coronal T1–weighted volume 
sequence, an axial T1–weighted fast–spoiled gradient echo (FSPGR) sequence, a 
magnetization transfer (MT–MRI) pulse sequence, and a diffusion MRI protocol, all 
acquired in Digital Imaging and Communications in Medicine (DICOM). Using 
MRIcron (Rorden, 2010), I converted the T1–weighted volume from DICOM to 
NIFTI–1 format (http://nifti.nimh.nih.gov/nifti–1) so to measure regional brain 
volumes. 
 
7.2.4 Brain MRI processing 
Regional brain volumes were extracted from each subject in native space and 
normalised by total intracranial volume (TIV) using the procedure described in 
chapter 5. Briefly, non–brain structure was removed by diffeomorphically warping 
(Avants et al., 2008) and applying the MNI152 brain atlas to each subject before 
manually correcting errors, e.g. remaining skull, slice–by–slice. Whole brain tissue 
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volumes were then calculated using FAST (Zhang et al., 2001). The SRI24 labelled 
brain atlas was then diffeomorphically warped to each subject and left and right 
amygdala, hippocampus, parahippocampal gyrus, caudate, putamen, and thalamus 
volumes were extracted from the whole brain GM volume. Because these structures 
represent a very small proportion of the TIV, sometimes much less than 1%, and to be 
consistent in tables throughout this chapter, I used scientific notation to present these 
results. 
 
7.2.5 Parametric and nonparametric distributions of brain volumes 
Parametric (Gaussian) distributions were calculated with the mean and standard 
deviation of brain volumes for each age group. Truly Gaussian distributions may be 
summarised as in Table 22 and Figure 3 in chapter 1. 
 
 
Table 22. Summary of the Gaussian distribution 
Percent of data (subjects) Area of distribution 
2.5–16 >= –2σ to –1σ 
>16–84 >   –1σ to +1σ 
>84–97.5 >   +1σ to +2σ 
Note: σ=standard deviation 
 
 
In other words, when data are Gaussian, the 2.5th percentile rank value is 
approximately equal to the mean minus 2 SD, the 16th percentile to the mean minus 
one SD, the 84th percentile to the mean plus one SD, and the 97.5th percentile to the 
mean plus 2 SD (Freedman et al., 2007). I used ±2 SD because ±1.96 SD sometimes 
underestimated the 95% limits (97.5th2.5th percentile rank) of simulated Gaussian 









I calculated percentile rank values using the ranking (nonparametric) approach 
described by equation 6,  
 gjnp    (6.1) 
 )(2/1 1 jj xxy  if g = 0 (6.2) 
 1 jxy  if g > 0  
 
where n is the number of subjects, for the tth percentile p=t/100,  j is the 
integer part of np, g is the fractional part of np, y is the tth percentile, and x1, x2, ... 
, xn are the ordered values of each brain volume. 
Parametric and nonparametric distributions of brain volumes were compared 
between age groups. That is, the parametric percentiles of each group were subtracted 
and the nonparametric percentiles were subtracted. These comparisons are described 
by equation 7, 
 1m,p–2m,p (7.1) 
 1m,p–3m,p (7.2) 
 1m,p–4m,p (7.3) 
 2m,p–3m,p (7.4) 
 2m,p–4m,p (7.5) 
 3m,p–4m,p (7.6) 
   
where 1 is age group, 25–34 years, 2 is age group 35–44 years, 3 is age group 
45–54 years, 4 is age group 55–64 years, m is method (parametric or nonparametric), 
and p is percentile rank, e.g. 2.5th; both m and p are the same within each comparison. 
In other words, I compared the percentile rank subtraction results between methods 
but not the differences between percentiles, e.g. 2.5th versus 97.5th. 
Differences in parametric and nonparametric comparisons were computed 
















where G is the result from comparison c (e.g. age group 1–2) of the 
parametrically (Gaussian) defined percentile p (e.g. 2.5th), and R is the corresponding 
result from comparison c (e.g. age group 1–2) of the nonparametrically (ranking) 
defined percentile p. A sign was added to the percent error if the direction of the 
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comparison result differed between methods, i.e. if the parametric method said age 
group 1 had a larger value while the nonparametric method said age group 2 had a 
larger value. 
 
7.2.6 Parametric and nonparametric effect sizes 








  (9) 
  where i is the mean of group i, e.g. young adults, j is the mean of group j, 
e.g. middle–aged adults, and σp is the pooled standard deviation of groups. Although a 
loose definition, parametric effect sizes of ≤0.2 are “small”, 0.5 is described as 
“medium”, and 0.8 is large (Cohen, 1988; Coe, 2002).  I have extrapolated this 
definition to that in Table 23. 
 
 
Table 23. Definition of effect sizes 
Effect size Definition 
d ≤ 0.2 Small 
0.2 < d < 0.5 Small, medium 
d = 0.5 Medium 
0.5 < d < 0.8 Medium, large 
d ≥ 0.8 Large 
 
 
For “Cohen’s d” to be reliable it requires the data be Gaussian distributed (Cohen, 









If data were Gaussian distributed then the result from equation 9 would approximate 











  (10) 
  
where i
~  is the median of group i, j
~ is the median of group j, and p
~  is the 
pool of the 50th percentile minus the 16th percentile in each group (when data are 
distributed Gaussian, the 50th percentile minus the 16th percentile is approximately 
equal to the standard deviation; Cohen, 1988; Freedman et al., 2007; Fritz et al., 
2012). 
Differences in parametric and nonparametric effect sizes were computed using 

















where d is the parametrically defined effect size between groups i and j, and 
d
~
is the nonparametrically defined effect size between groups i and j. A sign was 
added to percent error if the direction of the effect differed between methods. 
 For consistency of reporting, and because of the potential for small ratios of 
brain volumes, four significant figures are generally reported, e.g., 0.0005 may round 
up to 0.001 but that rounding doubles the apparent size of the effect. When ratios are 





7.3.1 Standard deviations in whole and regional brain volumes 





Table 24. Standard deviations of whole brain volumes in each age group 
Age group N GM %Err CSF %Err WM %Err 
1 21 1.5E–02 13 1.3E–02 14 7.3E–03 –36 
2 23 1.2E–02 –14 1.3E–02 12 9.2E–03 –20 
3 24 1.5E–02 12 1.0E–02 –10 1.6E–02 36 
4 12 9.3E–03 –31 6.9E–03 –40 1.1E–02 –1 
Pooled 80 1.3E–02  1.1E–02  1.1E–02  
Note: N=number of subjects; GM=grey matter; WM=white matter; 
CSF=cerebrospinal fluid; %Err=percent error. 
 
 
In general, there were no major difference between each age group and the pooled 
standard deviations. However, there were major differences between age groups, e.g. 
WM SD in age group 1 (25–34 years) was 36% smaller than the pooled WM SD 
whereas WM SD in age group 3 (45–54 years) was 36% larger, equating to a 
difference between these groups of 72% of the expected (pooled SD) value. This 
pattern of SD differences was repeated throughout the regional brain volumes, as 
shown in Table 25 and Table 26 (on the next page). The parametrically and 
nonparametrically derived distributions of these volumes are illustrated in section 






Table 25. Standard deviations of hippocampal complex volumes in each age group 
Age N Hippo_L %Err Hippo_R %Err PHippo_L %Err PHippo_R %Err Amygdala_L %Err Amygdala_R %Err 
1 21 1.1E–04 3 1.4E–04 16 1.1E–04 –8 1.2E–04 2 4.0E–05 12 4.5E–05 7 
2 23 1.2E–04 15 1.1E–04 –4 1.4E–04 17 1.2E–04 1 3.7E–05 3 4.4E–05 4 
3 24 7.4E–05 –28 9.9E–05 –15 1.0E–04 –15 1.1E–04 –7 2.9E–05 –18 3.5E–05 –17 
4 12 1.2E–04 14 1.2E–04 6 1.2E–04 4 1.3E–04 9 3.4E–05 –4 4.7E–05 13 
Pooled 80 1.0E–04  1.2E–04  1.2E–04  1.2E–04  3.6E–05  4.2E–05  





Table 26. Standard deviations of thalamus and basal ganglia volumes in each age group 
Age N Caud_L %Err Caud_R %Err Puta_L %Err Puta_R %Err Thalamus_L %Err Thalamus_R %Err 
1 21 1.2E–04 5 1.8E–04 14 1.7E–04 8 2.0E–04 7 1.2E–04 –35 1.2E–04 –30 
2 23 1.2E–04 4 1.4E–04 –11 1.3E–04 –18 1.7E–04 –7 2.2E–04 19 1.9E–04 15 
3 24 1.1E–04 –1 1.7E–04 7 1.6E–04 2 1.9E–04 4 1.7E–04 –9 1.9E–04 14 
4 12 9.7E–05 –16 1.2E–04 –24 1.7E–04 13 1.7E–04 –9 2.4E–04 27 1.3E–04 –19 
Pooled 80 1.2E–04  1.5E–04  1.6E–04  1.8E–04  1.9E–04  1.7E–04  





7.3.2 Parametric and nonparametric distributions of brain volumes 
The parametric and nonparametric distributions of whole brain volumes are shown in 
Figure 34. It can be seen that the Gaussian distribution (left panel) is often not a good 
approximation for the shape of the actual data (right panel). Taken in conjunction with 
Table 24, these figures show that equality of variance (equal SDs) does not necessarily 
mean that the overall shape of data is the same between groups. For example, the SD of 
CSF volume was almost exactly the same between age group 1 and age group 3, 
however, age group 1 had a heavy left tail, high peak, and light right tail whereas age 
group had a flatter distribution and heavy right tail (top right panel, Figure 34). 
 This pattern is repeated throughout the regional brain volumes. For example, the 
SD of right parahippocampal volume was almost exactly the same between age group 1 
and age group 2, and the shapes of their distributions were somewhat similar (bottom 
right panel, Figure 36). However, the SD of right thalamus was almost exactly the same 
between age group 2 and age group 3, whereas the shapes of their distributions were 
markedly different (bottom right panel, Figure 38). This further illustrates that, while it 
may in some instances, equality of variance (equal SDs) does not necessarily mean that 
the overall shape of data is the same between groups. 
 The differences in distribution shape in the following figures (only figures and no 
main body text appear on the next two pages) show that approximating brain volume data 
with the Gaussian distribution and equal variances sometimes leads to the smoothing 
away of differences between groups, and other times creates differences that do not exist 










Figure 34. Parametric and nonparametric distributions of whole brain volumes in each age group 
GM=grey matter; WM=white matter; CSF=cerebrospinal fluid; TIV=total intracranial volume; 26–35 









Figure 35. Parametric and nonparametric distributions of left hippocampal complex volumes in each age 
group 
Phippo Gy=parahippocampal gyrus; TIV=total intracranial volume; 26–35 years=age group 1; 36–45 
years=age group 2; 46–55 years==age group 3; 56–65 years=age group 4. The brain images are shown in 





Figure 36. Parametric and nonparametric distributions of right hippocampal complex volumes in each age 
group 
Phippo Gy=parahippocampal gyrus; TIV=total intracranial volume; 26–35 years=age group 1; 36–45 
years=age group 2; 46–55 years==age group 3; 56–65 years=age group 4. The brain images are shown in 













Figure 37. Parametric and nonparametric distributions of left thalamus and basal ganglia volumes in each 
age group 
26–35 years=age group 1; 36–45 years=age group 2; 46–55 years==age group 3; 56–65 years=age group 4. 
The parametric distributions of the left thalamus in subjects 25-34 and 35-44 years are almost entirely 
overlapping (bottom left). The brain images are shown in radiological convention, i.e. left on the image is 










Figure 38. Parametric and nonparametric distributions of right thalamus and basal ganglia volumes in each 
age group 
26–35 years=age group 1; 36–45 years=age group 2; 46–55 years==age group 3; 56–65 years=age group 4. 
The brain images are shown in radiological convention, i.e. left on the image is the patient’s right. 
 
 
7.3.3 Comparisons between groups according to parametric and nonparametric 
distributions 
The effect of differences in SD and overall distribution shape is quantitatively 
demonstrated in this section. The percent error column (%Err) in the tables in Appendix 
AI.3 indicates the absolute percentage differences between parametric and nonparametric 
percentile comparisons. Table AI.3.1.1 lists whole brain volume distributions, Tables 
AI.3.2 and AI.3.3 list hippocampal complex distributions, and Tables AI.3.4 and AI.3.5 
list basal ganglia and thalamus distributions. Negative percent errors indicate that the 
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parametric and nonparametric methods differed on the direction of the difference between 
groups. For example, in Table AI.3.1.1, the mean difference in CSF between groups 1 
and 2 was 139% larger than the median difference and was in the opposite direction, i.e. 
the mean difference said CSF volume was greater in group 2, whereas the median 
difference said CSF was less in group 2. 
Overall these tables demonstrate that the limits, i.e. 2.5th percentiles, of whole and 
regional brain volumes are often not well approximated by parametric methods, e.g. by 
extrapolating limits from the mean and standard deviation (see section 7.2.5 for a detailed 
description of how this is done). Further, there was no systematic difference between the 
methods: sometimes the parametric method reduced differences in the actual data while 
other times it exaggerated differences in the actual data. 
 
7.3.4 Parametric and nonparametric effect sizes 
The percent error column (%Err) in the following three tables indicates the absolute 
differences between parametric and nonparametric effect sizes. Negative percent errors 
indicate that the parametric and nonparametric methods differed on the direction of the 
effect between groups.  
The parametric and nonparametric effect sizes in whole brain volumes between 
age groups are shown in Table 27. Although some of these percent errors are very large, 
the general classification of effect (i.e. “small”, “medium”, or “large”; Cohen, 1988) 
between the methods is the same, e.g. the parametric effect of –0.027 in GM between 
groups 2 and 3 and the nonparametric effect of –0.175 are both considered “small”. 
Therefore, I highlighted in bold entries in tables 34, 35, and 36 where the differences in 
effect size between methods transcended classification boundaries. As discussed in the 
methods, effect sizes of ≤0.2 are “small”, 0.5 is described as “medium”, and 0.8 is large 
(see section 7.2.6 in the methods for further details; Cohen, 1988; Coe, 2002). This 
illustrates that of all tissue volume comparisons, parametric and nonparametric effect 









Table 27. Parametric and nonparametric effect sizes in whole brain volumes 
Volume Comparison Parametric Nonparametric %Err 
CSF "1–2" –3.44E–01 1.30E–01 –138 
 "1–3" –3.71E–01 –4.58E–02 88 
 "1–4" –1.11E+00 –7.82E–01 30 
 "2–3" –2.73E–02 –1.75E–01 543 
 "2–4" –7.68E–01 –9.12E–01 19 
 "3–4" –7.41E–01 –7.37E–01 1 
GM "1–2" 6.09E–01 9.20E–01 51 
 "1–3" 8.43E–01 5.43E–01 36 
 "1–4" 1.12E+00 1.12E+00 0 
 "2–3" 2.34E–01 –3.77E–01 –261 
 "2–4" 5.12E–01 2.00E–01 61 
 "3–4" 2.77E–01 5.77E–01 108 
WM "1–2" –3.75E–01 –4.14E–01 11 
 "1–3" –6.23E–01 –4.30E–01 31 
 "1–4" –2.10E–01 5.09E–02 –124 
 "2–3" –2.49E–01 –1.52E–02 94 
 "2–4" 1.65E–01 4.65E–01 183 
 "3–4" 4.13E–01 4.81E–01 16 




The parametric and nonparametric effect sizes in hippocampal complex volumes between 
age groups are shown in Table 28. Effect sizes in the left hippocampus and 
parahippocampal gyrus, and left and right amygdala were often reasonably similar 
between parametric and nonparametric methods. However, effect sizes in the right 















Table 28. Parametric and nonparametric effect sizes in hippocampal complex volumes 
Volume Comparison Parametric Nonparametric %Err 
Hippocampus_L "1–2" –4.57E–01 –7.40E–01 62 
 "1–3" –7.09E–01 –7.60E–01 7 
 "1–4" –7.86E–01 –9.67E–01 23 
 "2–3" –2.52E–01 –1.99E–02 92 
 "2–4" –3.29E–01 –2.27E–01 31 
 "3–4" –7.73E–02 –2.07E–01 167 
ParaHippocampal_L "1–2" –1.08E–01 –2.01E–01 86 
 "1–3" –1.08E–01 –2.54E–01 135 
 "1–4" –1.57E–01 –1.23E–01 22 
 "2–3" –8.40E–04 –5.37E–02 6294 
 "2–4" –4.96E–02 7.75E–02 –256 
 "3–4" –4.87E–02 1.31E–01 –369 
Amygdala_L "1–2" 5.27E–02 –2.36E–02 –145 
 "1–3" –2.11E–01 –1.99E–01 5 
 "1–4" –4.94E–01 –5.96E–01 21 
 "2–3" –2.63E–01 –1.76E–01 33 
 "2–4" –5.46E–01 –5.72E–01 5 
 "3–4" –2.83E–01 –3.96E–01 40 
Amygdala_R "1–2" –5.16E–01 –5.83E–01 13 
 "1–3" –7.28E–01 –5.10E–01 30 
 "1–4" –4.71E–01 –2.08E–01 56 
 "2–3" –2.11E–01 7.37E–02 –135 
 "2–4" 4.57E–02 3.75E–01 722 
 "3–4" 2.57E–01 3.02E–01 17 
Hippocampus_R "1–2" –4.78E–01 –4.74E–01 1 
 "1–3" –5.29E–01 –4.41E–01 17 
 "1–4" –4.99E–01 –9.14E–02 82 
 "2–3" –5.04E–02 3.25E–02 –164 
 "2–4" –2.05E–02 3.82E–01 –1964 
 "3–4" 2.99E–02 3.50E–01 1069 
ParaHippocampal_R "1–2" –2.79E–01 3.73E–04 –100 
 "1–3" –2.95E–01 –5.38E–02 82 
 "1–4" –3.52E–01 –1.34E–01 62 
 "2–3" –1.55E–02 –5.42E–02 249 
 "2–4" –7.24E–02 –1.34E–01 85 
 "3–4" –5.69E–02 –8.00E–02 41 
Note: ParaHippocampal=parahippocampal gyrus. 
 
 
The parametric and nonparametric effect sizes in thalamus and basal ganglia volumes 





Table 29. Parametric and nonparametric effect sizes in thalamus and basal ganglia volumes 
Volume Comparison Parametric Nonparametric %Err 
Caudate_L "1–2" 7.83E–03 8.75E–02 1018 
 "1–3" 2.72E–01 2.79E–01 2 
 "1–4" 4.64E–01 7.16E–01 54 
 "2–3" 2.64E–01 1.91E–01 28 
 "2–4" 4.57E–01 6.28E–01 38 
 "3–4" 1.92E–01 4.37E–01 127 
Putamen_L "1–2" 2.59E–01 3.15E–01 22 
 "1–3" 6.81E–01 6.64E–01 2 
 "1–4" 4.46E–01 3.81E–01 15 
 "2–3" 4.22E–01 3.49E–01 17 
 "2–4" 1.87E–01 6.59E–02 65 
 "3–4" –2.35E–01 –2.83E–01 21 
Thalamus_L "1–2" –1.23E–02 –2.05E–01 1566 
 "1–3" –4.57E–01 –6.18E–01 35 
 "1–4" –1.10E+00 –1.00E+00 9 
 "2–3" –4.44E–01 –4.13E–01 7 
 "2–4" –1.09E+00 –7.98E–01 27 
 "3–4" –6.42E–01 –3.85E–01 40 
Caudate_R "1–2" –2.22E–01 –3.44E–01 55 
 "1–3" –3.75E–01 –5.32E–01 42 
 "1–4" –6.82E–02 5.50E–01 –906 
 "2–3" –1.53E–01 –1.88E–01 23 
 "2–4" 1.54E–01 8.94E–01 481 
 "3–4" 3.07E–01 1.08E+00 252 
Putamen_R "1–2" 2.66E–01 3.21E–01 21 
 "1–3" 8.54E–01 1.02E+00 19 
 "1–4" 5.56E–01 7.96E–01 43 
 "2–3" 5.88E–01 6.96E–01 18 
 "2–4" 2.90E–01 4.74E–01 64 
 "3–4" –2.98E–01 –2.22E–01 26 
Thalamus_R "1–2" –2.15E–01 –5.19E–01 141 
 "1–3" –7.15E–01 –1.02E+00 42 
 "1–4" –1.36E+00 –1.91E+00 41 
 "2–3" –4.99E–01 –4.97E–01 1 
 "2–4" –1.14E+00 –1.39E+00 22 
 "3–4" –6.41E–01 –8.96E–01 40 
 
 
Effect sizes in the left and right putamen were generally similar between parametric and 
nonparametric methods. Although this was also true for the left thalamus, there were 







I have shown that parametric and nonparametric distributions of subregional brain 
volumes can be different, i.e. not only is the effect of age different across the brain, these 
regions do not have a uniformly Gaussian distribution. This suggests that parametric 
statistical models may not adequately represent the limits of brain volumes across 
adulthood. Some of the differences I found were exceptionally large and this is likely in 
part due to the limited number of subjects assessed. However, as demonstrated in the 
review in chapter 4, this number of subjects is not unusual for structural brain imaging 
analyses. Although these data may be transformed to better fit parametric models 
(Kruggel, 2006; Ziegler et al., 2011), the consistent differences I found suggest that these 
transforms may obscure the true limits of regional brain volumes. 
 Further to implications for defining the limits of normal brain volumes, and as I 
demonstrated by modelling effect sizes between ages, these changing and non-Gaussian 
distributions also have implications for central tendency analysis. Although the focus of 
this chapter was regional volumes, the parametric method led to consistent and large 
overestimation of the effect of age in whole brain GM. Within the hippocampal complex, 
the parametric method produced consistent overestimation of the effect of age in the right 
hippocampus and parahippocampal gyrus. This is especially noteworthy given that the 
hippocampus is often implicated in diagnoses of neurological diseases such as AD and 
schizophrenia (Jack Jr et al., 1997; Job et al., 2002). 
However, not all regions exhibited great differences between methods. In the 
basal ganglia, and in particular the putamen, and also in the amygdala, parametric and 
nonparametric effect sizes generally agreed. While these central tendency measures 
agreed, the parametric and nonparametric percentile ranks of these regions did not agree. 
This (further to the data presented in chapter 6) illustrates that differences between 
subjects that are removed from the mean are not well represented by parametric models. 
It is therefore apparent that, to robustly define the range of effect sizes across the brain, 
nonparametric models may have to be used in conjunction with the more commonly 
applied parametric models. 
By using the mean ± two SD, I may have slightly overestimated parametric limits. 
The associated error was 0.2% and this did not impact the large differences (>100%) I 
observed between parametric and nonparametric limits. I undertook this comparison in a 
single, relatively small sample. The oldest age group was smaller than the other groups so 
cannot be used for definitive measures but illustrates the potential dangers of making 
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these assumptions in similarly sized samples (that are common in brain imaging, chapter 
4). The bimodal nature of the nonparametric distributions (e.g., in Figure 34) may have 
been due in part to the limited number of subjects (n ~20 per group). However, there is 
evidence from much larger studies (n>4000) of other biological variables (e.g., serum 
calcium; Elveback et al., 1970) and from other neuroimaging studies (Rorden et al., 
2007) that suggest bimodal distributions of neuroimaging data are plausible. Future 
studies with much larger samples, e.g. at least 1 subject per percentile, will be required to 
confirm whether population distributions of neuroimaging data are actually bimodal.  
The structural brain data I used were acquired using atlas based segmentation. 
Although I visually inspected results to ensure that there were no gross errors, there may 
have been more subtle errors that contributed to the unequal variance and lack of 
conformance to the Gaussian distribution. However, this is a commonly used method to 
extract regional brain volumes (Maldjian et al., 2003). I have illustrated that if data are 
acquired by this method then they may not be suitable for parametric statistical analyses. 
Future work will determine whether the method of segmentation contributes to the 
variance and distribution of regional brain volumes.  
Although regional brain volumes may provide more sensitive markers for disease 
than whole brain volumes (Jack Jr et al., 1997; Fox and Schott, 2004), the differences 
between groups may be even more subtle than entire regional brain volumes, i.e. they 
may exist within regions at the voxel level (Job et al., 2002). I therefore developed a 
series of voxel-based statistical methods for assessing the subtlest of differences between 
normal and diseased individuals and groups.
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8. Robust voxel–based statistics for identifying subtle brain pathology in 





It is clear that human brain structure changes with age. But as I (and many others) 
have demonstrated, these changes are not uniform and their pattern and consequences 
are not fully understood (chapters 6 and 7; Ge et al., 2002; Resnick et al., 2003; 
Sowell et al., 2003; Allen et al., 2005; Farrell et al., 2009; Ferguson et al., 2010). A 
wide range of atrophy and other anomalies, e.g. white matter hypointensities/ 
hyperintensities on T1/ T2, can be seen in ageing brain magnetic resonance imaging 
(MRI). This is true even between subjects of the same age and with no apparent 
difference in cognitive or physical function (Farrell et al., 2009; Aribisala et al., 
2012). It can then be difficult to establish whether whole and regional brain volumes 
are normal for age or suggestive of neurodegenerative disease (Shenton et al., 2001; 
Fotenos et al., 2005; Farrell et al., 2009; Ferguson et al., 2010). In these cases, voxel–
based assessment/ classification may be a more sensitive marker for disease (Job et 
al., 2002). 
Voxel–based null hypothesis significance testing (VBNHST) was developed 
to determine differences in MR brain structure between normal and diseased groups, 
but has recently been used to compare individual subjects to a clinically normal 
dataset (Ashburner and Friston, 2000; Scarpazza et al., 2013). To be robust, 
parametric VBNHST requires that data meet a number of assumptions about their 
generation and distribution, e.g. that they were randomly generated, and are equally 
Gaussian between subject groups (homoscedastic; Elveback et al., 1970; Freedman et 
al., 2007). These assumptions may not always be met in group studies of MR brain 
image data (Nichols and Holmes, 2002; Rorden et al., 2007) and VBNHST may not 
be reliable in individual subject analyses, e.g. it leads to a number of false positive 
                                                 
6 Some of the work described in this chapter was presented as follows: 
Dickie, D.A., Job, D.E., Rodríguez González, D., Shenkin, S.D., Wardlaw, J.M. (2013). How normal is 
this brain? Development and testing of a new MR template for voxel–based brain ranking. Proceedings 




results (Scarpazza et al., 2013). Further, VBNHST was not originally designed to be 
used for individual subject analyses (Ashburner and Friston, 2000). 
Rather than comparing individual subjects to a clinically normal dataset with 
VBNHST, others have directly calculated the placement of individuals relative to the 
distribution of clinically normal values (Pernet et al., 2009; Aubert-Broche et al., 
2011). These studies estimated the distributions of clinically normal voxel values for 
younger subjects (<60 years) based on the Gaussian distribution. However, as I have 
shown, brain structure data may not always follow the Gaussian distribution 
(especially at older ages).  
Further to deviations from assumed distributions, significance values, e.g. P–
values from t–tests, may be difficult to interpret if the sample of subjects was not 
derived randomly. In such cases it is useful to calculate effect sizes between groups 
and compare these between cohorts (Meehl, 1978; Cohen, 1994; Freedman et al., 
2007). One of the most widely used measures of effect size is “Cohen’s d”; this is 
essentially the mean difference between groups normalised by their pooled SD 
(Cohen, 1988; Coe, 2002). As it is based on the standardised mean difference, this 
statistic still relies on the data being equally Gaussian between groups. Even small 
departures from the Gaussian distribution may lead to uninterpretable and/or 
unreliable results (Cliff, 1993; Coe, 2002). In these cases, it may be more appropriate 
to calculate the so called, “d statistic” – a type of nonparametric effect size that 
calculates the overlap between the distributions of two groups (Siegel and Castellan, 
1988; Cliff, 1993; Coe, 2002). Although the overlap statistic is referred to as “d” in 
the literature, I use the Greek equivalent “delta” (δ) to avoid confusion with “Cohen’s 
d”. Despite not providing a measure of central tendency shift, i.e. mean or median 
shift, delta is still a clinically relevant and useful measure in itself, given that central 
tendency measures may not adequately describe the differences between two clinical 
groups (Elveback et al., 1970). 
In this chapter I assess parametrically and nonparametrically defined normal 
reference distributions (normal atlases) for determining “how normal” voxel values 
are in individual subjects. I also develop methods for assessing the distributions of 
voxel values so to determine their suitability for subsequent parametric or 
nonparametric analyses. Finally, I implement voxel–based measures of effect size 






8.2.1 Subjects and brain MRI 
Brain MRI from 236 normal subjects and 224 subjects diagnosed with AD (all aged 
between 55 and 90 years) were acquired from ADNI (AD=124; controls=138) and 
OASIS (AD=100; controls=98). The normal subjects did not have dementia, but 
potentially had non–debilitating conditions common in ageing, e.g. hypertension. 
Their demographics were more thoroughly described in section 5.2.3. At the time of 
the present analyses, ADNI and OASIS were the only public sources of structural 
MRI brain scans with clinical metadata that fully represented normal older people 
(chapter 2). Simulation and permutation testing may provide an indication of the 
representativeness of such small amounts of data (Freedman and Lane, 1983). 
Permutations of the normal ageing GM atlas are presented later (section 8.3.4.1). 
Both ADNI and OASIS provided 1.5T MP–RAGE T1–weighted MR brain 
images that were acquired in the sagittal plane at approximately 1x1x1mm resolution. 
I removed non–brain structure from the images before extracting grey matter 
proportion images (as described in chapter 5). I then calculated the range of voxel–
based statistics described in the following sections. 
 
8.2.2 Voxel–based statistics 
I developed methods to calculate a number of parametric and nonparametric voxel–
based statistics of grey matter proportion but, given that parametric statistics rely on 
data being Gaussian distributed (Elveback et al., 1970; Freedman et al., 2007), I first 
developed a method to assess the shape of voxel–wise data distributions. 
 
8.2.2.1 Assessing voxel–wise data distributions 
The distribution of data can be assessed with statistical tests such as the Kolmogorov–
Smirnov test (Massey Jr, 1951) but they do not thoroughly describe the shape of data. 
These tests mainly state that the population data may or may not be shaped like the 
Gaussian distribution, e.g. they do not overtly specify whether the sample data are 
sharply peaked, or their mode is skewed to the left. Further, it is highly questionable 
whether the sample sizes studied in this work are sufficient to make true population 
inferences (Cohen, 1994; Freedman et al., 2007). Until we have sufficient population 
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data and to ensure that correct statistical models are used in the interim, it is important 
to understand how the available sample data are distributed. Whether or not sample 
data are Gaussian distributed and the shape of their distribution can be determined by 
calculating kurtosis and skewness. 
 
8.2.1.1.1 Kurtosis 
Kurtosis illustrates the central and outer appearance of a data distribution (DeCarlo, 
















where xi–n are all the values of variable x,  is the mean of variable x, and σ is 
the standard deviation of variable x. The Gaussian distribution has kurtosis of 3, 
distributions with kurtosis less than 3 are flatter with lighter tails, and distributions 
with kurtosis more than three have higher peaks and heavier tails (DeCarlo, 1997).  
 
8.2.1.1.2 Skewness 
















where xi–n are all the values of variable x,  is the mean of variable x, and σ is 
the standard deviation of variable x.  
When skewness is equal to zero the data are perfectly symmetrical (like the 
Gaussian, bimodal, or uniform distributions); when it is above zero the data have a 
heavy left tail; and when it is below zero the data have a heavy right tail (Figure 39). 
The shape of distributions, as determined by kurtosis and skewness, can inform the 





Figure 39. Examples of data (X) with +1 (blue dotted line), zero 
(black solid line), and –1 (dashed red line) skewness 
 
 
8.2.2.2 Summarising voxel–wise data distributions for a normal reference brain atlas 
Most previous brain atlases were constructed by calculating parametric (mean and 
standard deviation) voxel values. Parametric values are assumed to approximate the 
distribution of voxel values, i.e. equate to nonparametric percentile ranks. I tested this 
by constructing parametric and nonparametric distributional brain atlases of normal 
ageing brain structure to assess brain structure in older subjects with AD.  
To derive the atlases I registered all atlas subjects (n=98 randomly selected 
normal ageing subjects, 49 ADNI; 49 OASIS) to the standard space described in 
chapter 5 via “nonlinear surface” (Nsurf) registration (also discussed in chapter 5). 
These normal ageing atlas subjects were not used for any other analyses in this 
chapter. Once all subjects were in this space I calculated parametric and 
nonparametric measures of voxel–wise distributions of grey matter proportion. 
 
8.2.2.2.1 Parametric brain atlas 








The percentile rank values of these distributions are approximated as in equation 14, 
 p   
 2.5th   (2  σ) (14.1) 
 25th   (0.7  σ) (14.2) 
 50th  (14.3) 
 75th  + (0.7  σ) (14.4) 
 97.5th  + (2  σ) (14.5) 
    
 where p is the percentile rank,  is the mean, and σ is the standard deviation. I 
used ±2 SD because ±1.96 SD sometimes underestimated the 95% limits (97.5th2.5th 
percentile rank) of simulated Gaussian brain structure data. There was almost no 
discernable difference between atlases based on ±2 SD versus ±1.96 SD, but ±2 SD 
provided assessments slightly closer to the “true” nonparametric percentile ranks. For 
example, in simulated GM proportion data there were 1,847,047 voxels in agreement 
between parametric and nonparametric methods when using the ±1.96 SD atlas, and 




Figure 40. Parametric simulations of the 2.5th percentile rank of grey matter 
proportion using 1.96 SD (left panel) and 2 SD (right panel) 
 
 
If data follow the Gaussian distribution, the parametrically estimated values of these 
percentile ranks should be approximately equal to the rank calculated nonparametric 






8.2.2.2.2 Nonparametric brain atlas 
Nonparametric methods use a ranking approach to directly calculate percentile rank 
values as in equation 15, 
 gjnp    (15.1) 
 )(2/1 1 jj xxy  if g = 0 (15.2) 
 1 jxy  if g > 0  
 
where n is the number of subjects, for the tth percentile p=t/100,  j is the 
integer part of np, g is the fractional part of np, y is the tth percentile, and x1, x2, ... 
, xn are the ordered values of each brain volume.  
 
8.2.2.3 Assessing brain structure with a normal reference brain atlas: voxel 
classification 
Much like clinical brain atlases are used to diagnose whole brain atrophy in patients 
(Farrell et al., 2009), I used voxel–based atlases to classify brain structure voxel–by–
voxel in individual subjects. AD subjects (n=138, 89 ADNI; 49 OASIS) were 
registered to the atlas using Nsurf registration (described in chapter 5). In each voxel 
in atlas space, subject tissue proportion was compared to the tissue proportions of 
each level in the atlas and then assigned the rank to which their tissue proportion was 
nearest (Figure 41).  
Note: although I illustrate this method using grey matter proportion images from T1-
weighted images of normal older subjects and subjects diagnosed with AD, the 
software I developed can produce a percentile rank reference for any image sequence 
from any group, e.g. it can produce a T2–weighted percentile rank atlas from normal 
young adults for assessing brain structure in individuals and groups with 
schizophrenia or a T1–weighted percentile rank atlas from full term infants to assess 





Figure 41. Schematic of voxel–based classification of brain 
structure with a normal reference atlas 
The subject's original voxel value is compared to each of the atlas 
percentile rank values and is then assigned the rank to which its 
value is nearest. 
 
 
Further to generating voxel–wise statistics for individual subject analyses, I developed 
methods to compute voxel–wise effect sizes for group studies. 
 
8.2.2.4 Voxel–wise effect sizes for group studies 
There are parametric and nonparametric methods for computing effect size in group 
studies. I sought to determine the difference in these measures in a study of GM 
proportion between normal ageing (n=138, 89 ADNI; 49 OASIS) and AD (n=138, 89 
ADNI; 49 OASIS). 
 
8.2.2.4.1 Parametric effect size: Cohen’s d 
When the random sample assumption of statistical tests is not met it is useful to 
calculate effect sizes between case and control groups so that results from replicated 
studies can be compared and validated (Meehl, 1978; Cohen, 1988; Siegel and 












  (16) 
  
where cntrl is the mean of the control group, case is the mean of the case 
group, and σp is the pooled standard deviation of the two groups. Although a loose 
definition, parametric effect sizes of ≤0.2 are “small”, 0.5 is described as “medium”, 
and 0.8 is large (Cohen, 1988; Coe, 2002).  If the data are Gaussian, a positive 
parametric effect means that, across the distribution, the control group is dSD (σp) 
larger than the case group, e.g. for an effect size of d=0.8 between controls and AD 
subjects, each percentile rank of the control group is 0.8 SD larger than the AD group.  
If data are not equally Gaussian the parametric effect size becomes difficult to 
interpret (Coe, 2002), e.g. the standard difference between each group’s percentiles 
(2.5th, 25th, …, 97.5th) will likely not be equal to the (mean) effect size. 
 
8.2.2.4.2 Nonparametric effect size: delta 
When data are not equally Gaussian, the effect size, “delta”, may be a more reliable 
indicator of the effect of a variable (note this is actually referred to as “the d statistic” 
but to avoid confusion with “Cohen’s d”, I use the Greek equivalent “delta”, δ). Delta 
does not require data to be Gaussian or equally distributed (homoscedastic) between 
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where all values of x in group i are compared with all values of x in group j, 
and mn is the total number of comparisons (number of subjects in group i × number of 
subjects in group j). The interpretation of delta is that it is a direct measure of how 
often one group, e.g. a control group, has a higher value than another group, e.g. a 
group of AD subjects. For example, δ=0.75 means that in 75% of cases, controls have 




8.2.2.4.3 Comparing parametric and nonparametric effect sizes 
The parametric and nonparametric effect sizes that I have described are measuring 
slightly different things: the parametric effect size is measuring the shift between 
distributions and the nonparametric effect size is measuring overlap between 
distributions. However, these can both be transformed to the probability that a 
randomly selected subject from the control group will have a higher value than a 
randomly selected AD subject; referred to as the “common language effect size 
statistic (CLES)” (McGraw and Wong, 1992; Coe, 2002). 
In fact, there is no transformation required for the nonparametric effect size, it 
is directly calculated and is just the left side of equation 17, i.e. #(xi>xj)/nm, where all 
values of x in group i are compared with all values of x in group j, and mn is the total 
number of comparisons (number of subjects in group i × number of subjects in group 
j).  
The parametrically derived CLES is the cumulative Gaussian distribution 
function of Cohen’s d, i.e. the P–value in the Gaussian distribution table (Freedman et 
al., 2007) that corresponds to the calculated Cohen’s d (Cohen’s d is equivalent to a 
Z–score of the Gaussian distribution). Providing the data are Gaussian distributed, the 
parametric CLES should be approximately equal to the nonparametric CLES 
(McGraw and Wong, 1992; Vargha and Delaney, 2000; Coe, 2002).  
 
8.2.2.5 Lobular reporting of voxel-wise statistics 
Because of the apparently lobular weighted pattern of atrophy in ageing and AD, e.g. 
there are thought to be relatively weak effects in the parietal lobe, partial effects in the 
frontal lobe, and strong effects in the temporal lobe (e.g. Thompson et al., 2003), I 
report all voxel-wise statistics by lobe. That is, I segmented the aged standard space 
into the four major lobes: frontal, temporal, parietal, and occipital (Figure 42). I did 
this using atlas-based segmentation (chapter 5) with the “Hammers-mith” atlas 






Figure 42. Segmentation of aged standard space into the four major 
lobes: frontal, temporal, parietal, and occipital 
These lobes were segmented via atlas-based segmentation using the 
"Hammers-mith" atlas (Hammers et al., 2003) for the purpose of 






Before constructing parametric and nonparametric reference atlases, I assessed the 
voxel–wise distributions of grey matter proportion in the reference atlas subjects. 
 
8.3.1 Assessments of voxel–wise grey matter distributions in the normal reference 
atlas subjects 
Examples of grey matter proportion distributions in the cortex and subcortical regions 
are shown in Figure 43. 
 To assess grey matter distributions throughout the cortex I calculated the 





Figure 43. Grey matter proportion distributions in 98 normal aged subjects (60–90 years) at single 
voxels in the superior temporal gyrus (top left), superior central cortex (top right), putamen (bottom 
left), and hippocampus (bottom right) 









Figure 44. Voxel–wise kurtosis and skewness in the grey matter proportion atlas subjects 
The Gaussian distribution has kurtosis of 3 (yellow) and skewness of 0 (light green/blue). 
 
 
Figure 44 shows that kurtosis and negative skewness was greatest in the hippocampal 
region and Table 30 shows that grey matter proportion was not Gaussian distributed in 
much of the cortex (Gaussian distributed data have kurtosis of 3 and skewness of 0). 
 
 
Table 30. Median kurtosis and skewness in voxels in the grey matter proportion atlas 
subjects  
 Kurtosis Skewness 
(median, IQR) 1.95, 0.95 0.11, 0.92 
 
 
As much of the cortex was not Gaussian distributed (Figure 44 and Table 30), I 
constructed parametric and nonparametric atlases of grey matter proportion. 
 
8.3.2 Parametric and nonparametric atlases of grey matter proportion 






Figure 45. Atlases of the distribution of normal voxel–wise grey matter proportion calculated with 
parametric (P – upper panel) and nonparametric (NP – lower panel) statistics in 98 aged normal 
subjects (60–90 years) 
The parametric atlas frequently overestimates the lower normal limits of grey matter (dark blue 
negative proportions) and the upper limits (dark red proportions greater than 1). The ranking method 
used in nonparametric statistics means that it does not make these errors. This z–slice location shows 
the hippocampal region. 
 
 
As shown in Figure 45, the parametric method determined that the lower clinical limit 
of grey matter proportion in many voxels was less than zero and that the upper clinical 
limit was greater than one. This does not make sense mathematically or 
physiologically. The lower clinical limit of any voxel in the nonparametric atlas was 
not less than zero and the upper clinical limit was never greater than one. Further 
differences between the atlases are illustrated by the histograms of voxel values in 
Figure 46. 
 The visually apparent differences between the parametric and nonparametric 
atlases (Figure 45 and Figure 46) are quantified in Table 31. Although they are often 
thought to be approximately equal (Freedman et al., 2007), the mean (parametric 50th 
percentile) and median (nonparametric 50th percentile) histograms had similar kurtosis 
but differed in skewness by more than 200%, i.e. the parametric method generally 
overestimated the central tendency of grey matter proportion. The methods were in 
most agreement at the 75th percentile but even here the parametric method generally 
overestimated grey matter proportion by 52%. As a reminder, in commonly used brain 
imaging analyses, e.g. the GLM, parametrically derived estimates for percentile ranks 






Figure 46. Histograms of the parametric and nonparametric grey matter atlas percentile levels 
 
 
The greatest difference between the atlases was at the lower clinical limit (2.5th 
percentile) and this led to the parametric atlas producing false classifications in many 








Table 31. Kurtosis and skewness in parametric and nonparametric grey matter 
proportion atlas histograms 
Percentile 
Kurtosis Skewness 
Parametric Nonparametric %Err Parametric Nonparametric %Err 
2.5th 5.99 33.76 –464 1.55 5.27 –240 
25th 3.29 4.63 –41 0.75 1.45 –93 
50th 2.45 2.04 17 0.06 0.20 –233 
75th 2.53 2.42 4 –0.52 –0.79 –52 
97.5th 3.43 10.31 –201 –1.13 –2.69 –138 
Note: %Err=percent error between parametric and nonparametric templates 
 
 
8.3.3 The effect of parametric assumptions in voxel classification: false classifications 
False classifications occur in parametric methods when data do not follow the 
Gaussian distribution: when the parametrically defined lower clinical limit (2.5th 
percentile) is less than the nonparametric limit it produces false negatives (false 
normals) and when the parametric limit is greater than the nonparametric limit it 




Table 32. Median percentage of voxel–wise false classifications in ADNI and OASIS 
with the parametric GM atlas 
Classification ADNI (median, IQR) OASIS (median, IQR) 
False negatives 32.2, 8.2% 34.1, 9.3% 
False positives  48.4, 6.2% 45.5, 6.6% 
Note: ADNI=Alzheimer’s Disease NeuroImaging Initiative; OASIS=Open Access Series of Imaging 
Studies; IQR=interquartile range. 
 
 
Table 32 was derived from the percentage of voxel–wise false classifications within 
each subject to determine the median percentage of voxel–wise false negatives and 
false positives that occurred in the ADNI and OASIS samples (with the parametric 
GM atlas). This shows that, for most subjects in both samples, the parametric atlas 
incorrectly classified ~25–45% of true positive (abnormal) voxels as normal (false 
negatives); ~40–50% of the voxels classified as abnormal by the parametric atlas were 
within the normal range (false positives).  
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In both samples there were concentrated regions of false negatives in the mid sagittal 
caudal and anterior regions (Figure 47). Throughout whole lobular structures, the 
proportions of false negatives were approximately equal between the frontal and 





Figure 47. The locations of false negative/ false normal (FN) voxels in Alzheimer’s disease (AD) subjects 
(aged 60–90 years) from ANDI (n=89) and OASIS (n=49) via voxel classification with the parametric grey 
matter atlas 
The parametrically defined lower clinical limit (2.5th percentile) was less than the nonparametric limit 
(when it should have been the same) in these voxels and so defined these voxels as normal when in fact 
they were out with the normal range, i.e. abnormal. 
 
 
Approximately two thirds of false positives occurred in the temporal lobe (Table 33), 
including the hippocampal region (Figure 48). 
The concentrations of false classifications (Table 33, Figure 47 and Figure 48) 
suggest that parametric statistics may overestimate some differences, e.g. in the 
hippocampus, and underestimate other differences, e.g. in the frontal lobe, between 
normal ageing and Alzheimer’s disease. Given the potential for misclassifications 
using the parametric method, I implemented voxel-based classification (and created 





Figure 48. The locations of false positive/ false abnormal (FP) voxels in Alzheimer’s disease (AD) subjects 
(aged 60–90 years) from ANDI (n=89) and OASIS (n=49) via voxel classification with the parametric grey 
matter atlas 
The parametrically defined lower clinical limit (2.5th percentile) was higher than the nonparametric limit 
(when it should have been the same) in these voxels and so defined these voxels as abnormal when in fact 
they were still in the normal range. 
 
 
Table 33. Proportions of misclassifications by lobe in ADNI and OASIS 
  Frontal Temporal Parietal Occipital 
FN ADNI 0.36 0.38 0.09 0.17 
 OASIS 0.39 0.41 0.08 0.12 
FP ADNI 0.28 0.57 0.06 0.08 
 OASIS 0.27 0.61 0.06 0.06 
Note: FN=false negative; FP=false positive; ADNI=Alzheimer’s Disease Neuroimaging 
Initiative; OASIS=Open Access Series of Imaging Studies. 
 
 
8.3.4 A novel brain data transformation method: Percentile rank atlas-based (“clinical 
rank”) transformation 
Since the parametric template did not provide sufficiently close approximations of its 
assumed values, e.g. the minus two SD was often not equal to the 2.5th percentile, I 
used the nonparametric method to create the percentile rank atlas. Further to providing 
voxel-based classifications in individuals, this atlas may be used to meaningfully 
transform brain structure data for subsequent group-wise statistical analyses. So that 
they are representative of the group population, I first attempted to determine the 







8.3.4.1 Determining the number of subjects required for a representative percentile 
rank brain atlas 
The representativeness of percentile rank atlases given their number of subjects are 
illustrated in Figure 49. This shows the percent similarity of percentile rank atlas 





Figure 49. Determining the number of subjects required to recreate a complete percentile rank atlas 
representative of the total sample n=98 subjects 
Each coloured line represents the change in each percentile (2.5th – 97.5th) given the addition of more 
subjects. Seventy subjects (~71%) were required to create an atlas that was 95% similar to the total 
n=98 atlas (referenced with the dashed vertical line) and 90 subjects (~92%) were required to create an 
atlas that was 99% similar to the total n=98 atlas (referenced with the solid vertical line). 
 
 
For all percentile rank levels of the atlas, i.e. 2.5th–97.5th percentile ranks, 70 subjects 
(~71%) were required to create an atlas that was 95% similar to the total n=98 atlas. 
Ninety subjects (~92%) were required to create an atlas that was 99% similar to the 
total n=98 atlas. Each iteration of the atlas (e.g., 10, 20,… 70 subjects) was a random 
sample of the same 98 subjects. This information and repeated analysis will be useful 
when a much bigger sample of subjects is available, e.g. to determine a reasonable 
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amount of subjects to process when it is not feasible to process them all. For now I 
proceed with the total n=98 atlas and demonstrate how this may be used to 
meaningfully transform brain structure data so that it is suitable for subsequent 
statistical analysis. 
 
8.3.4.2 Percentile rank atlas-based (“clinical rank”) transformation 
For many nonparametric comparisons between groups, e.g. Wilcoxon–Mann–
Whitney, data distributions do not require to be Gaussian, however, they still require 
to be approximately equally shaped and have approximately equal variance (chapter 
4). Figure 50 shows normal and AD subject distributions of grey matter proportion in 




Figure 50. Distributions of grey matter proportion in a randomly selected voxel in the hippocampus in 
AD and control subjects 





Interquartile range (IQR, a measure of variance) of grey matter proportion was 0.2391 
in the normal subjects and 0.8322 in the AD subjects. This meant that neither the 
distribution shapes nor variances between these groups were equal.  
There are various data transformation methods available, e.g. logarithmic 
transformation, but these can be difficult to interpret and cause data to lose their 
meaning. By ranking grey matter proportion values in each subject in each group 
(according to the previously defined nonparametric reference for grey matter 
proportion; section 8.2.2.3), I transform these data into similarly shaped distributions 
but maintain a meaningful reference to the original data. Figure 51 shows an example 
of this “atlas-based clinical rank transformation” in GM from an individual AD 
subject. In this individual, the red region highlights the subtle hippocampal atrophy 
pathology associated with AD. This is consistent with their clinical diagnosis and 











Each of the 89 AD and 89 normal subjects were ranked as in Figure 51. Figure 52 
shows the distributions of ranks of grey matter proportion in these subjects 




Figure 52. Distributions of grey matter ranks in the same randomly selected voxel in the hippocampus 
in AD and control subjects 
This shows that the distributions of data in these groups now have a similar shape, a requirement for 




The histograms of both groups were in the same shape (frame of reference) following 
ranking but the original differences are generally maintained, e.g. the differences 
between groups at the limits of grey matter proportions and ranks. Further, the IQR of 
ranks of grey matter proportion was also similar after ranking: 72.5 in the normal 
subjects and 70 in the AD subjects.  
This suggests that voxel–based ranking may support more reliable 
nonparametric testing between groups. But, as in any transformation of data, this 
should be carefully considered before use (Scott and Wild, 1991). In particular, grey 
matter proportion may take an infinite range of values between 0 and 1. I defined only 
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6 percentiles (including the abnormal, i.e. <2.5th, percentile) to rank these values. 
Therefore, while making the data more amenable to nonparametric statistical testing, 
clinically ranked image data may inherently have less information than the original 
image data.  
A type of nonparametric effect size, “delta” (δ), does not require data to be 
normal, share distributions shapes, nor have equal variance (Cliff, 1993; Coe, 2002), 
i.e. does not require data transformation. Before implementing delta I tested the 
voxel–wise distributions of GM proportion to determine whether the more commonly 
applied parametric effect size was appropriate. 
 
8.3.5 Effect sizes in group studies 
To determine whether the parametric effect size was appropriate I first computed 
voxel–wise kurtosis and skewness. Kurtosis in Gaussian distributed data is equal to 
three and skewness is equal to zero. There was high kurtosis (≥5) and negative 
skewness (<–2) in the hippocampal region in both subject cohorts (ADNI Figure 53, 
OASIS Figure 54). Kurtosis and skewness by lobe in ADNI are shown in Table 34 
and Table 35 (rounding errors mean that not all rows sum to exactly 1). Across both 
controls and AD subjects in ADNI, the temporal lobe consistently had the largest 
proportions of high kurtosis (>3.5) and negative skewness (<-0.5). The frontal lobe 
had the second largest proportions of these highly non Gaussian values. 
 Overall, from Table 34 and Table 35, only approximately 30% of the cortex in 
ADNI subjects was distributed approximately Gaussian. 
 
 
Table 34. Proportions of voxel kurtosis by lobe in ADNI 
 Kurt 
Lobe 
k<2.5 2.5≤ k ≤3.5 k >3.5 
Controls Frontal 0.73 0.26 0.02 
 Temporal 0.59 0.35 0.06 
 Parietal 0.76 0.24 0.01 
 Occipital 0.75 0.25 0.00 
AD Frontal 0.72 0.27 0.01 
 Temporal 0.67 0.30 0.04 
 Parietal 0.71 0.28 0.01 
 Occipital 0.73 0.27 0.00 




Table 35. Proportions of voxel skewness by lobe in ADNI 
 Skew 
Lobe 
s<-0.5 -0.5≤ s≤0.5 s >0.5 
Controls Frontal 0.09 0.67 0.25 
 Temporal 0.29 0.56 0.16 
 Parietal 0.03 0.65 0.32 
 Occipital 0.04 0.68 0.28 
AD Frontal 0.07 0.66 0.28 
 Temporal 0.19 0.63 0.18 
 Parietal 0.02 0.59 0.40 
 Occipital 0.02 0.68 0.31 




Figure 53. Voxel–wise kurtosis and skewness in the ADNI control (n=89) and AD (n=89) subject 
groups 




I found a similar pattern of kurtosis and skewness in the OASIS data (Figure 54). 
Kurtosis and skewness by lobe in OASIS are shown in Table 36 and Table 37. As in 
ADNI, the temporal lobe consistently had the largest proportions of high kurtosis 
(>3.5) and negative skewness (<-0.5). The frontal lobe had the second largest 
proportions of these highly non Gaussian values. Again as in ADNI, only 




Table 36. Proportions of voxel kurtosis by lobe in OASIS 
 Kurt 
Lobe 
k<2.5 2.5≤ k ≤3.5 k >3.5 
Controls Frontal 0.70 0.29 0.02 
 Temporal 0.56 0.39 0.04 
 Parietal 0.78 0.21 0.01 
 Occipital 0.73 0.27 0.01 
AD Frontal 0.70 0.28 0.02 
 Temporal 0.60 0.36 0.04 
 Parietal 0.77 0.22 0.01 
 Occipital 0.73 0.27 0.01 




Table 37. Proportions of voxel skewness by lobe in OASIS 
 Skew 
Lobe 
s<-0.5 -0.5≤ s≤0.5 s >0.5 
Controls Frontal 0.13 0.67 0.20 
 Temporal 0.23 0.62 0.15 
 Parietal 0.06 0.71 0.23 
 Occipital 0.09 0.71 0.19 
AD Frontal 0.12 0.66 0.22 
 Temporal 0.22 0.59 0.19 
 Parietal 0.05 0.68 0.27 
 Occipital 0.07 0.71 0.22 





Figure 54. Voxel–wise kurtosis and skewness in the OASIS control (n=49) and AD (n=49) subject 
groups 
The Gaussian distribution has kurtosis of 3 (yellow) and skewness of 0 (light green/blue). 
 
 
Figure 53 and Figure 54 show that the largest deviations from the Gaussian 
distribution are in the frontal and temporal lobes, specifically in the hippocampal 
region. 
This suggests that, especially in these areas, parametric effect size may not be 
a reliable indicator of differences between normal ageing and AD subjects. I assessed 
this by comparing parametric CLES with nonparametric CLES. If data are Gaussian, 
parametric CLES will be equal to nonparametric CLES (McGraw and Wong, 1992; 
Vargha and Delaney, 2000; Coe, 2002). 
The CLES derived from parametric effect size (Cohen’s d) and nonparametric 
effect size (delta, δ) between AD and control subjects in ADNI and OASIS are shown 
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in Figure 55 and Figure 56, respectively. It is apparent that the largest effects between 
groups are in the temporal lobe, particularly the hippocampus. However, the 
parametric CLES frequently overestimated the differences between normal ageing 
controls and AD in this region by up to 55% (Figure 57). As already discussed (in the 
methods section 8.2.2.4.3), if the data were Gaussian distributed, parametric CLES 
would have been approximately equal to nonparametric CLES (McGraw and Wong, 
1992; Vargha and Delaney, 2000; Coe, 2002). 
Parametric and nonparametric CLES in ADNI and OASIS are listed by lobe in 
Table 38 and Table 39 (rounding errors mean that not all rows sum to exactly 1). 
These show that as the number of subjects increases from 49 per group (OASIS) to 89 
per group (ADNI), parametric and nonparametric methods tend to generally agree on 
the proportion of high effects (CLES≥71). This was apparent in all lobes with the 
exception of the temporal lobe. Differences between the actual sizes of effects 
determined by each method are listed by lobe in Table 40 (rounding errors mean that 
not all rows sum to exactly 1). 
Across all lobes, the differences in CLES between methods were generally 
reduced with an increased number of subjects but even with 82% more subjects, 
agreement between the methods improved by no more than 10%. Although there was 
general agreement between methods in approximately 80% of the cortex, even with 
this increase in subjects, 20% of the cortex still exhibited marked differences (>10%) 
between methods. This means that parametric methods may produce misleading 
results, i.e. results that do not correspond to the meaning of effect size in figure 40,   
in a significant part (20%) of the cortex. The highest differences between methods (d 
≥30%) within the frontal lobe were reduced, but not eliminated entirely with this 
increase in subjects. The highest differences remained within the temporal lobe 
regardless of the number of subjects. Although only ~2% of voxels exhibited these 
differences, Figure 55, Figure 56, and Figure 57 show that these were in the very 









Table 38. Proportions of Voxel CLES by lobe in ADNI 
 CLES 
Lobe 
c<56 56≤ c <64 64≤ c <71 c ≥71 
Parametric Frontal 0.61 0.35 0.04 0.00 
 Temporal 0.46 0.39 0.11 0.04 
 Parietal 0.63 0.33 0.03 0.00 
 Occipital 0.62 0.34 0.03 0.00 
Nonparametric Frontal 0.90 0.10 0.00 0.00 
 Temporal 0.75 0.22 0.02 0.01 
 Parietal 0.91 0.09 0.00 0.00 
 Occipital 0.88 0.12 0.00 0.00 
Note: CLES(c)=common language effect size, the units of which are percent; These ranges of 
CLES were chosen as they correspond to the previously defined small (0.2/56), medium (0.5/64), 




Table 39. Proportions of Voxel CLES by lobe in OASIS 
 CLES 
Lobe 
c<56 56≤ c <64 64≤ c <71 c ≥71 
Parametric Frontal 0.53 0.38 0.08 0.01 
 Temporal 0.49 0.39 0.10 0.02 
 Parietal 0.54 0.38 0.07 0.01 
 Occipital 0.53 0.38 0.08 0.01 
Nonparametric Frontal 0.87 0.12 0.01 0.00 
 Temporal 0.83 0.15 0.02 0.00 
 Parietal 0.85 0.14 0.01 0.00 
 Occipital 0.84 0.15 0.01 0.00 
Note: CLES(c)=common language effect size, the units of which are percent; These ranges of 
CLES were chosen as they correspond to the previously defined small (0.2/56), medium (0.5/64), 




Table 40. Proportions of Voxel Parametric/ Nonparametric CLES differences by lobe 
in ADNI and OASIS 
 Diff 
Lobe 
d<10 10≤ d <20 20≤ d <30 d ≥30 
ADNI Frontal 0.79 0.17 0.04 0.01 
 Temporal 0.83 0.12 0.03 0.02 
 Parietal 0.83 0.15 0.02 0.00 
 Occipital 0.82 0.15 0.03 0.00 
OASIS Frontal 0.72 0.19 0.07 0.02 
 Temporal 0.73 0.19 0.07 0.02 
 Parietal 0.76 0.18 0.05 0.01 
 Occipital 0.76 0.17 0.05 0.01 
Note: Diff(d)=difference in common language effect size (measured in percent) 









Figure 55. i. Parametric “common language effect size statistic” (P CLES) and  ii. Nonparametric CLES (NP CLES) in the ADNI Alzheimer's disease (AD)–control (C) 
group study 









Figure 56. i. Parametric “common language effect size statistic” (P CLES) and  ii. Nonparametric CLES (NP CLES) in the OASIS Alzheimer's disease (AD)–control (C) 
group study 




ADNI CLES DIFFERENCE 
 
i. 
OASIS CLES DIFFERENCE 
 
ii. 
Figure 57. Differences between parametric and nonparametric common language effect size (CLES) in the ADNI and OASIS Alzheimer's disease (AD)–control (C) group 
studies 
Calculated by parametric (P) minus nonparametric (NP) CLES. ADNI=Alzheimer’s Disease Neuroimaging Initiative; OASIS=Open Access Series of Imaging Studies.
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Figure 55, Figure 56, and Figure 57 show that the separation between the distributions 
of GM in AD and controls may not be as extreme as suggested by the parametric 
effect size. The probability that a randomly selected subject from the control group 
will have a higher value than a randomly selected AD subject was artificially 
increased with the parametric method (by up to 40%; Figure 57).  
I further tested the reliability of the parametric effect size by calculating 
standard differences at percentile ranks across the AD and control distributions (these 
should be approximately equal to the parametric effect size; Coe, 2002). The 




Figure 58. Example of grey matter proportion distributions in a 
randomly selected hippocampus voxel in AD and control subjects  
The parametrically assumed (upper panel) and actual distributions 
(lower panel) are shown. 
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Table 41. Parametric effect size and standard differences in a randomly selected 
hippocampus voxel between AD and control subjects 
Parameter AD Control Standard difference 
Mean 0.4493 0.8444 1.1687* 
2.5th 0.0000 0.0021 0.0064 
25th 0.0247 0.7609 2.1777 
50th 0.3667 1.0000 1.8731 
75th 0.8569 1.0000 0.4232 
97.5th 1.0000 1.0000 0.0000 
Note:*this is the overall parametric effect size (“Cohen’s d”). 
 
 
The standard difference column in Table 41 shows that the parametric effect size 
cannot reliably be generalised across the actual data distributions, i.e. at some points 
in the distributions (2.5th, 75th, 97.5th percentiles) the standard differences is much 
smaller than the effect size whereas it is much larger at others (25th percentile). 
Although these data were from only one randomly selected voxel, Figure 53 and 
Figure 54 show that similarly shaped distributions were found throughout the 
hippocampus. I am not refuting that there are differences between AD and controls in 
the hippocampus – Figure 55, Figure 56, and Figure 58 show that there clearly are 
differences. It may be that these differences are not best described by parametric 
methods.  
 Further to the potential unreliability of parametric effect sizes, Figure 58 
shows that parametric methods may inverse the actual data. The parametric 
distribution suggests that the majority of AD subjects have GM proportion about 0.5 
whereas the inverse is true, the majority have either approximately 0 or 1 (this is an 
actual example of “the problem with Averages”, that was vividly illustrated by Sir 
Francis Galton in 1889 – chapter 1). Furthermore, the parametric distribution leads to 
nonsensical grey matter proportion values, e.g. less than zero and greater than one. 
This provides more evidence that, when data are not Gaussian distributed, parametric 
statistics may not adequately describe the differences in brain structure between two 










The changes in brain structure that occur in neurodegenerative diseases, such as 
Alzheimer’s, may be highlighted using a voxel-based normal reference (atlas). Many 
previous normal brain atlases were derived from mean (parametric) values (chapter 
3). To reliably extrapolate these values to define the limits of normal brain structure, 
data must be distributed approximately Gaussian (Elveback et al., 1970; Freedman et 
al., 2007). I found that data were not distributed Gaussian in approximately 70% of 
the cortex (these data had either high kurtosis and/or negative skewness). Largest 
deviations from the Gaussian distribution were in the temporal and frontal lobes. The 
effect of this is that, if extrapolating mean values to define the limits of normal brain 
structure, parametric atlases produced many misclassifications (false positives and 
false negatives) in AD patients. A large percentage (60%) of false positives were in 
the temporal lobe, specifically focused in the hippocampus. This suggests that 
pathology in this region may be more subtle than expected by parametric atlases. 
Further, many (40%) of false negatives were in the frontal lobe which, although often 
not reported in research, is often implicated individual clinical diagnoses of AD 
(Geroldi et al., 1999; Thompson et al., 2003). My atlases therefore illustrate that the 
pathology of AD may not always be temporal lobe and hippocampus-centric, rather it 
may sometimes manifest in a fronto-temporal pattern. 
 The nonparametric atlas that I developed may be used when the Gaussian 
distribution assumption is not met. Further to classifying normal and abnormal voxel 
values, this atlas may be used to transform data in preparation for subsequent 
nonparametric analyses. By classifying data with this atlas data are transformed to 
have a similar distribution shape and IQR. This is a requirement of nonparametric 
analyses such as Wilcoxon-Mann-Whitney. Many data transformation methods 
currently exist, such as the commonly applied Box-Cox (Box and Cox, 1964; 
Kruggel, 2006). However, my ranking method may provide a meaningful reference to 
the original data, i.e. it describes the “clinical normality” of voxel values. While it 
provides this meaningful framework, my rank-based transformation method does not 
make data more Gaussian so should not be used for subsequent parametric analyses. 
Further, as with any transformation method, this should be carefully considered before 
use (Scott and Wild, 1991). In particular, grey matter proportion may take an infinite 
range of values between 0 and 1. I defined only 6 percentiles (including the abnormal, 
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i.e. <2.5th, percentile) to rank these values. Therefore, while making the data more 
amenable to nonparametric statistical testing, ranked image data may inherently have 
less information than the original image data. This loss of information is true for any 
image transformation, e.g. voxel-smoothing. But despite this, I have still provided a 
potentially useful and meaningful way of preparing data for nonparametric statistical 
analyses of normal and diseased groups. 
 Further to assessments of individuals, I tested parametric and nonparametric 
methods for assessing normal and diseased groups. Specifically, I implemented 
parametric and nonparametric measures of the CLES. Prior to this, I tested the 
distributions of two independent cohorts of normal and AD subjects. In both cohorts, I 
again found that much of the cortex was not Gaussian distributed (high kurtosis and 
negative skewness were again found in the temporal lobe, specifically the 
hippocampus, and frontal lobe). The result of this was that, even with an 82% increase 
in the number of subjects (from 49 to 89), parametric CLES provided markedly 
different results in approximately 20% of the cortex. For parametric measures of 
effect size to be meaningful, they should be approximately equal to the nonparametric 
measures (McGraw and Wong, 1992; Cliff, 1993; Vargha and Delaney, 2000; Coe, 
2002). Following the increase in number of subjects, the highest differences between 
methods (≥30%) were reduced but not eliminated within the frontal lobe; while these 
differences remained within the temporal lobe regardless of the number of subjects. 
Although only ~2% of voxels exhibited these differences, these were in the very 
significant hippocampal region. Taken in consideration with the misclassifications I 
found in individuals, this suggests that nonparametric (rather than parametric) 
methods should be implemented when creating statistical models to support diagnoses 
of AD.  
By using the mean ±2 (rather than exactly 1.96) SD, I may have slightly 
overestimated parametric limits but the associated error in classifications was 0.03%. I 
defined normal brain structure limits for subjects aged between 60 and 90 years. 
There are large differences in brain structure between these ages (Ge et al., 2002; 
Resnick et al., 2003; Farrell et al., 2009; Ferguson et al., 2010). Future work will 
create separate atlases for each year of life. Further, I will incorporate other clinical 
and cognitive data into these templates, e.g. atlases for specific blood pressures and/ 
or cognitive ability. 
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Given the reasonably well defined lobular pattern of atrophy in ageing and cognitive 
decline (Braak and Braak, 1997; Thompson et al., 2003; Fox and Schott, 2004), I 
reported voxel-wise statistics by atlas-based segmentation of the major lobes (frontal, 
temporal, parietal, and occipital). This segmentation was not manually edited and 
therefore not perfect. Further, I could not tabulate voxel-wise statistics specifically for 
subregional volumes within these lobes, e.g. the hippocampus. While I automatically 
segmented these volumes in younger subjects, this process was not reliable in aged 
subjects. Despite this, I still provided qualitative assessments of the hippocampus and 
future work will use semi-automatic segmentation to support reporting of statistics at 
the subregional level. 
Further to automated subregional volume segmentations, I did not implement 
other commonly applied image processing methods. In particular, I did not use 
conventional nonlinear registration (I used Nsurf, which was described in chapter 5), 
nor did I apply voxel smoothing. Smoothing is used to reduce noise in images and 
also to make the distributions of intensities more closely follow the Gaussian 
distribution (Ashburner and Friston, 2000; Good et al., 2001). By essentially 
averaging the intensities of adjoining voxels, smoothing may mask subtle differences 
between health and disease (Shenton et al., 2001). Moreover this is a subjective 
process and there are no quantitatively derived optimal parameters (Zhao et al., 2012).  
This means, however, that I do not know how the distributions of voxels will 
behave after conventional nonlinear registration and voxel smoothing. Indeed, my 
finding that brain structure is least Gaussian in the hippocampus is in conflict with a 
previous study that showed approximate concordance with their hippocampus data 
and the Gaussian distribution (Bonilha et al., 2006; Rorden et al., 2007). The 85 
subjects in that study were much younger (mean age ~31 years, SD ~8.0; range: 17–
60), and they used a different processing method (SPM) that implemented voxel 
smoothing. One reason for voxel smoothing is to make data more Gaussian 
(Ashburner and Friston, 2000; Good et al., 2001). I have presented a method that does 
not require data to be Gaussian. This may be a useful alternative for others when they 
cannot justify the use of smoothing. For example, differences between normal and 
neurologically diseased groups are often subtle and these may be removed by 
smoothing (Shenton et al., 2001; Fotenos et al., 2005).  
I illustrated my individual and group assessments using grey matter proportion 
images from normal older subjects and subjects diagnosed with AD. However, the 
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software I developed may be applied to any image sequence from any group, e.g. it 
can produce a T2–weighted percentile rank atlas from normal young adults for 
assessing brain structure in individuals and groups with schizophrenia or a T1–
weighted percentile rank atlas from full terms infants to assess brain structure in 
preterm individuals and groups. 
Finally, I attempted to validate the results from this chapter by repeating my 
analyses in separate, independent samples. While I found relative agreement, these 
data are not sufficient to make reliable population inferences. Despite 70 subjects 
providing a reasonable approximation of the 5 percentile ranks I defined (2.5th, 25th, 
50th, 75th, 97.5th), this will likely not be sufficient to define the “true” values of all 100 
whole number percentile ranks. At least 100 subjects, i.e. 1 subject per percentile, 
would be required for this. Even then, repeated nonparametric versus parametric 
analyses in multiple samples would be required to determine “true” population values. 
However, at the time of my analyses, these were the only publicly available 
brain image data from subjects that were cognitively and medically representative of 
normal ageing. Given this lack of data, we are developing the Brain Images of Normal 








The analyses in previous chapters (and those of others, e.g. Manolio et al., 1994; Ge et 
al., 2002; Resnick et al., 2003; Kruggel, 2006; Farrell et al., 2009) have shown that 
large amounts of data will be required to better understand the range of brain structure 
changes that occur through the lifecourse and neurological disease. For example, I 
found considerable overlap in brain volumes between normal ageing and AD subjects 
(chapter 6). Multivariate metrics, e.g. WMH volumes, from a range of MRI sequences 
will therefore be required to better differentiate these subjects. Brain MRI databanks 
have the facility to store the required data and the derived atlases of brain structure 
that may highlight pathology associated with neurological disorder (chapter 8). 
 As described in chapter 2, banks of brain data have been in development since 
at least the 1980s (Foulkes et al., 1988) and these banks started to include images 
from the 1990s (Cocosco et al., 1997). This meant that several publicly accessible 
brain MRI databanks existed prior to the present work, notably the ADNI, Human 
Connectome Project, IXI, ICBM, MIRIAD, and OASIS databanks. Although they 
serve their own purposes very well, these banks may be limited by a lack of: (1) 
medical metadata, e.g. blood pressure and cognitive tests, to support the classification 
of “normal” subjects; (2) subjects that represent the characteristics of cognitively 
normal older people (>60 years), e.g. high blood pressure; (3) demographic diversity, 
e.g. most subjects were acquired in American centres; (4) MR image sequences, e.g. 
FLAIR and T2–weighted images for segmentation of potential lesions and venous 
sinuses; and (5) robust, i.e. nonparametric, atlases of brain structure. 
 In this chapter I describe the “Brain Images of Normal Subjects (BRAINS)” 
bank and the atlases I intend to derive from these data. My atlases will be used to 
investigate the range of brain structure in normal ageing and to highlight pathology of 
neurological diseases. After describing the BRAINS bank infrastructure, I describe 
development of: (1) “normal mean difference” assessment in my preterm infant 
subjects using the publicly available MNI normal infant atlas; (2) an “adultspan” (25–
90 year) atlas of brain structure that I created from ADNI, OASIS, and our early to 
middle adult subjects; and (3) an “aged” (60–90 year) atlas that I created from ADNI 
and OASIS data and used to highlight pathology associated with AD. 
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9.2 BRAINS bank methods 
 
9.2.1 Subjects 
The BRAINS bank will initially include 1595 different normal subjects aged <1–80 
years (~50% female). These were acquired in 10 separate studies, specifically to 
assess normal brain development and ageing or as controls for studies of neurological 
disease (Table 42).  
 
 
Table 42. BRAINS bank MRI data 
Study Name N Age1 Tesla Sequences 
Preterm infant controls 10 <1 3 T1, T2, DTI 
Bipolar controls 
(McIntosh et al., 2008) 
102L 16–25 1.5 T1, T2 
High risk controls 
(Job et al., 2002) 
179L 16–25 1, 1.5 T1, T2 
Psychiatry controls 
(McIntosh et al., 2007) 
70L 20–50  1.5 T1, T2 
CaliBrain 
(Moorhead et al., 2009) 
15M 25–42 1.5 T1 
Amygdala controls 
(Hall et al., 2008) 
100 25–45 1.5 T1, T2 
NIH DTI 80 25–64 1.5 T1, T2, T2*, MT–MRI, 
FLAIR, DTI 
Normal Ageing Brain 
(MacLullich et al., 2002) 
150L 65–75 1.5, 2 T1, T2, T2*, FLAIR 
LBC 1936 
(Deary et al., 2007) 
729L 70–75 1.5 T1, T2, T2*, FLAIR, DTI 
LBC 1921 
(Shenkin et al., 2003) 
160 L 75–90 2, 1.5 T1, T2, T2*, FLAIR, DTI 
All 1595 <1–80   
Note: 1Age is in years; L=longitudinal data; M=multicentre data; NIH DTI=National Institutes of 
Health Diffusion Tensor Imaging; LBC=Lothian Birth Cohort. 
 
 
Longitudinal data were acquired for at least 1119 subjects (data collection is ongoing) 
and multicentre data for 15 subjects (highlighted with an “L” and “M”, respectively in 







9.2.2 Medical assessment 
The majority of subjects aged under 65 years were determined to be medically normal 
if they were not on any long term medication (with the exception of the contraceptive 
pill), not diagnosed with diabetes or high blood pressure, and had no history of 
diagnosed neurological disorder, major psychiatric disorder, substance misuse 
(including alcohol), or cranial surgery.  
 Medical history was also acquired in subjects over 65 years and further to this 
they received a physical examination (Deary et al., 2007). This examination recorded: 
height, weight, visual acuity in both eyes, time to walk six metres, ability to stand 
from sitting, demi–span, head circumference, activities of daily living (Townsend, 
1979), blood pressure, peak expiratory flow rate in the lungs, forced expiratory 
volume in one second, forced vital capacity, grip strength in both hands, and date of 
the menopause in women. We have limited data on the ethnicity of subjects. 
 Following medical tests and examinations, each subject completed a battery of 
cognitive tests. 
 
9.2.3 Cognitive assessment 
To determine that they were cognitively normal, all subjects under 65 years (except 
the infants) completed at least a subset of: the Wechsler Adult Intelligence Scale III 
(WAIS-III; Wechsler, 1997a), Wechsler Memory Scale III (WMS-III; Wechsler, 
1997b), National Adult Reading Test (NART; Nelson and Willison, 1991), verbal 
fluency (Lezak et al., 2004), and simple and four–choice reaction time (Deary et al., 
2001) tasks. Subjects used as controls in psychiatric studies were also assessed using 
the Structured Clinical Interview for DSM–IV (SCID).  
Subjects aged over 65 years completed a similar battery of tests but further to 
these they completed the Hospital Anxiety and Depression Scale (Zigmond and 
Snaith, 1983) and Mini–Mental State Examination (MMSE; Folstein et al., 1975). 
Moreover, over 700 of the aged subjects have cognitive data that were acquired at 11 
years (Deary et al., 2007). For subjects aged over 65 years, these are data unique in 
the world to BRAINS. After completing the medical and cognitive assessments, 





9.2.4 Brain MRI 
The majority of brain MRI data were acquired in the Brain Research Imaging Centre, 
The University of Edinburgh with a GE Signa Horizon HDxt 1.5 T clinical scanner 
(General Electric, Milwaukee, WI). For most subjects the imaging protocol consisted 
of: axial T2–, T2*–, and FLAIR–weighted sequences, a coronal T1–weighted volume 
sequence, an axial T1–weighted fast–spoiled gradient echo (FSPGR) sequence, a 
magnetization transfer (MT–MRI) pulse sequence, and a diffusion MRI protocol, all 
acquired in DICOM. All image sequences were determined to be within normal 
appearing limits by a consultant neuroradiologist. The DICOM metadata and 
aforementioned cognitive and medical data were automatically catalogued to populate 
the databank structure.  
 
 
9.3 Databank structure 
 
The internally housed databank was built by Dr. Dominic Job and Dr. David 
Rodriguez Gonzalez, The University of Edinburgh, using the MySQL database 
software. We intend to make the databank publicly available using the Extensible 
Neuroimaging Archive Toolkit (XNAT) platform. XNAT is a widely used and 
customisable platform that will provide external users a portal to the internal 
databank. This portal will allow various levels of access that will determine what data 
users can access, e.g. data owners will have full access whereas unaffiliated users will 
have restricted access based on data owner specifications. 
At the time of writing, the internal databank was still under construction. 
However, its general structure may be described briefly as follows: each subject is 
assigned a row in each metadata table (containing various columns of variables) and 
each of these records (rows) are linked via their anonymised ID number. Subject 
images are stored in a computer server external to the MySQL tables. Corresponding 
subject images are similarly linked to the metadata tables via their anonymised ID 







9.3.1 Metadata schema 
Adding all of the studies together, there are 220 demographic and clinical variables 
(Appendix AII.1). These include blood pressure, ethnicity, pulse, body mass index 
(BMI), medications, and a wide range of cognitive tests, e.g. MMSE, NART. These 
data were not collected for all subjects, e.g. infant subjects did not complete the 
MMSE, but each subject had at least the data listed in Table 43. Cognitively normal 
status was established from the infants’ mother. 
 
 





MRI report Qualitative 
Cognitively normal Binary 
Medically normal Binary 
 
 
Further to these demographic and clinical metadata, we also stored MRI metadata 
(e.g., sequence name, image orientation) for each subject via an automatic cataloguing 
tool I developed. 
 
9.3.2 MRI data cataloguing tools 
9.3.2.1 Automatic cataloguing of DICOM header information (MRI metadata) 
As well as subject specific information, e.g. age, gender, databank queries may be 
interested in image specific information, e.g. in a volumetric study T1–weighted 
images are likely to be needed while MT–MRI may not. To allow these queries I had 
to extract this information from the DICOM headers and insert them into a databank 
table. The large number of images contained in BRAINS (Table 42) meant that this 
would have taken a long time to do by hand (I would have needed to open 4785 
DICOM headers by hand and then manually copy and paste the required information 
into a databank table). Further, this amount of manual work provided a high 
probability of human error. 
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I therefore wrote a program in the MATLAB computing language to automatically 
read DICOM headers and extract the required information to a databank table. The 
metadata I extracted from the DICOM headers are listed in Table 44. Some of the data 
I extracted were for quality control, e.g. ensuring correct age with acquisition and 
birth date, and will not be included in the public BRAINS databank. 
 
 
Table 44. Metadata automatically extracted from DICOM headers 
DICOM header field Definition 
StudyIDP Identification of each scan session, usually in numerical 
order from 1, e.g. the ID of the scanners first session is 1. 
SeriesNumberP Number of each scan sequence, usually in numerical order 
from 1, e.g. the localiser sequence is 1. 
PatientBirthDateP Patient date of birth 
AcquisitionDateP Date of scan session 
MagneticFieldStrength Magnet field strength of scanner in tesla (T) 
SeriesDescription Description of each sequence, e.g. “ax FLAIR” (axial 
FLAIR) 
ImageOrientationPatient Acquisition plane, e.g. sagittal =[~0;~1;~0;~0;~0;~1] 
RepetitionTime Time between sequence pulses 
EchoTime Time between sequence pulse and maximum signal 
Width In–plane image width 
Height In–plane image height 
SliceThickness In–plane image thickness 
SpacingBetweenSlices Space between in–plane images 
Note: P=private data, will not be included in the public BRAINS databank. 
 
 
After extracting these metadata we converted the DICOM images into NIFTI–1 
format using MRIcron (Rorden, 2010). 
 
9.3.2.2 MRI format conversion 
For computational analysis of brain MRI, DICOM format images are often converted 
to NIFTI–1 (as I did here). However, neuroradiologists may wish to view the results 
of computational analyses, e.g. voxel–based brain ranking (chapter 8), beside original 
images on their DICOM format workstations. To allow this I wrote a program in the 
MATLAB computing language to convert NIFTI–1 images back to DICOM. Since 
NIFTI–1 does not contain all of the DICOM header fields, I wrote a program to 
reinsert the DICOM header information lost in the initial NIFTI–1 conversion.  
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We chose to provide images in the NIFTI–1 format because it is the most commonly 
used image format among other established brain MRI databanks. I was able to 
ascertain this and other information about established brain MRI databanks through a 
series of visits I made (Table 45). 
 
9.3.3 Links with established brain MRI databanks 
To improve utility of the BRAINS bank, I sought to create collaborations with 
existing brain MRI databank centres. With a “Postdoctoral and Early Career 
Researcher Exchange” award from the Scottish Funding Council, I visited three of the 
worldwide leading brain MRI databank centres (Table 45). The aim of these visits 
was to initiate a worldwide brain MRI databank and atlas of brain structure across the 
lifecourse. By bringing together data from centres across the world, this databank and 
atlas may provide better understanding of normal brain structure variation and 
potentially diagnoses of neurological disorders. 
 
9.3.3.1 Centres visited 




Table 45. Centres and principal investigators visited 
University Centre PI Visit date 
McGill University Montreal Neurological Institute 
(MNI) 
Alan C. Evans 30/03/13–
06//04/13 
University of California, 
Los Angeles (UCLA) 










Northwestern University Neuroimaging and Applied 
Computational Anatomy Lab 









As a result of these visits I acquired additional resources, data, and methods to 
develop the BRAINS bank and atlas. As described in the following list, I: 
 
1. Was granted access to global computing and image processing resources 
(http://cbrain.mcgill.ca/) 
2. Learned the MNI (http://www.bic.mni.mcgill.ca/ServicesSoftware/CIVET – 
Figure 59) and LONI (http://BrainSuite.loni.ucla.edu/ – Figure 60) image 
processing pipelines to 
a. Significantly reduce my processing times (by 50%, see section 5.4.1.3) 
b. Measure cortical thickness (previously I was only able to measure 
volume) 
3. Learned methods to extract brain tissue volumes from infant subjects 
4. Secured technical support for public release of the BRAINS bank on the 
widely used XNAT platform (https://central.xnat.org/) 
5. Increased our sample size by ~1800 subjects 
 
Preliminary results from the analyses conducted using the MNI and LONI pipelines 
are shown in Figure 59 and Figure 60, respectively. I used the MNI pipeline to 
calculate cortical thickness in the 80 normal younger to middle adult subjects (chapter 
5). I then calculated the lower normal limit (2.5th percentile) of cortical thickness 
using the parametric and nonparametric methods described in chapters 7 and 8. The 
blue areas in Figure 59 show where parametric were less than the nonparametric 
limits and the red areas where the parametric were greater than the nonparametric 
limits (the green areas show where the methods were equal). 
For one of the young to middle adulthood subjects, I also computed cortical 






Figure 59. Illustration of the work I completed at MNI 
Normal lower limit (2.5th percentile rank) of cortical thickness across adulthood (80 
normal subjects aged 25–64 years) calculated with parametric and nonparametric methods. 
The red areas show where the parametric method underestimated the normal lower limit 
and the blue areas where the parametric method overestimated the normal lower limit; the 






Figure 60. Illustration of the work I completed at LONI 
Cortical thickness in an individual subject aged 25 years (left), 
measured using the LONI pipeline. The blue areas are ~2mm and the 
darkest red areas are ≥5mm. The LONI atlas (upper right) and resulting 





To measure reproducibility across methods, future work may compute cortical 
thickness in the same group of subjects and compare the results from MNI and LONI 
pipelines. As well as incorporating these methods and data from established banks, we 
will expand BRAINS in future by adding more local data. 
 
 9.3.4 BRAINS expansion 
Further to the normal subjects that have already been recruited in The University of 
Edinburgh, we will integrate data from: all future normal subjects collected in 
Edinburgh; normal subjects already recruited in other centres across Scotland, e.g. 
University of Glasgow; and abnormal subjects already collected in Edinburgh, e.g. 
dementia patients, preterm infants. These data will allow us and others to test whether 
my atlases are useful for image processing, statistical analyses, and detection of 
pathology. 
I am developing a series of BRAINS atlases and methods that may be useful 
for qualitative and quantitative image analyses. The following sections describe 
ongoing work into infant, “adultspan”, “aged” brain atlases. 
 
 
9.4 Future directions 
 
9.4.1 Infant BRAINS assessment 
 
At the time of writing, infant control subjects were still being recruited (these have 
proved a challenge to recruit as compared to the preterm subjects). However, once a 
sufficient number have been collected I will develop a normative percentile rank atlas 
from these and use this in a similar way to the older adult percentile rank atlas, i.e. to 
highlight potential pathology in preterm subjects. 
 For present purposes I calculated percent differences between voxel values in 
the MNI normal infant atlas and voxel values in each preterm subject. This procedure 








To determine the normalcy of voxel values in preterm infant subjects (their 
demographics were described in section 5.2.1), I calculated percent differences from 




Figure 61. MNI normal infant atlas 
This is the mean atlas derived from normal subjects at term equivalent age to the preterm subjects 
described in chapter 5. I used this to create “mean distance” images for the preterms. 
 
 
Prior to calculating percent differences, I processed each subject according to the 
detailed procedures in chapter 5. Briefly, each subject was brain extracted and 
registered to the atlas space using Nsurf registration. The MR intensity range of each 
subject was then normalised to the atlas range using the SIS procedure, also described 
in detail in chapter 5. The intensity standardisation did not appear to unduly alter brain 
structure however I could only validate this qualitatively. 
I did not perform N4 bias correction on the infant subjects prior to comparing 
them to the atlas because this appeared to unduly alter the developing deep grey 
matter structure, e.g., the contrast between the deep grey matter and surrounding 






Figure 62. The effect of bias correction (corr) on a preterm infant subject 
The contrast between deep grey matter and white matter was reduced after bias correction (highlighted 
by the red circles). 
 
 
Following these processing steps percent differences between all voxel values in the 











where i is voxel i in the atlas, and xij is voxel i in subject j. 
 
9.4.1.2 Results 
The results from SIS in the preterm subjects are shown in Figure 63. This shows that 
the voxel intensity range of each of the 29 subjects was initially varied but normalised 
to the atlas range following SIS. Qualitative assessment of the images indicated that 
there were no undue alterations to contrast or brain structure in any subject following 
SIS. 
The majority (75.9%, n=22/29) of preterm subjects had markedly greater than 
normal interhemispheric fissure cerebrospinal fluid volume, and more still (89.7%, 
n=26/29) had either increased interhemispheric fissure CSF or greater than normal 
inferior cerebellum CFS volume (red areas in Figure 64). Calculated quantitatively 
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with the normal reference atlas, these observations are consistent with radiological 
diagnoses of an experienced consultant neonatologist (Dr James Boardman, Royal 
Infirmary of Edinburgh). Moreover, they illustrate the high degree of skewness in 




Figure 63. Standardised intensity scale (SIS) algorithm in 
the preterm subjects 
Original subject intensity ranges (top panel) were 
transformed into the template range (middle panel) to 




Figure 64. Preterm infant 
mean distance images 
These show how far (in 
percent) each preterm 
infant voxel was from the 
mean normal atlas. The 
red areas indicate 
hypointensities (reduced 
grey matter/ increased 
cerebrospinal fluid 
proportion) in preterms 
that are generally not 




The reference used to derive the images in Figure 64 was based on the mean intensity 
of 36 normal infant subjects. I have already discussed (chapters 3 and 4) and 
demonstrated (chapters 6, 7, 8) the limitations of mean values of brain structure and 
they still apply here. However, when we have collected a sufficient amount of normal 
infant data ourselves, I will create a percentile rank template to determine if this can 
improve sensitivity to detect pathology associated with preterm infancy. 
While I did not have sufficient data to create a normal percentile rank atlas for 
infants, I did have sufficient data to create percentile rank atlases for adults. I describe 
these in the following sections. 
 
9.4.2 Percentile rank “adultspan” BRAINS atlas 
 
As the review in chapter 3 showed, there was a lack of brain MRI atlases for studies 
across adulthood. The few existing atlases were created with less than 100 subjects 
each and were based on mean voxel values. I therefore created a percentile rank 
“adultspan” atlas with 160 subjects aged 25–90 years.  
 
9.4.2.1 Methods 
To derive the standard space for the adultspan (25–90 years) atlas I followed the 
procedure described in chapter 5. Briefly, each subject was 6 pt registered to MNI 
space and a mean intensity image calculated; each subject was then 12 pt registered to 
the 6 pt mean intensity image and a final mean intensity image calculated. The 12 pt 
mean intensity images from the MNI152 atlas, my adultspan (25–90 years) and aged 
(60–90 years) atlases are shown in Figure 65. This shows that an atlas representative 
of the span of adulthood has ventricles and sulcal spaces larger than the MNI152 atlas 
but not as large as an aged atlas. Further, my adultspan atlas is more representative of 
the size of the average adult brain (because I removed residual variance that led to the 
overestimated size of the MNI atlas; chapter 3). 
 The MRI intensity range in each subject was standardised to the intensity 
range of the adultspan standard space using the SIS procedure described in chapter 5. 
The 2.5th, 25th, 50th, 75th, and 97.5th percentile ranks of intensities were then calculated 
in each voxel (with the procedure described in section 8.2.2.2.2). The result of which 
was a four dimensional (4D) percentile rank atlas of the normal levels and limits of 




The standard space for the adultspan atlas is shown in Figure 65 alongside the 
standard space for the aged adult atlas and the MNI152 atlas. The results from SIS are 
shown in Figure 66, illustrating that all subjects, from 62 different sites (ADNI, 
OASIS, and Edinburgh), were in the same intensity range (this procedure was 
validated in section 5.4.3). The subsequently derived percentile rank adultspan atlas is 
shown in Figure 67. Although data were not available at the time of writing, I will use 
this atlas to investigate the pathology associated with schizophrenic individuals (that 
may be too subtle to detect with parametric methods; Shenton et al., 2001; Job et al., 
2002). Further, by ranking subjects with this template, data in subsequent lifecourse 
studies (25–90 years) will be more amenable to nonparametric analyses, e.g. the 
Wilcoxon–Mann–Whitney test, while still in a relative transformation space, i.e. 
rather than a Box–Cox (Box and Cox, 1964) or logarithm transform, their voxel 
values are replaced with percentile ranks of “how normal” they are. Voxel–based 




Figure 65. MNI152, adultspan, and aged atlases 
The sagittal view of the atlases overlaid with one another is shown in 
the top right; this illustrates the differences in brain sizes between 
ages, e.g. brain size generally shrinks with age. MNI152 is shown in 




Figure 66. SIS in the “adultspan" BRAINS atlas subjects 
The original voxel intensities of 160 different subjects (25–90 years) from 
62 different sites (ADNI, OASIS, and Edinburgh; top panel) were 
standardised (bottom panel) to the standard space intensities (middle panel) 







Figure 67. “Adultspan” (25–90 years) whole brain percentile rank atlas 
This shows the normal range of intensities (from the 2.5th to 97.5th percentile rank values) in each voxel for subjects aged 25–90 years; min=minimum; max=maximum; 
norm=normal value; Int=voxel intensity. Because it is calculated at the voxel level these images do not literally correspond to, for example, a single brain with lots of 
cortical cerebrospinal fluid/grey matter (at the 2.5th percentile). Rather, for the 2.5th percentile, these are just the minimum normal values at each voxel shown (in any given 




9.4.3 Percentile rank “aged” BRAINS atlas and AD pathology map 
 
I created a percentile rank “aged” whole brain atlas using SIS and 236 normal subjects 
aged 60–90 years because of the issues I identified with GM proportion images and 
atlases in aged subjects (chapter 5). 
 
9.4.3.1 Methods 
The percentile rank aged whole brain atlas was created using the same procedure as 
the adultspan atlas. Two hundred and thirty–six normal subjects from ADNI and 
OASIS (aged 60–90 years; described fully in chapter 5) were registered to the aged 
standard space (section 5.3.5.1) with Nsurf registration (section 5.3.6). I then 
standardised the voxel intensity range of each subject to the standard space voxel 
intensity range using SIS (section 5.4.3). After which I calculated the 2.5th, 25th, 50th, 
75th, and 97.5th percentile ranks of intensities in each voxel to produce a four 
dimensional percentile rank atlas of the normal levels and limits of voxel intensities 
for subjects 25–90 years. 
 I then applied the same processing steps to 224 AD subjects from ADNI and 
OASIS (aged 60–90 years) that were described in chapter 5. This allowed me to 
classify each of their voxel values with the percentile rank atlas. 
 
9.4.3.2 Results 
The percentile rank aged whole brain atlas is shown in Figure 68. By ranking 224 AD 
subjects with this atlas I produced a “pathology map”, i.e. the median of the ranked 
images where voxels less than or equal to the lower quartile of normal values were 
marked in red. The AD subjects had mixed CDR greater than 0, i.e. 0.5-1. This 
highlighted established regions of pathology associated with AD, e.g. ventricular 
enlargement and MTL and hippocampal atrophy (Figure 69). It also highlighted white 
matter hypointensities (hyperintensities on T2) that are emerging as a potential marker 
of cognitive decline and dementia (Breteler et al., 1994). Further, it highlighted GM 
regions that I found parametric tests to produce false positive results, and a potentially 
new marker of Sylvian fissure (lateral sulcus) enlargement. From qualitative 
assessment of the pathology map, the Sylvian fissure showed a large area of voxels 
that were less than the lower quartile of normal values. This is consistent with the 
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large areas of lower quartile values in established regions of pathology, e.g. lateral 
ventricles and hippocampus. Although not a definitive new marker, the proximity of 
the Sylvian fissure to the medial temporal lobe, and similarities of ranks between the 
Sylvian fissure and established pathology areas, suggests this area merits further 
investigation with more subjects and nonparametric analysis.  
The previously identified markers were found using a variety of techniques 
and sequences whereas I replicated them with an atlas–based ranking approach in a 
single sequence. This suggests that the SIS percentile rank atlas may highlight 
previously unknown pathology of other neurological disorders, e.g. schizophrenia. 
However, these findings are by no way definitive and are only meant to drive 
hypotheses for further analyses. They may also support individual diagnoses, e.g. by a 
priori highlighting specific regions for clinicians to investigate in new individuals 









Figure 68. Aged adult (60–90 years) whole brain percentile rank atlas 
This shows the normal range of intensities (from the 2.5th to 97.5th percentile rank values) in each voxel for subjects aged 60–90 years; min=minimum; max=maximum; 
norm=normal value; Int=voxel intensity. The inclusion of only subjects aged ≥60 years led to a median (50th percentile) image with slightly larger lateral ventricles and sulcal 
spaces than the “adultspan” atlas (figure 67). Because it is calculated at the voxel level these images do not literally correspond to, for example, a single brain that is made up 





Figure 69. Alzheimer's disease pathology map 
This is the median of 224 AD subjects (aged 60–90 years) from ADNI and OASIS that were 
ranked with the aged percentile rank brain atlas. This highlights regions in AD where voxel 
intensities are at the lowest quartile of normal values (or below) and illustrates pathology 
established in the literature, medial temporal lobe atrophy and ventricle enlargements (top left), 
potentially emerging pathology, white mater hypointensities (hyperintense on T2), areas where 
parametric methods previously produced false negatives (FN), in the frontal region, and a 






In this thesis I have attempted to determine the amount of brain imaging and metadata 
required to effectively describe the full range of normal ageing brain structure. The 
large amounts of data that are required to understand normal and pathological brain 
ageing, and the current lack of these data, led us to develop the BRAINS bank. Many 
brain image banks are currently available but their representation of normal older 
people is limited (chapter 2). Medical, cognitive, and image sequence data for subjects 
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currently available on the internet may not be sufficient to create robust statistical 
models of normal ageing brain structure for identification and prediction of pathology. 
I discuss here how BRAINS may provide the data and methods needed to do this. 
 
9.5.1 BRAINS image bank 
The BRAINS image bank, in the first instance, will consist of 1595 different normal 
subjects aged <1-80 years (~50% female). These were acquired in 10 separate studies 
that were conducted at different points in time. While this may at first seem a 
limitation, e.g. due to technology updates, it is actually a strength. Data are often 
collected at different points in time (e.g. in longitudinal studies) and with the data that 
we have, I may identify the potentially spurious effect of year of scan between 
individuals (there is clearly a strong and significant effect across ages). For example, 
in a group of subjects of the same age, I could include the year they were scanned, e.g. 
2005 vs. 2010, as a controlling variable. Adding this effect to longitudinal data may 
then control for factors such as technological and image sequence advances. Other 
factors that may confound studies of normal ageing include blood pressure and 
prescription medication use (Mazziotta et al., 2009). These were not always provided 
in existing banks but were provided in BRAINS when collected in the original 
studies. 
 We collected a vast array of medical and cognitive data for the aged BRAINS 
subjects. Unlike in previous banks (Mazziotta et al., 2009), these data were not used 
to exclude subjects but provided for others to make that exclusion. Our normal 
subjects therefore had no dementia, other debilitating disorder or history but common 
ageing indications such as hypertension. This means that they are generally not 
“super-normal” but investigators can exclude subjects on these variables if 
appropriate for their study. Following medical testing each subject received a battery 
of medical tests and, as long as they were within normal limits (e.g. MMSE>27), we 
did not exclude or stratify subjects based on these measures. Again, these data will be 
provided for individuals to exclude/ co-vary as they see fit. After we determined that 
subjects were normal via these medical and cognitive data, they underwent a series of 
imaging sequences. 
 All of the aged (>60 years) subjects in BRAINS were acquired in multiple 
imaging sequences. The T1-weighted images provide the basic data required to 
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segment whole brain and subregional volumes. This is not always sufficient for aged 
subjects, e.g. misclassifications of WMH in chapter 5. The T2, T2*, and FLAIR 
sequences provided in BRAINS will support robust segmentation of these volumes 
(Wardlaw et al., 2011; Aribisala et al., 2012). We have also acquired longitudinal data 
for the majority of the aged subjects. This will allow us to compare the cross-sectional 
models described here with future longitudinal models. Further, these data will allow 
us to test whether my atlases can support diagnoses/ predictions of cognitive decline 
and neurodegenerative disease.  
 
9.5.2 BRAINS atlases 
BRAINS atlases and voxel-based pathology detecting methods were developed for 
subjects from <1 year to 90 years. Normal infant (<1 year) subjects were not available 
at the time of this work and so I used an existing mean based atlas (Fonov et al., 2009) 
to illustrate how I may automatically detect pathology in preterm infants.  
This allowed me to determine how far away preterms were from the general pattern of 
normal infant brain structure but did not allow me to determine whether these 
differences were out with the normal range. Although the vast majority of subjects 
showed large (>50%) deviations from normal infancy values in the interhemispheric 
fissure and inferior cerebellum, some showed smaller (~10-20%) deviations.  
Prior to this atlas-based assessment I did not perform bias field correction, but 
I did normalise all subject intensity ranges using SIS (described in chapter 5). Bias 
field appeared to unduly alter the deep GM structures and there are several challenges 
to reliably segmenting tissues from infant brains, e.g. the grey/white boundary is 
inversed on T1–weighted images in infancy. Future work will address these 
challenges and whether or not there are any ill effects in intensity standardisation that 
cannot be determined visually. Furthermore, a future percentile rank atlas will show 
whether or not the deviations I highlighted are within normal limits. 
 I was able to develop percentile rank atlases across the span of adulthood (25-
90 years) and old age (60-90 years). These atlases were derived in the coordinate 
framework of the widely used Talairach/ MNI space, but did not inherit the 
limitations I discussed previously (chapter 3). For example, neither of my atlases were 
volumetrically symmetrical and had overall brain size close to that of most people. 
My atlases may therefore be more amenable to image processing (by being similar to 
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more people’s brain size they give registration algorithms a better chance of good 
correspondence) and subsequently reduce potential errors in atlas-based assessment, 
e.g. those due to misalignment of overall brain size.  
Atlas-based assessment with the aged adult atlas allowed me to create AD 
pathology maps. That is, from the median classification image of 224 AD subjects, I 
highlighted regions that were equal to or below the lowest quadrant of normal values. 
Using just their normalised T1-weighted images, this map highlighted much of the 
pathology identified in literature that used a number of sequences, e.g. hippocampus 
atrophy and WM hypointensities (hyperintense on T2). Further, previously identified 
regions of false negatives in GM images (chapter 8) were highlighted and a 
potentially new marker was found in the Sylvian fissure (lateral sulcus). Although 
temporal lobe atrophy and WMH markers are supported by a large body of evidence 
(Breteler et al., 1994; Jack Jr et al., 1997; Thompson et al., 2003), there is much less 
independent evidence to support frontal lobe and Sylvian fissure expansion as markers 
of AD. Therefore, my pathology maps are not intended to be definitive measures of 
brain structure in diseases like AD. Rather, they are intended to drive hypotheses for 
further analyses and support individual subject diagnoses. For example, a future study 
may specifically investigate the potential WMH marker in white matter tracts or 
measure cortical thickness in the Sylvian fissure. In clinical diagnoses, a pathology 
map may provide a reference for areas to check in subjects that are suspected to have 
incipient disease. Many more subjects will be required to create robust and 
representative atlases but I have at least described a method for doing this when these 
subjects become available. 
While most commonly used atlases were representative of only one race or 
nationality, my “adultspan” atlas was created with normal subjects from the United 
Kingdom and United States. This suggests that it may be useful for increasingly 
international brain imaging projects (Mueller et al., 2005; Ellis et al., 2010; Simmons 
et al., 2011). The next section discusses how BRAINS fits into the context of existing 
international banks and atlases. 
 
9.5.3 The place of BRAINS in the context of existing brain image banks and atlases 
Banks of brain data have been in development since at least the 1980s (Foulkes et al., 
1988) and image banks started to become prominent in the 1990s (Cocosco et al., 
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1997). Prominent brain image centres, such as the MNI and LONI, developed their 
strong international reputations partly on the back of their databank and atlas work 
(Evans et al., 1993; Toga, 2002). While they have successfully addressed many of the 
concerns with historical brain atlases and the previous lack of validation data, my 
visits to these centres also demonstrated there are still gaps that may be filled by 
BRAINS. 
 The ADNI databank is housed at LONI and is an extremely valuable 
neuroimaging data source. Much of the present work was partly based on analyses of 
ADNI data. It was designed to provide earlier diagnoses for AD and so, in a range of 
MR sequences and with rich cognitive and medical data, recruited over 800 AD and 
normal control subjects. There are, however, some limitations to ADNI. The youngest 
of the control subjects are aged 70 years. People as young as forty may develop AD. 
Prodromal pathology may occur in the brain up to 10 years or more prior to clinical 
symptom onset (Tondelli et al., 2012). This suggests that normal subjects younger 
than 70 years are required for effective earlier diagnoses. These, and subjects from 
across the lifespan, will be provided in BRAINS. This means that BRAINS will be 
useful for investigating neurological disorders across the lifespan, from autism to 
Alzheimer’s. 
 Further to BRAINS data, my atlas method also represents a novel approach. 
The most widely used brain image atlases were developed at MNI (Evans et al., 1993; 
Ashburner and Friston, 2000). The so-called “MNI” or “ICBM” atlases/ templates, 
they were derived from the mean voxel values of several hundred subjects aged 18-44 
years. These are very useful for image processing, e.g. tissue segmentation, voxel-
based reporting. However, they may introduce bias into studies of subjects aged 
younger than 18 and older than 40 years, e.g. overexpansion of aged brains (Buckner 
et al., 2004). Moreover, these mean-based atlases may lead to errors if used for voxel-
based classification (chapter 8). BRAINS atlases will be derived from subjects across 
the lifespan using robust percentile rank voxel values. The next and final chapter 
discusses the implications, limitations, and contribution of these methods. 
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Robust methods are required to understand the complexity of the human brain and 
how it changes through life and disease. Following assessment of existing methods, I 
provided novel methods for highlighting changes that occur in the brain before and 
during neurological diseases. Here I discuss the conclusions from the hypotheses set 
in Chapter 1 and the main contributions of this work: 
 
A1. Collated and summarised previously disparate information about brain 
image data publicly available worldwide 
A1.1 Described how many existing brain image atlases were built and 
what they may be used for. 
A1.2 Reviewed the most commonly applied statistical models in brain 
imaging. 
 
H1. I rejected the hypothesis that parametric atlases adequately describe the 
distribution of brain structure across the lifecourse: 
A2. I therefore built novel percentile rank brain image atlases of the 
“adultspan” (25-90 years) and ageing (60-90 years) 
A2.1 Highlighted the potential for errors in individual assessments with 
current atlas methods. 
A2.2 Provided a more robust method for assessing brain structure in 
individuals. 
A2.3 Developed “atlas-based clinical rank transformation” to prepare 
data for nonparametric testing while maintaining a relative frame of 
reference. 
A2.4 Determined that a robust atlas of the distribution of brain structure 
across the lifespan would require approximately 6,370 subjects. 
 
H2. I rejected the hypothesis that parametric statistical models adequately 
describe the distributions and boundaries of brain structure in normal ageing and 
disease: 
A3. I therefore implemented novel percentile rank statistical models of brain 
structure 
A3.1 Highlighted the potential for errors in definition of the distribution 
of ageing brain volumes with current (mean-based) methods. 
A3.2 Provided a method for directly calculating distribution levels and 




10.2 MRI brain structure data 
 
A systematic review of structural MRI brain databanks found that there are fewer than 
350 cognitively normal older subjects (≥60 years) publicly available worldwide and 
98 of these are openly available worldwide. I found many other subjects were 
available but they did not have cognitive and medical data to support their definition 
of normal. The definition of normal subjects should be supported with thorough 
cognitive and medical testing to show that they have no cognitive or other debilitating 
disorder but clinical characteristics that are common in ageing e.g. prescription 
medications, diabetes, hypertension and arthritis (Jernigan et al., 2001; DeCarli et al., 
2005; Grady et al., 2006; Marcus et al., 2007c; Ellis et al., 2009; Farrell et al., 2009; 
Mazziotta et al., 2009; Marcus et al., 2010). As long as these characteristics are 
carefully documented and searchable, this will allow others to draw subjects 
appropriate for their study group and/or representative of the wider population. To 
fully represent the range of brain structure seen in ageing, multiple image sequences, 
e.g. T1, T2, T2*, FLAIR, are required. Related to this, these sequences are also 
required to support reliable image processing across the lifecourse. For example, to 
reliably segment CSF and white matter hyperintensities, T2 and FLAIR sequences are 
required (Wardlaw et al., 2011; Aribisala et al., 2012). The wide range of brain 
structure seen in older ages requires that these data are available for all subjects, 
otherwise this variance may not be adequately quantified, i.e. by excluding subjects 
without the required images I may artificially reduce the natural range of variance. 
To reasonably define the range of brain structure in a group of subjects I 
determined that approximately 70 subjects would be required (percentile ranks in 
Figure 49 converged to within 5% after 90 subjects). This suggests that a robust atlas 
of the distribution of brain structure across the lifespan (0-90 years) would require 
approximately 6,370 subjects (70 subjects per year × the 91 years of life included).  
 
 
10.3 Brain structure atlases 
 
A formal review of existing MRI brain structure atlases (chapter 3) found that the vast 
majority were derived from the mean intensity images of young to middle aged adult 
subjects. These are appropriate for studies of these subjects but may introduce bias in 
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studies of other ages, e.g. older subjects (≥60 years; Buckner et al., 2004). It has 
therefore been recommended that atlases should represent the range of subjects under 
study (Buckner et al., 2004; Rorden et al., 2012). For adult lifecourse studies, i.e. 18–
90 years, there were two existing atlases available but these only had 40 subjects at 
most (Desikan et al., 2006; Rohlfing et al., 2010). Further, mean intensity atlases may 
not well represent the other levels and limits of brain structure. I therefore created 
larger, percentile rank atlases specifically for studies of ageing subjects and adult 
lifecourse studies. 
 I created parametric (mean–based) and nonparametric atlases of the range of 
GM proportion in normal ageing (60–90 years).  The parametric atlas produced 
nonsensical lower limits of GM proportion in voxels throughout the brain, i.e. 
proportion limits less than zero. This led to false negative (normal) classifications in 
the mid caudal region in two samples of AD subjects. Parametric models assume that 
the lower clinical limit (2.5th percentile rank) is equal to the mean minus two SD. 
However, in many voxels throughout the brain, specifically in the MTL and 
hippocampus, the parametric limit was less than the 2.5th percentile rank. This led to a 
number of false positive (abnormal) classifications in the MTL and hippocampus in 
the two samples of AD subjects. I therefore recommend that, when creating an atlas to 
describe the levels and limits of brain structure, percentile ranks are directly 
calculated using a nonparametric (rank–based) method rather than a mean–based 
method. 
 I created nonparametric whole brain atlases for the normal range of brain 
structure in ageing (≥60 years) and across the adult lifecourse (25–90 years). These 
were created with intensity normalised T1 images rather than tissue proportion images 
that may include misclassified voxels, e.g. white matter hypointensities 
(hyperintensities on T2) as GM. By ranking AD subjects with the aged adult atlas I 
was able to produce a “pathology map” that automatically highlighted established 
areas of pathology in AD, e.g. MTL atrophy, while also highlighting potentially novel 
markers of the disease, e.g. Sylvian fissure atrophy. This map is not definitive but 
may form hypothesis for future studies and support diagnoses of individual patients. 
Although I did not have sufficient data to create a percentile rank template of 
normal infant brain structure I calculated “mean differences” from an existing mean 
intensity normal infant template. This automatically highlighted regions of pathology, 
e.g. increased interhemispheric fissure CSF, found in preterm infants by an 
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experienced neonatologist. This suggests that a future percentile rank atlas may 
support diagnosis of abnormal brain structure in preterm infants. Whole brain 
templates were created for infants because of the difficulty in segmenting tissues at 
this age (WM/ GM contrast is low and reversed from adulthood). However, despite 
the potential for misclassifications, tissue image atlases are easier to create and useful 
for voxel–based ranking in older subjects. 
 Voxel–based GM ranking with the nonparametric atlas allowed assessment of 
individual subjects without the need to apply a statistical test, e.g. t–test, that may not 
be appropriate for individuals (Scarpazza et al., 2013). This method highlighted the 
subtle brain structure changes associated with AD in individual subjects. Further, by 
ranking individual subjects with the nonparametric atlas it transformed data to be 
more amenable for subsequent nonparametric statistical testing while maintaining a 
relevant transformation space, i.e. “how normal” each voxel value was. This 
transformed the shape and variance of individuals into a common framework which is 
a requirement for nonparametric tests such as the Wilcoxon–Mann–Whitney test. 
However, as with any transformation, there are inherent limitations to this (discussed 
in section 8.3.4.2) and therefore should only be applied with due consideration. For 
situations where data transformations are not desirable, I developed and/or 
implemented a number of novel statistical modelling methods. 
 
 
10.4 Statistical models of brain structure across the lifecourse 
 
A formal review of existing statistical models of normal brain structure across the 
lifecourse found that the vast majority of results were obtained with parametric 
methods. These methods are successful at defining general (mean) changes in brain 
structure but, given their varying robustness under departures from their assumptions, 
may not be the most appropriate method for defining changes at the limits of 
normality (Elveback et al., 1970; Meehl, 1978; Ashburner and Friston, 2000; 
Courchesne et al., 2000; Good et al., 2001; Freedman et al., 2007). I therefore 
developed nonparametric statistical models that may be more appropriate for defining 
changes in brain structure at levels and limits other than the mean. 
It was known that whole brain tissue volume generally decreases with age, but 
it was not known whether general (mean) decreases were reflected at percentile ranks 
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above and below the mean, e.g. clinical limits. I therefore developed percentile rank 
models of whole brain tissue volumes in normal ageing and AD and compared these 
to the mean differences. I found that mean differences in whole brain tissue were not 
replicated at other percentile ranks in the publicly available data (ADNI and OASIS 
databanks). This suggests that to accurately define the levels and limits of normal 
ageing whole brain tissue volumes, nonparametric percentile rank models will be 
required. 
 As neurological diseases are associated with subtle changes that may occur 
earlier in life (Shenton et al., 2001; Tondelli et al., 2012), I also assessed whether 
mean differences in regional brain volumes between younger adults were 
representative of percentile rank differences. In a sample of 80 young to middle adult 
(25–60 years) subjects, I found that mean differences were not representative of 
nonparametric percentile rank differences. This was particularly evident in the 
hippocampal region and caudate. The hippocampal region has been implicated in 
several neurological diseases, e.g. AD and schizophrenia (Jack Jr et al., 1997; Job et 
al., 2002), therefore it is important to accurately define the normal levels and limits of 
volumes in this region. Although a sample of 80 subjects is very limited, these 
preliminary data suggest that nonparametric percentile rank, rather than parametric, 
models may be required for accurate definition of these distributions and boundaries. 
 
 
10.5 Benefits and limitations of parametric and nonparametric methods 
 
This work reviewed existing methods for assessing brain structure, many of which 
were based on parametric statistical models. These are strong, well validated methods 
for making general (mean) statistical inferences (Freedman et al., 2007; Hogg and 
Tanis, 2010). The point of this work was not to condemn these methods but to 
demonstrate that when their prerequisites are not met, they may lead to unexpected 
and potentially unreliable results. This is especially true when attempting to define the 
boundaries of normal and pathological brain volumes (chapters 6 [whole brain], 7 
[regional], and 8 [voxel]). Although this may appear obvious, I found little in the way 
of previous work that assessed the effect of statistical assumptions in structural brain 
imaging. Further, I found few reports that explicitly stated they checked the 
assumptions of their models (chapter 4). Smoothed brain structure has previously 
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been shown to be at least approximately Gaussian (Rorden et al., 2007) and it may be 
that in other reports the use of parametric models in itself indicated that their 
assumptions were met. 
 My aim is therefore not to criticise others, but to show that there are many 
other statistical methods that may be more useful when parametric assumptions are 
not met. In particular, as noted by Sir Francis Galton in 1889 (chapter 1), there can be 
many interesting statistics other than those based on means. For example, I showed in 
chapter 6 that percentile rank may indicate how one person will change compared to 
another at the opposite extreme of normality, e.g. subjects at the lowest percentile 
ranks of brain tissue may atrophy quicker than those at percentile ranks above the 
mean. This, however, is the first structural brain imaging implementation of percentile 
rank regression and further testing will be required to determine if it is actually true. 
There are therefore a number of benefits and limitations of parametric and 
nonparametric methods. These are summarised in Table 46. 
 
Table 46. Benefits and limitations of parametric and nonparametric methods 
Parametric Nonparametric 
Benefits Limitations Benefits Limitations 
Robust and 
reproducible method 




results when data 
are not equally 
Gaussian, e.g., 





measures for the full 
range of percentile ranks 
with a sufficiently large 
sample. 
Cannot be used to 
describe the full range 
of percentile ranks with 




when data are equally 
Gaussian. 
Results may not 
be extrapolated to 
values beyond 






e.g., whether mean 
differences are caused by 
skewed distributions. 
Produces, at least in the 
work presented here, 4 
additional statistics 
(percentile ranks further 
to the central tendency) 
that may be difficult to 
interpret. 
Has increased power to 
detect subtle mean 
differences when data 
are equally Gaussian. 
May overestimate 
mean differences 
when data are not 
equally Gaussian. 
Provides a “true” 
measure of the central 
tendency between 
groups. 
The “true” differences 
are only true in the 
samples assessed. 
These differences are 
not generalizable to the 
population without 




There are further limitations in my work, related to image quality (MRI field 
strength), image processing, the representativeness of atlases, and validation of results 





The methods that I developed in this work are limited by a number of factors related 
to image quality (MRI field strength), image processing, the representativeness of 
atlases, and validation of results.   
 
10.6.1 Image quality (MRI field strength) 
The brain MRI used in this work were acquired at 1.5 T. Substructures such as the 
hippocampus are visible at 1.5 T however subfields of these structures are not clearly 
visible. This means that subtle differences between groups of controls and 
neurologically diseased groups, e.g., Alzheimer’s disease, may not be apparent at 1.5 
T, and therefore not apparent in the present study. Higher field strengths, e.g. 3 to 7 T, 
will be needed to clearly differentiate structures such as the boundary between the 
hippocampus and amygdala within the hippocampal complex (Wisse et al., 2014). 
There are a broad range of hippocampal sizes in normal ageing and AD (Jack Jr et al., 
1997; Ferguson et al., 2010). This means that longitudinal imaging data are required 
to differentiate the scarring of disease and markers of disease. The cross-sectional data 
used here is limited in differentiating disease scarring from markers of disease. For 
example, it may have been that some AD subjects always had smaller hippocampi and 
it is the relative change, rather than the absolute size, that is a marker for disease. 
Future work with longitudinal data and higher field strengths will be required to 
determine subtle disease markers prior to onset. 
Subtle longitudinal changes within individuals that occur through time may be 
obscured at 1.5 T (Shenton et al., 2001). Furthermore, there is variability within 
individuals between scanning sessions at different times of the same day and between 
different scanners and sequence parameters (Gountouna et al., 2010). Future work 
with data from the same subjects across different scanners and varying time points, 
e.g. within a week and across years, will be required to determine whether parametric 
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or nonparametric methods are better at differentiating spurious changes in MRI signal 
from signs of disease. 
The software I developed is not specific to 1.5 T, scanner, nor sequence 
parameters and may be implemented with any field strength, scanner, and sequence 
parameters. This will allow for an assessment of the impact of field strength, scanner, 
and sequence parameters in nonparametric versus parametric assessments of brain 
MRI. 
 
10.6.2 Image processing 
This work attempted to define normal and pathological variation in brain structure 
across the lifecourse. For that reason I implemented very specific image processing 
methods. In my voxel–based statistical analyses, I developed a novel registration 
(spatial normalisation) method, Nsurf as described in chapter 5. Nsurf attempted to 
address issues with conventional registration methods. Linear, i.e. 12pt affine, 
registration does not always adequately account for head size. Nonlinear registration 
removes a large part of the variance of interest, e.g. lateral ventricle volume. Nsurf 
performed nonlinear registration on mask (binary) images so to adequately account 
for head size but retain within brain variance. This means that my results are not 
directly comparable with previous studies. Additionally, unlike many previous studies 
(Ashburner and Friston, 2000; Good et al., 2001), I did not perform voxel smoothing. 
I did not do this because, by essentially averaging adjoining voxels into one, it may 
have obscured subtle differences between normality and pathology. Further, there are 
not yet consistent, quantitative means for determining smoothing parameters (Zhao et 
al., 2012). Furthermore, one reason for smoothing is to make data more Gaussian 
distributed (Ashburner and Friston, 2000; Good et al., 2001); this was not required for 
my nonparametric methods. But despite my reasons for not smoothing, this may have 
led to a degree of noise in my results and may partially explain the non-Gaussian 
voxel distributions.  
I attempted to develop methods that were independent of the Gaussian 
distribution but sensitive enough to correctly detect subtle differences between normal 
and diseased groups. In particular, I created or applied normal brain image atlases for 
detecting pathology in subjects across the lifecourse. While I have shown the potential 




I created two atlases: one for subjects aged between 25 and 90 years and another for 
those aged 60-90 years. These will be useful for assessing brain structure in adult 
lifecourse or elderly adult studies (Buckner et al., 2004). However, there are large 
differences in brain structure between these ages (e.g. chapters 6, 7; Ge et al., 2002; 
Resnick et al., 2003; Farrell et al., 2009; Ferguson et al., 2010). This means that my 
atlases may not be as useful in studies with shorter age intervals. Further, my adult 
atlases were only in T1-wieghted sequences or images derived from T1 (GM images).  
 When we have collected sufficient data, I will create a third atlas from normal 
infant subjects. This will be used to highlight pathology in preterm infants. In the 
present work I used a mean-based normal atlas and so could determine the distance of 
preterm subjects from mean normal brain structure. I could not, however, determine 
whether these distances were out with the normal range. This, and validation of the 
other results reported here, will come with collection of more normal and pathological 
data from across the lifecourse. 
 
10.6.4 Data and validation of statistical results 
The data that I used in this work were cross-sectional. Previous work has shown that 
cross-sectional and longitudinal brain structure data produce similar results (Marcus et 
al., 2007c); but this may not always be the case (Freedman et al., 2007). The results in 
the present work may therefore not truly represent changes in brain structure but 
rather differences between ages and diagnoses. Nonetheless, I have provided methods 
that may be applied and validated in future longitudinal studies, e.g. the effect of 
percentile rank in conversion to AD. 
I attempted to validate my results by repeating analyses between different 
samples. Although this is considered the most reliable way to make causal inferences 
in social and epidemiological science (Meehl, 1978; Cohen, 1994; Freedman, 2010), I 
only had two normal ageing samples (combined n=236) in which to validate my 
results. This is clearly not adequate to make reliable population inferences. There are 
large databanks of brain images from older subjects, e.g. the Rotterdam (Cees De 
Groot et al., 2000) and Framingham (Jeerakathil et al., 2004) study databanks, but 
these were not available to me during this work. In the future I may seek 
collaborations with these groups. Such collaborations are in line with the growing 
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recognition of the need for large, publicly accessible repositories of brain image data 
and statistical models (Poline and Poldrack, 2013).  
The data available for many of the subjects I studied did not include risk 
factors such as blood pressure and number of prescriptions. Although high blood 
pressure and several prescriptions are common in older people and these data were 
collected in the original studies (Marcus et al., 2007c), these actual measures were not 
available to me. Without having these measures I was unable to determine potential 
sources of the variance in normal ageing brain structure. Further, I was not able to 
determine whether non-normal distributions were due to the inclusion of subjects with 
and without disease that effects brain structure, e.g., hypertension. It may be that a 
group of aged subjects who were entirely disease-free, i.e., “super-normal” (Mazziotta 
et al., 2009), have distributions that more closely follow the normal distribution. 
Furthermore, early neurodegenerative disease (that has not yet reached the point of 
abnormal clinical scores) may have contributed to the bimodal distributions I found 
e.g., Figure 58. Future work with longitudinal conversion rates may be used to 
exclude data from these subjects retrospectively. Subsequent repeated assessments of 
nonparametric versus parametric methods (in data where early neurodegenerative 
disease is retrospectively excluded) will determine whether it is an unknown mixture 
of populations that is causing normal ageing brain MRI data to appear non-normally 
distributed. 
Future work with the BRAINS bank, and the considerable medical metadata it 
contains (chapter 9), may be able to determine whether unknown mixtures of 
populations are causing normal ageing brain MRI data to appear non-normally 
distributed. Other future work is described in the next section. 
 
 
10.7 Future work 
 
Limitations in the present work provide several directions for future work. The 
immediate priority is to implement parametric and nonparametric models of 
longitudinal whole brain volume changes (with the same subjects over time). This will 
determine if mean changes in brain volume are reflected in subjects at percentile ranks 
surrounding the mean, e.g. the 2.5th, …, 97.5th percentile ranks. Further, as data 
become available, I will test whether percentile rank level of brain volume change is 
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an early marker for the development of cognitive decline and neurodegenerative 
disease. Given that these diseases are often associated with subtle changes in brain 
structure (Shenton et al., 2001; Farrell et al., 2009; Ferguson et al., 2010), I will also 
test whether percentile ranks of regional and voxel tissue volumes can provide more 
sensitive markers. 
 The possibility for subtle differences between normal and diseased groups led 
me to not using conventional nonlinear registration or voxel smoothing. In future I 
will perform these common image processing steps and determine their effect on 
voxel distributions and statistical modelling results. Conversely, because I found it to 
be used most often in brain image analyses (Chapter 4), I only assessed the Gaussian 
distribution in this work. Future work may assess the applicability of other 
distributions, e.g. “Chi-square”. 
I found the distributions of normal ageing brain structure to be highly variable 
(chapters 6-8). Potential sources of this variation were not investigated in the present 
work. Future work will investigate whether it is due to, for example, blood pressure, 
years of education, or socioeconomic status. Regardless of its’ source, this variation 
suggests that a percentile rank–based reference for brain volumes may be useful to 
quantitatively rank individuals or to determine if the distributions of brain volumes in 
control groups are skewed. The relatively small sample used here (n=316 normal 
subjects 25-90 years), indicates that this reference will likely require much more data 
than are publicly available at present (chapters 2 and 8). The BRAINS bank (chapter 
9) may allow us to determine if ~70 subjects per year (~6,370 subjects across the 





Parametric methods have allowed us to understand general changes that occur in 
human brain structure through life. Nonparametric methods will allow us to take this 
understanding further: to understand the distributions and limits of these changes. 
This will ultimately improve diagnoses, treatment, and outcome of the 
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APPENDIX I: Supplementary material 
 
AI.1 Individual descriptions of each databank included in the systematic review    
 
AI.1.1 ADNI databank 
The ADNI was setup to determine which combination of neuroimaging, cerebral 
spinal fluid (CSF), and blood biomarkers provides the earliest and most accurate 
diagnosis and expected course of Alzheimer’s disease (AD). Housed at the Laboratory 
of Neuroimaging (LONI) Image Data Archive (IDA), the ADNI databank contained 
serial MR brain images, separated by 6–12 months over 2–3 years, from 
approximately 229 normal, 398 mild cognitive impairment (MCI), and 192 AD 
subjects aged 55–90 years (normal subjects were aged 70–90 years; Table 3). Normal 
subjects may have had some medical problems common in ageing. The criteria for 
normality also included results from a battery of cognitive tests including the 
American National Adult Reading Test (ANART), Clinical Dementia Rating (CDR) 
and Mini Mental State Examination (MMSE). These results were included in the 
databank and subject retrieval parameters. Image analysis results, e.g. brain masks, 
were in the databank but statistical results were not. The LONI IDA also supported 
subject retrieval by clinico–demographic and scan acquisition parameters.  
 
AI.1 2 AIBL databank 
The AIBL study was designed to understand the pathology and early clinical 
manifestation of AD, improve the diagnosis of AD, and identify diet and lifestyle 
factors that are significant in the development of AD. Also housed at the LONI IDA, 
the AIBL databank contained serial MR brain images acquired from 177 normal, 57 
MCI, and 53 AD subjects aged 60–100 years. Although medical and cognitive test 
results were part of the criteria for normality, the normal subjects were not 
representative of the normal ageing population because they were preferentially 
selected as APOE ɛ4 allele carriers (Ellis et al., 2010). The LONI IDA, which housed 







AI.1 3 Designed Database of MR Brain Images of Healthy Volunteers 
The Designed Database of MR Brain Images of Healthy Volunteers was created to 
assess the effects of healthy ageing on brain structure and provide references for the 
assessment of disease. It contained MR brain images from 100 normal subjects aged 
18–72 years (15 subjects were aged ≥60 years; Table 3). These subjects had “no 
history of diabetes, hypertension, head trauma, psychiatric disease, or other symptoms 
or history likely to affect the brain”. Therefore, they may not have been representative 
of the entire normal ageing population. I did not find cognitive test results to be in the 
criteria for normality. Subject demographics age, gender, race and handedness were in 
the database and these could be used to retrieve subjects. 
 
AI.1.4 The fMRIDC 
The fMRIDC was created to allow the functional magnetic resonance imaging (fMRI) 
research community to validate methods and hypotheses and perform meta–analyses 
of a large number of peer reviewed studies. It stored structural MR brain images as 
well as the fMRI from these studies. I did not have access to the overall composition 
of the databank, e.g. I could not determine the total number of subjects, but found 66 
normal subjects aged ≥60 years. These subjects had no history of stroke, heart attack 
or psychiatric disorder but had medical characteristics common in ageing e.g. 
hypertension, arthritis. Fifty of these subjects were also in the OASIS and XNAT 
Central databanks. Subjects could be retrieved by study title, author, keywords, 
abstract or “special collections” (selected novel datasets) but not directly by subject 
clinico–demographic, imaging or cognitive parameters. 
 
AI.1.5 IXI dataset 
The IXI dataset was acquired to develop computer aided diagnostics of MR brain 
images. It contained MR brain images from 593 normal, healthy subjects aged 19–86 
years (197 subjects were aged ≥60 years; Table 3). I did not find the criteria for 
normality and medical and cognitive test results were not in the dataset. Subject 
demographics such as age, gender, weight, ethnicity and qualification were in the 





AI.1.6 ICBM databank 
The ICBM study will develop a probabilistic atlas and reference system for the 
normal human brain throughout the lifespan (Mazziotta et al., 2001). The ICBM 
databank, also housed at the LONI IDA, contained MR brain images from 851 normal 
subjects aged 18–90 years (approximately 76 subjects were aged ≥60 years; Table 3). 
The criteria for normality included results from several medical and cognitive tests 
such as the MMSE. As the criteria for normality were the same regardless of age, the 
older subjects may not have been representative of the entire normal ageing 
population e.g. subjects with any prescription medications (with some exceptions such 
as antibiotics) or hypertension were excluded regardless of age. The LONI IDA, 
which housed this databank, was further described previously (section 2.3.2.1). 
 
AI.1.7 OASIS: Cross–sectional MRI Data in Young, Middle Aged, Nondemented, 
and Demented Older Adults 
The OASIS cross–sectional databank was created to provide the data needed for 
widespread study of ageing and dementia and to develop new MR brain image 
analysis techniques. It contained MR brain images from 316 normal and 100 
demented subjects aged 18–96 years (98 normal subjects were aged ≥60 years; Table 
3). Some of the normal older subjects had hypertension and treated diabetes. The 
criteria for normality also included MMSE score and CDR. The databank supported 
subject retrieval by clinico–demographics, cognitive test results (CDR and MMSE), 
scanning acquisition parameters, and parameters derived from analyses of brain 
images, e.g. brain tissue volume normalised by head size. Although these image 
analysis results were included in the databank, statistical results were not. 
 
AI.1.8 OASIS: Longitudinal MRI Data in Nondemented and Demented Older Adults 
The OASIS longitudinal databank was created for reasons similar to the OASIS 
cross–sectional databank.  It contained serial MR brain images, acquired over two or 
more sessions and separated by at least 1 year, from 86 normal (14 of which later 
converted to dementia) and 64 demented subjects aged 60–96 years. Many of the 
older subjects in the OASIS cross–sectional databank were also in this longitudinal 
databank but were assigned new subject identifiers. The criteria for normality and 
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subject retrieval parameters were the same as in the OASIS cross–sectional databank 
(section 2.3.2.7).  
 
AI.1.9 The Extensible Neuroimaging Archive Toolkit (XNAT) Central databank 
The XNAT Central databank was designed to allow secure and quality controlled data 
(medical image and metadata) sharing among local colleagues, external collaborators 
and the broader neuroscience community. It contained over 3000 subjects from 
approximately 200 medical imaging studies, including the OASIS data. In addition to 
the OASIS subjects, I found 9 subjects (with brain images) aged ≥60 years. However, 
these subjects were not normal (they were neurosurgery patients). I did not have 
access to the remaining subjects or criteria for normality. Subjects could be retrieved 




AI.2 Criteria for normality in each normal ageing brain volume statistical model    
 
AI.2.1 Allen, et al. (2005) 
All subjects were right–handed (and had no left–handedness in first degree relatives), 
healthy, and had no history of neurological or psychiatric illness. Subjects over 60 
years were interviewed for general health status and medication usage. Included 
subjects had no clinical history of heart disease, hypertension, diabetes, or any other 
common age–related disease. 
 
AI.2.2 Blatter et al. (1995) 
There were no neurologic or neuropsychiatric examinations but all subjects answered 
a questionnaire and were excluded if they had a history of: previous head injury 
causing loss of consciousness; any disease affecting the nervous system, including 
dementia or psychiatric illness; or alcohol or drug abuse. Based on an assessment of 






AI.2.3 Courchesne, et al. (2000) 
Based on their responses to questionnaires, included subjects showed no evidence of 
developmental, educational, medical, psychological, or psychiatric abnormalities or 
deficiencies. Subjects older than 50 years were tested with the California Verbal 
Learning Test and had normal or above scores. 
 
AI.2.4 DeCarli, et al. (2005)  
By a review of medical history and physical examination, subjects with stroke, 
dementia, multiple sclerosis, or other clinically evident neurological conditions were 
excluded. Included subjects had various diseases of the vascular system such as 
hypertension and peripheral vascular disease. 
 
AI.2.5 Fotenos, et al. (2005) 
Older subjects with severe comorbidities such as depression or disabling stroke were 
excluded. 
 
AI.2.6 Ge, et al. (2002) 
A structured clinical interview excluded subjects with present or past neuropsychiatric 
illnesses, abuse of alcohol or illicit drugs, or psychiatric disease in first–degree 
relatives. Included subjects showed normal findings in a physical examination and 
none reported a history of any serious medical condition. 
 
AI.2.7 Giorgio, et al. (2010) 
Included subjects had no history of psychiatric or neurological disease or substance 
abuse. They did not show white matter lesions or overt abnormalities on MR brain 
images, e.g. infarct, vascular malformation, or tumour. 
 
AI.2.8 Good, et al. (2001) 
Subjects with neurological, medical, psychiatric conditions, or migraine were 
excluded. Included subjects had no history of: alcohol intake of more than 30 units per 
week or more than 10 units within 48h of scan; head trauma requiring medical 
attention; cognitive difficulties; treated hypertension (leading to a small number of 
subjects aged > 70 years). Measures were obtained by a questionnaire but no 
cognitive tests were performed. 
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AI.2.9 Gur, et al. (1991) 
Subjects with central nervous system infection, seizure, head trauma with loss of 
consciousness, cerebrovascular disease, cognitive decline, alcohol or other substance 
abuse, psychiatric disorders, or psychiatric disorders in first–degree relatives were 
excluded. 
 
AI.2.10 Jernigan, et al. (2001) 
Included subjects were screened for current and significant medical, psychiatric, 
intellectual, or neurological disorders. Middle–aged and elderly subjects had a 
physical examination, showed normal cognitive function and were living 
independently. Elderly subjects with medical conditions common with age, e.g. 
hypertension and cardiac conditions, were not excluded if stable and well controlled. 
 
AI.2.11 Kruggel (2006) 
Included subjects passed a brief history and physical inspection by a physician. 
 
AI.2.12 Li et al. (2012) 
Subjects with below normal cognitive scores, e.g. MMSE < 28, hypertension, 
prescription medications, or a history of central nervous system (CNS) diseases were 
excluded.  
 
AI.2.13 Long et al. (2012) 
Medical history was reviewed and subjects with endocrinal, neurological, or 
psychiatric illnesses were excluded. 
 
AI.2.14 Peelle et al. (2012) 
Self reports and a standard pre–MRI screening questionnaire were used to assess 
neurological difficulty and general health. Included subjects had no neurological 
difficulty and were in good general health at the time of scan. 
 
AI.2.15 Sowell, et al. (2003) 
Subjects with a history of concussion, substance abuse, or seizure disorder were 
excluded. Included subjects showed no neurological impairments, psychiatric illness, 
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history of learning disability, or development delay according to a structured 
diagnostic interview. 
 
AI.2.16 Walhovd, et al. (2005) 
Included subjects were right–handed, felt well and healthy, had normal or normal–
corrected sight, did not use a hearing aid, and did not have an illness known to affect 
the central nervous system e.g. hypothyroidism, multiple sclerosis, Parkinson’s 
disease, stroke, or head injury. Excluded subjects had either health or cognitive 
problems according to a structured interview, Beck depression inventory (BDI) score 
>14, mini–mental state examination MMSE) score <26, and >1 SD below the mean 
Wechsler abbreviated intelligence scale (WASI) score. 
 
AI.2.17 Ziegler et al. (2011) 
All subjects were reported to be “normal and healthy” but no criteria for this were 
found; 79.9% of subjects had advanced or even higher educational levels. 
 
 
AI.3 Differences between parametric and nonparametric distributions of brain 
volumes across early to middle adult life 
 
The differences between parametric and nonparametric distributions of brain volumes 
that were illustrated in the figures in Chapter 7, “The accuracy of Gaussian 




Table AI.3.1. Differences in parametric and nonparametric distributions of whole brain volumes between age groups 
Volume Comparison P2.5TH NP2.5TH % Err P16TH NP16TH % Err P50TH NP50TH % Err P84TH NP84TH % Err P97.5TH NP97.5TH % Err 
CSF "1–2" –3.9E–03 –1.1E–02 172 –3.9E–03 –3.0E–03 25 –3.9E–03 1.5E–03 –139 –3.9E–03 –7.4E–03 88 –3.9E–03 –4.6E–03 18 
 "1–3" –4.2E–03 –1.1E–02 152 –4.2E–03 –4.7E–03 11 –4.2E–03 –5.4E–04 87 –4.2E–03 –5.1E–03 21 –4.2E–03 –1.2E–04 97 
 "1–4" –1.3E–02 –3.1E–02 145 –1.3E–02 –1.6E–02 28 –1.3E–02 –9.2E–03 27 –1.3E–02 –9.9E–03 22 –1.3E–02 2.3E–03 –118 
 "2–3" –3.1E–04 0.0E+00 Inf –3.1E–04 –1.7E–03 458 –3.1E–04 –2.1E–03 564 –3.1E–04 2.3E–03 –825 –3.1E–04 4.5E–03 –1543 
 "2–4" –8.8E–03 –2.0E–02 133 –8.8E–03 –1.3E–02 51 –8.8E–03 –1.1E–02 23 –8.8E–03 –2.5E–03 71 –8.8E–03 6.9E–03 –178 
 "3–4" –8.5E–03 –2.0E–02 142 –8.5E–03 –1.2E–02 36 –8.5E–03 –8.7E–03 3 –8.5E–03 –4.8E–03 43 –8.5E–03 2.4E–03 –128 
GM "1–2" 8.2E–03 –2.9E–03 –135 8.2E–03 9.3E–03 14 8.2E–03 1.3E–02 59 8.2E–03 1.2E–02 41 8.2E–03 1.5E–02 87 
 "1–3" 1.1E–02 1.7E–02 54 1.1E–02 1.8E–02 54 1.1E–02 7.7E–03 32 1.1E–02 1.5E–02 32 1.1E–02 1.8E–02 63 
 "1–4" 1.5E–02 3.9E–03 74 1.5E–02 1.6E–02 3 1.5E–02 1.6E–02 5 1.5E–02 2.0E–02 33 1.5E–02 3.2E–02 110 
 "2–3" 3.2E–03 2.0E–02 546 3.2E–03 8.2E–03 160 3.2E–03 –5.4E–03 –270 3.2E–03 3.3E–03 6 3.2E–03 3.1E–03 0 
 "2–4" 6.9E–03 6.8E–03 1 6.9E–03 6.3E–03 9 6.9E–03 2.8E–03 59 6.9E–03 8.4E–03 22 6.9E–03 1.6E–02 138 
 "3–4" 3.7E–03 –1.4E–02 –463 3.7E–03 –1.9E–03 –152 3.7E–03 8.2E–03 119 3.7E–03 5.1E–03 36 3.7E–03 1.3E–02 255 
WM "1–2" –4.3E–03 –6.5E–04 85 –4.3E–03 1.0E–04 –102 –4.3E–03 –4.6E–03 8 –4.3E–03 –8.1E–03 89 –4.3E–03 –4.8E–03 13 
 "1–3" –7.1E–03 –1.4E–03 80 –7.1E–03 2.7E–03 –138 –7.1E–03 –4.8E–03 32 –7.1E–03 –1.9E–02 160 –7.1E–03 –2.9E–02 307 
 "1–4" –2.4E–03 3.2E–03 –232 –2.4E–03 8.7E–04 –136 –2.4E–03 5.7E–04 –124 –2.4E–03 –1.1E–02 374 –2.4E–03 –8.7E–03 262 
 "2–3" –2.8E–03 –7.4E–04 74 –2.8E–03 2.6E–03 –191 –2.8E–03 –1.7E–04 94 –2.8E–03 –1.0E–02 267 –2.8E–03 –2.4E–02 750 
 "2–4" 1.9E–03 3.8E–03 103 1.9E–03 7.7E–04 59 1.9E–03 5.2E–03 177 1.9E–03 –3.3E–03 –275 1.9E–03 –3.9E–03 –305 
 "3–4" 4.7E–03 4.6E–03 4 4.7E–03 –1.8E–03 –139 4.7E–03 5.4E–03 14 4.7E–03 7.2E–03 52 4.7E–03 2.0E–02 330 
Note: P=parametric/ NP=nonparametric percentile rank; GM=grey matter; WM=white matter; CSF=cerebrospinal fluid; %Err=percent error; Comp=comparison; 1=26–35 










Table AI.3.2. Differences in parametric and nonparametric distributions of left hippocampal complex volumes between age groups 
Volume Comp P2.5TH NP2.5TH % Err P16TH NP16TH % Err P50TH NP50TH % Err P84TH NP84TH % Err P97.5TH NP97.5TH % Err 
Left Amyg "1–2" 1.9E–06 –1.4E–05 –825 1.9E–06 3.6E–06 92 1.9E–06 –7.3E–07 –139 1.9E–06 –3.1E–06 –263 1.9E–06 1.3E–05 570 
 "1–3" –7.6E–06 –5.1E–05 570 –7.6E–06 –1.1E–05 50 –7.6E–06 –6.2E–06 19 –7.6E–06 3.5E–06 –147 –7.6E–06 –9.5E–06 25 
 "1–4" –1.8E–05 –7.0E–05 295 –1.8E–05 1.7E–06 –110 –1.8E–05 –1.8E–05 4 –1.8E–05 –8.2E–06 54 –1.8E–05 –2.6E–05 47 
 "2–3" –9.5E–06 –3.7E–05 291 –9.5E–06 –1.5E–05 58 –9.5E–06 –5.4E–06 43 –9.5E–06 6.6E–06 –170 –9.5E–06 –2.2E–05 134 
 "2–4" –2.0E–05 –5.7E–05 187 –2.0E–05 –1.9E–06 90 –2.0E–05 –1.8E–05 10 –2.0E–05 –5.1E–06 74 –2.0E–05 –3.9E–05 98 
 "3–4" –1.0E–05 –1.9E–05 91 –1.0E–05 1.3E–05 –228 –1.0E–05 –1.2E–05 20 –1.0E–05 –1.2E–05 15 –1.0E–05 –1.7E–05 64 
Left Hippo "1–2" –4.7E–05 7.2E–05 –254 –4.7E–05 –5.9E–05 25 –4.7E–05 –9.0E–05 92 –4.7E–05 –5.2E–05 10 –4.7E–05 2.2E–05 –147 
 "1–3" –7.3E–05 –1.3E–04 77 –7.3E–05 –1.0E–04 38 –7.3E–05 –9.3E–05 27 –7.3E–05 –5.4E–05 26 –7.3E–05 3.9E–05 –153 
 "1–4" –8.1E–05 –7.6E–05 6 –8.1E–05 –2.2E–05 73 –8.1E–05 –1.2E–04 46 –8.1E–05 –1.3E–04 59 –8.1E–05 3.5E–05 –143 
 "2–3" –2.6E–05 –2.0E–04 675 –2.6E–05 –4.2E–05 61 –2.6E–05 –2.4E–06 91 –2.6E–05 –2.5E–06 90 –2.6E–05 1.7E–05 –164 
 "2–4" –3.4E–05 –1.5E–04 338 –3.4E–05 3.7E–05 –209 –3.4E–05 –2.8E–05 19 –3.4E–05 –7.7E–05 127 –3.4E–05 1.3E–05 –138 
 "3–4" –8.0E–06 5.3E–05 –762 –8.0E–06 7.9E–05 –1087 –8.0E–06 –2.5E–05 216 –8.0E–06 –7.4E–05 833 –8.0E–06 –4.0E–06 50 
Left Phippo "1–2" –1.3E–05 –2.0E–06 84 –1.3E–05 4.9E–05 –484 –1.3E–05 –2.5E–05 95 –1.3E–05 –6.8E–05 432 –1.3E–05 –4.0E–05 211 
 "1–3" –1.3E–05 5.4E–05 –516 –1.3E–05 –4.2E–05 228 –1.3E–05 –3.2E–05 146 –1.3E–05 1.7E–05 –229 –1.3E–05 6.9E–05 –632 
 "1–4" –1.9E–05 –5.5E–06 71 –1.9E–05 5.0E–05 –366 –1.9E–05 –1.5E–05 18 –1.9E–05 –5.4E–05 190 –1.9E–05 –3.6E–05 93 
 "2–3" –1.0E–07 5.6E–05 –55804 –1.0E–07 –9.2E–05 91446 –1.0E–07 –6.7E–06 6600 –1.0E–07 8.5E–05 –84860 –1.0E–07 1.1E–04 –108539 
 "2–4" –5.9E–06 –3.5E–06 41 –5.9E–06 6.3E–07 –111 –5.9E–06 9.7E–06 –264 –5.9E–06 1.4E–05 –335 –5.9E–06 3.7E–06 –162 
 "3–4" –5.8E–06 –5.9E–05 920 –5.8E–06 9.2E–05 –1689 –5.8E–06 1.6E–05 –382 –5.8E–06 –7.1E–05 1122 –5.8E–06 –1.0E–04 1706 
Note: P=parametric/ NP=nonparametric percentile rank; %Err=percent error; Amyg=amygdala; Hippo=hippocampus; Phippo Gy=parahippocampal gyrus; 










Table AI.3.3. Differences in parametric and nonparametric distributions of right hippocampal complex volumes between age groups 
Volume Comp P2.5TH NP2.5TH % Err P16TH NP16TH % Err P50TH NP50TH % Err P84TH NP84TH % Err P97.5TH NP97.5TH % Err 
Right Amyg "1–2" –2.2E–05 –3.8E–06 83 –2.2E–05 –1.5E–05 32 –2.2E–05 –2.6E–05 19 –2.2E–05 –1.0E–05 53 –2.2E–05 –1.6E–05 26 
 "1–3" –3.1E–05 –7.7E–05 153 –3.1E–05 –2.7E–05 11 –3.1E–05 –2.3E–05 26 –3.1E–05 –2.7E–05 12 –3.1E–05 –3.3E–05 9 
 "1–4" –2.0E–05 –5.3E–05 168 –2.0E–05 –8.3E–06 58 –2.0E–05 –9.2E–06 53 –2.0E–05 –1.8E–05 10 –2.0E–05 –4.9E–05 148 
 "2–3" –8.9E–06 –7.3E–05 727 –8.9E–06 –1.3E–05 41 –8.9E–06 3.3E–06 –137 –8.9E–06 –1.7E–05 86 –8.9E–06 –1.7E–05 95 
 "2–4" 1.9E–06 –4.9E–05 –2660 1.9E–06 6.5E–06 237 1.9E–06 1.7E–05 764 1.9E–06 –7.5E–06 –492 1.9E–06 –3.3E–05 –1819 
 "3–4" 1.1E–05 2.4E–05 126 1.1E–05 1.9E–05 76 1.1E–05 1.3E–05 23 1.1E–05 9.0E–06 17 1.1E–05 –1.6E–05 –245 
Right Hippo "1–2" –5.6E–05 –5.2E–05 7 –5.6E–05 –7.7E–05 37 –5.6E–05 –6.1E–05 10 –5.6E–05 –6.7E–05 21 –5.6E–05 –5.0E–06 91 
 "1–3" –6.2E–05 –7.8E–05 26 –6.2E–05 –1.3E–04 109 –6.2E–05 –5.7E–05 7 –6.2E–05 –3.9E–05 37 –6.2E–05 4.6E–06 –107 
 "1–4" –5.8E–05 –5.1E–05 13 –5.8E–05 –1.2E–04 111 –5.8E–05 –1.2E–05 80 –5.8E–05 –1.3E–04 116 –5.8E–05 –1.7E–06 97 
 "2–3" –5.9E–06 –2.6E–05 340 –5.9E–06 –5.2E–05 788 –5.9E–06 4.2E–06 –171 –5.9E–06 2.9E–05 –584 –5.9E–06 9.6E–06 –263 
 "2–4" –2.4E–06 1.2E–06 –151 –2.4E–06 –4.7E–05 1840 –2.4E–06 5.0E–05 –2166 –2.4E–06 –5.9E–05 2348 –2.4E–06 3.3E–06 –238 
 "3–4" 3.5E–06 2.7E–05 677 3.5E–06 5.8E–06 67 3.5E–06 4.5E–05 1196 3.5E–06 –8.7E–05 –2595 3.5E–06 –6.3E–06 –280 
Right Phippo "1–2" –3.2E–05 –2.8E–05 15 –3.2E–05 –6.7E–05 106 –3.2E–05 5.0E–08 –100 –3.2E–05 –5.3E–05 63 –3.2E–05 –9.0E–05 178 
 "1–3" –3.4E–05 –3.6E–05 4 –3.4E–05 –8.0E–05 134 –3.4E–05 –7.2E–06 79 –3.4E–05 –6.3E–05 84 –3.4E–05 –1.0E–05 69 
 "1–4" –4.1E–05 –1.9E–05 53 –4.1E–05 –1.5E–05 63 –4.1E–05 –1.8E–05 56 –4.1E–05 –3.3E–05 18 –4.1E–05 –8.1E–05 98 
 "2–3" –1.8E–06 –8.1E–06 352 –1.8E–06 –1.3E–05 639 –1.8E–06 –7.3E–06 303 –1.8E–06 –1.0E–05 458 –1.8E–06 7.9E–05 –4514 
 "2–4" –8.4E–06 8.3E–06 –199 –8.4E–06 5.2E–05 –716 –8.4E–06 –1.8E–05 114 –8.4E–06 1.9E–05 –332 –8.4E–06 9.0E–06 –207 
 "3–4" –6.6E–06 1.6E–05 –349 –6.6E–06 6.5E–05 –1086 –6.6E–06 –1.1E–05 62 –6.6E–06 3.0E–05 –547 –6.6E–06 –7.0E–05 967 
Note: P=parametric/ NP=nonparametric percentile rank; %Err=percent error; Amyg=amygdala; Hippo=hippocampus; Phippo Gy=parahippocampal gyrus; 










Table AI.3.4. Differences in parametric and nonparametric distributions of left thalamus and basal ganglia volumes between age groups 
Volume Comp P2.5TH NP2.5TH % Err P16TH NP16TH % Err P50TH NP50TH % Err P84TH NP84TH % Err P97.5TH NP97.5TH % Err 
Left Caudate "1–2" 9.0E–07 –5.6E–06 –727 9.0E–07 –1.2E–05 –1404 9.0E–07 9.8E–06 990 9.0E–07 –1.4E–05 –1697 9.0E–07 –2.1E–05 –2442 
 "1–3" 3.1E–05 3.1E–06 90 3.1E–05 1.5E–05 51 3.1E–05 3.1E–05 0 3.1E–05 1.1E–05 65 3.1E–05 6.5E–05 106 
 "1–4" 5.3E–05 –6.0E–05 –212 5.3E–05 9.1E–06 83 5.3E–05 8.0E–05 50 5.3E–05 –4.2E–06 –108 5.3E–05 1.6E–04 195 
 "2–3" 3.0E–05 8.8E–06 71 3.0E–05 2.7E–05 11 3.0E–05 2.1E–05 29 3.0E–05 2.5E–05 17 3.0E–05 8.6E–05 182 
 "2–4" 5.3E–05 –5.4E–05 –203 5.3E–05 2.1E–05 60 5.3E–05 7.0E–05 34 5.3E–05 1.0E–05 81 5.3E–05 1.8E–04 240 
 "3–4" 2.2E–05 –6.3E–05 –385 2.2E–05 –6.1E–06 –128 2.2E–05 4.9E–05 122 2.2E–05 –1.5E–05 –168 2.2E–05 9.3E–05 321 
Left Putamen "1–2" 4.0E–05 –4.0E–05 –199 4.0E–05 8.7E–06 78 4.0E–05 5.6E–05 40 4.0E–05 4.3E–05 8 4.0E–05 1.4E–04 238 
 "1–3" 1.1E–04 5.7E–05 46 1.1E–04 1.4E–04 33 1.1E–04 1.2E–04 12 1.1E–04 9.2E–05 13 1.1E–04 1.3E–04 21 
 "1–4" 6.9E–05 –1.7E–05 –124 6.9E–05 1.5E–04 114 6.9E–05 6.8E–05 2 6.9E–05 9.3E–06 87 6.9E–05 6.2E–05 10 
 "2–3" 6.5E–05 9.6E–05 47 6.5E–05 1.3E–04 101 6.5E–05 6.2E–05 5 6.5E–05 4.9E–05 26 6.5E–05 –7.9E–06 –112 
 "2–4" 2.9E–05 2.3E–05 20 2.9E–05 1.4E–04 379 2.9E–05 1.2E–05 60 2.9E–05 –3.4E–05 –217 2.9E–05 –7.3E–05 –352 
 "3–4" –3.6E–05 –7.3E–05 101 –3.6E–05 7.6E–06 –121 –3.6E–05 –5.0E–05 38 –3.6E–05 –8.3E–05 127 –3.6E–05 –6.5E–05 79 
Left Thalamus "1–2" –2.3E–06 3.0E–04 –13147 –2.3E–06 1.3E–04 –5540 –2.3E–06 –3.5E–05 1416 –2.3E–06 –1.7E–04 7207 –2.3E–06 –1.5E–05 554 
 "1–3" –8.5E–05 6.1E–05 –172 –8.5E–05 –3.5E–05 59 –8.5E–05 –1.1E–04 23 –8.5E–05 –1.7E–04 101 –8.5E–05 –4.0E–05 54 
 "1–4" –2.1E–04 –1.2E–04 39 –2.1E–04 –7.3E–05 65 –2.1E–04 –1.7E–04 17 –2.1E–04 –3.0E–04 48 –2.1E–04 –4.8E–04 135 
 "2–3" –8.3E–05 –2.4E–04 187 –8.3E–05 –1.6E–04 92 –8.3E–05 –7.0E–05 15 –8.3E–05 –3.6E–06 96 –8.3E–05 –2.5E–05 70 
 "2–4" –2.0E–04 –4.2E–04 109 –2.0E–04 –2.0E–04 3 –2.0E–04 –1.4E–04 33 –2.0E–04 –1.4E–04 33 –2.0E–04 –4.7E–04 131 
 "3–4" –1.2E–04 –1.9E–04 55 –1.2E–04 –3.8E–05 68 –1.2E–04 –6.6E–05 45 –1.2E–04 –1.3E–04 10 –1.2E–04 –4.4E–04 270 










Table AI.3.1.5. Differences in parametric and nonparametric distributions of right thalamus and basal ganglia volumes between ages 
Volume Comp P2.5TH NP2.5TH % Err P16TH NP16TH % Err P50TH NP50TH % Err P84TH NP84TH % Err P97.5TH NP97.5TH % Err 
Right Caudate "1–2" –3.4E–05 –9.4E–05 175 –3.4E–05 –6.6E–05 92 –3.4E–05 –4.1E–05 21 –3.4E–05 –3.8E–05 10 –3.4E–05 1.2E–04 –448 
 "1–3" –5.8E–05 –6.1E–05 5 –5.8E–05 –3.8E–05 34 –5.8E–05 –6.4E–05 11 –5.8E–05 –7.7E–05 33 –5.8E–05 –2.1E–05 64 
 "1–4" –1.0E–05 –2.5E–04 2283 –1.0E–05 –6.0E–05 475 –1.0E–05 6.6E–05 –730 –1.0E–05 –4.3E–06 59 –1.1E–05 1.1E–04 –1169 
 "2–3" –2.4E–05 3.3E–05 –240 –2.4E–05 2.8E–05 –217 –2.4E–05 –2.3E–05 4 –2.4E–05 –3.9E–05 66 –2.4E–05 –1.4E–04 493 
 "2–4" 2.4E–05 –1.6E–04 –759 2.4E–05 5.3E–06 78 2.4E–05 1.1E–04 353 2.4E–05 3.3E–05 41 2.4E–05 –6.8E–06 –128 
 "3–4" 4.7E–05 –1.9E–04 –500 4.7E–05 –2.2E–05 –147 4.7E–05 1.3E–04 175 4.7E–05 7.3E–05 53 4.7E–05 1.3E–04 182 
Right Putamen "1–2" 4.9E–05 –1.9E–05 –139 4.9E–05 –4.9E–06 –110 4.9E–05 5.9E–05 21 4.9E–05 9.1E–06 81 4.9E–05 1.0E–04 105 
 "1–3" 1.6E–04 9.2E–05 41 1.6E–04 1.3E–04 15 1.6E–04 1.9E–04 20 1.6E–04 1.4E–04 11 1.6E–04 2.2E–04 38 
 "1–4" 1.0E–04 –3.0E–05 –130 1.0E–04 3.8E–05 63 1.0E–04 1.5E–04 44 1.0E–04 8.3E–05 18 1.0E–04 2.2E–04 114 
 "2–3" 1.1E–04 1.1E–04 3 1.1E–04 1.4E–04 28 1.1E–04 1.3E–04 19 1.1E–04 1.3E–04 20 1.1E–04 1.2E–04 7 
 "2–4" 5.3E–05 –1.1E–05 –121 5.3E–05 4.3E–05 19 5.3E–05 8.7E–05 64 5.3E–05 7.4E–05 40 5.3E–05 1.2E–04 121 
 "3–4" –5.4E–05 –1.2E–04 125 –5.4E–05 –9.4E–05 73 –5.4E–05 –4.1E–05 25 –5.4E–05 –5.5E–05 1 –5.4E–05 2.0E–06 –104 
Right Thalamus "1–2" –3.5E–05 1.2E–04 –430 –3.5E–05 6.5E–05 –282 –3.5E–05 –6.6E–05 85 –3.5E–05 –7.5E–05 111 –3.5E–05 –2.0E–04 455 
 "1–3" –1.2E–04 9.2E–05 –178 –1.2E–04 –7.6E–05 35 –1.2E–04 –1.3E–04 9 –1.2E–04 –1.4E–04 20 –1.2E–04 –3.7E–04 214 
 "1–4" –2.2E–04 –2.2E–04 2 –2.2E–04 –1.7E–04 23 –2.2E–04 –2.4E–04 8 –2.2E–04 –2.4E–04 6 –2.2E–04 –1.7E–04 23 
 "2–3" –8.2E–05 –2.5E–05 70 –8.2E–05 –1.4E–04 71 –8.2E–05 –6.3E–05 24 –8.2E–05 –6.7E–05 19 –8.2E–05 –1.7E–04 110 
 "2–4" –1.9E–04 –3.4E–04 78 –1.9E–04 –2.4E–04 26 –1.9E–04 –1.8E–04 7 –1.9E–04 –1.6E–04 14 –1.9E–04 2.4E–05 –113 
 "3–4" –1.1E–04 –3.1E–04 193 –1.1E–04 –9.6E–05 9 –1.1E–04 –1.1E–04 7 –1.1E–04 –9.5E–05 11 –1.1E–04 2.0E–04 –286 
Note: P=parametric/ NP=nonparametric percentile rank; %Err=percent error; Comp=comparison; 1=26–35 years; 2=36–45 years; 3=46–55 years; 4=56–65 years. 
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APPENDIX II: Technical material 
 
AII.1 BRAINS schema 
 
The BRAINS schema was developed mainly by Dr Dominic Job, Dr Susan Shenkin, 
Dr David Rodriguez Gonzalez, and Prof Joanna Wardlaw, The University of 
Edinburgh. 
 
Entity /Attributes Description Status 
Subject   
BraINS Trial /Study ID Reference to Trial /Study invisible 
BraINS Subject ID Alphanumeric identifier foreground 
Sex Male; Female; Other foreground 
   
Demographics   
BraINS Subject ID Reference to Subject invisible 
Age at data collection Age in years at physical data collection time foreground 
Age at scan time Age in years at image data collection time foreground 
Age at cognitive data collection time Age in years at cognitive data collection time foreground 
Handedness Left; Right; Both foreground 
First language Language code foreground 
Age at leaving school Age in years foreground 
Years of formal education Number of years foreground 
Highest qualification Qualification code foreground 
Occupation Occupation code foreground 
Ethnicity Ethnicity code foreground 
Country of Birth Country of Birth foreground 
Country of Data Collection Country of Data Collection foreground 
Demographics Notes Text background 
   
Measurements   
BraINS Subject ID Reference to Subject invisible 
Age at data collection Age in years foreground 
Blood pressure - systolic Reading in mmHg foreground 
Blood pressure - systolic Reading in mmHg background 
Blood pressure - diastolic Reading in mmHg foreground 
Blood pressure - diastolic Reading in mmHg background 
Pulse Reading in BPM background 
Weight Weight in kg foreground 
Height Height in cm foreground 
BMI Score foreground 
Medical examination normal Y/N REMOVE 
Measurements Notes Text background 
   
Medical History   
BraINS Subject ID Reference to Subject invisible 
Age at data collection Age in years foreground 
Method of Collection Self Report; Medical Records; Interview background 
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Prior head trauma Y/N background 
Prior ischaemic stroke Y/N foreground 
Prior TIA Y/N foreground 
Prior Stroke or TIA Y/N foreground 
Prior haemorrhagic stroke Y/N foreground 
Peripheral vascular disease Y/N foreground 
Peripheral vascular disease duration Duration in years background 
IHD /MI Y/N foreground 
IHD /MI duration Duration in years background 
AF clinical history Y/N foreground 
AF on ECG Y/N foreground 
AF duration Duration in years background 
Hypercholesterolaemia Y/N foreground 
Hypercholesterolaemia duration Duration in years background 
Hypertension Y/N foreground 
Hypertension duration Duration in years background 
Diabetes Type I Y/N foreground 
Diabetes Type I duration Duration in years background 
Diabetes Type II Y/N foreground 
Diabetes Type II duration Duration in years background 
Epilepsy Y/N foreground 
Epilepsy duration Duration in years background 
Dementia Y/N foreground 
Dementia duration Duration in years background 
Cognitive Impairment Y/N foreground 
Cognitive Impairment duration Duration in years background 
Depression Y/N foreground 
Depression duration Duration in years background 
Schizophrenia Y/N foreground 
Schizophrenia duration Duration in years background 
Parkinson's Y/N foreground 
Parkinson's duration Duration in years background 
Peripheral arthritis/osteoarthritis Y/N foreground 
Peripheral arthritis/osteoarthritis Duration in years background 
Medical History Notes Text background 
   
Medication summary   
BraINS Subject ID Reference to Subject invisible 
Any anti-platelet Y/N foreground 
Any statin Y/N foreground 
Any anti-hypertensive Y/N foreground 
Any psychiatric drug Y/N foreground 
Any dementia drug Y/N foreground 
   
Medications   
BraINS Subject ID Reference to Subject invisible 
Age at data collection Age in years background 
Aspirin Y/N background 
Warfarin Y/N background 
Low dose heparin Y/N REMOVE 
High dose heparin Y/N REMOVE 
Anticoagulant (unspecified) Y/N background 
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Clopidogrel Y/N background 
Dipyridamole Y/N background 
Antiplatelet (unspecified) Y/N background 
Beta blocker Y/N background 
ACE inibitor or angiotensin II receptor antagonist Y/N background 
Calcium antagonist Y/N background 
Diuretic Y/N background 
Statin Y/N background 
Cardiovascular drug (unspecified) Y/N background 
Benzodiazepine Y/N background 
Antidepressant (unspecified) Y/N background 
Antipsychotic (unspecified) Y/N background 
Memantine Y/N background 
Cholinesterase inhibitor Y/N background 
Antidementia (unspecified) Y/N background 
Thyroxine Y/N background 
Analgesic (excluding NSAID) Y/N background 
NSAID Y/N background 
Steroid (excluding cream/inhaler) Y/N background 
Anti-inflammatory (unspecified) Y/N background 
Oral hypoglycaemic Y/N background 
Insulin Y/N background 
Inhaler (steroid) Y/N background 
Inhaler (cholinergic; beta agonist; other) Y/N background 
Proton pump inhibitor /H2 blocker Y/N background 
Parkinson's medication (unspecified) Y/N background 
Anticholinergic Y/N background 
Total number oral medications Number of meds foreground 
Medications Notes Text background 
   
Risk Factors   
BraINS Subject ID Reference to Subject invisible 
Age at data collection Age in years foreground 
Smoking Never; Previous; Current foreground 
Smoking - age started Age in years background 
Smoking - age stopped Age in years background 
Smoking - Number of cigarettes background 
Alcohol - units /week Number of units foreground 
Family history of stroke Y/N background 
Family history of peripheral vascular disease Y/N background 
Family history of IHD /MI Y/N background 
Family history of hypercholesterolaemia Y/N background 
Family history of hypertension Y/N background 
Family history of diabetes Type I Y/N background 
Family history of diabetes Type II Y/N background 
Family history of epilepsy Y/N background 
Family history of dementia Y/N background 
Family history of cognitive impairment Y/N background 
Family history of depression Y/N background 
Family history of schizophrenia Y/N background 
Family history of Parkinson's Y/N background 
Diet history available Y/N background 
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Risk Factors Notes Text background 
 
Clinical data - Scan Findings   
BraINS Subject ID Reference to Subject invisible 
Age at scan Age in years foreground 
Focal lesions - Infarct - Cortical Y/N background 
Focal lesions - Infarct - Striatocapsular Y/N background 
Focal lesions - Infarct - Borderzone Y/N background 
Focal lesions - Infarct - Lacunar Y/N background 
Focal lesions - Infarct - Brainstem /Cerebellum Y/N background 
Focal lesions - Haemorrhage Y/N background 
Focal lesions - Non-Stroke Y/N background 
Cerebral tumour Y/N foreground 
EPVS - basal ganglia Score (0-4) background 
EPVS - centrum semiovale Score (0-4) background 
EPVS - hippocampus Score (0-4) background 
BMBs Score foreground 
Atrophy score Score foreground 
Atrophy ventricle Score foreground 
Atrophy sulci Score foreground 
White matter lesions - Fazekas (PVH) Score (0-3) foreground 
White matter lesions - Fazekas (DWMH) Score (0-3) foreground 
White matter lesions - Longstreth (PVH+DWMH) Score (0-8) foreground 
White matter lesions - Wahlund (PVH+DWMH) Score (1-3) background 
Brain volume Volume in mm3 foreground 
ICV Volume in mm3 background 
CSF vol Volume in mm3 background 
Brain vol as % of ICV Volume in mm3 background 
WML vol Volume in mm3 background 
WML vol as % of ICV Volume in mm3 background 
Intracranial area Area in mm2 foreground 
Incidental findings Text background 
Incidental findings Y/N foreground 
Scan Findings Notes Text background 
Neuroradiology report Text foreground 
Normal Scan  Y/N 
   
Clinical data - Cognitive Tests   
BraINS Subject ID Reference to Subject invisible 
Age at test Age in years at time of cognitive test foreground 
MMSE Score foreground 
Moray House Test Score background 
NART Score foreground 
Ravens Progressive Matrices Score background 
Wechsler Matrices Score background 
Wechsler (WASI) Score background 
Wechsler (WRAT) Score background 
Digit symbol Score background 
Auditory verbal learning test Score background 
IDED Score background 
CVLT Score background 
Extended Rivermead memory test Score background 
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HADS - anxiety Score foreground 
HADS - depression Score foreground 
MoCA Score foreground 
ACE-R Score foreground 
Verbal Fluency Score background 
Logical Memory Score background 
Cognitive Tests Notes Text background 
   
Clinical data - Functional Tests   
BraINS Subject ID Reference to Subject invisible 
Townsend Score background 
Barthel Score background 
Grip strength Score background 
6 meter walk Score background 
   
Clinical data - Laboratory Tests   
BraINS Subject ID Reference to Subject invisible 
Hb Score background 
HbA1c Score background 
cholesterol Score background 
triglyc Score background 
creatinine Score background 
Albumin Score background 
CRP Score background 
Note: The third column (“Status”) refers to the visibility of a variable in the databank. 
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APPENDIX III: Key outputs and awards 
 
AIII.1 List of key publications and presentations 
DICKIE, D.A., et al.: 
(Accepted). Variance in brain volume with advancing age: implications for defining 
the limits of normality. PLOS ONE.  
(Submitted). Evidence of non-normal distributions in brain imaging data from normal 
subjects: implications for diagnosis of disease. ISMRM 2014 Annual Meeting. 
(2013). How normal is this brain? Development and testing of a new MR template for 
voxel–based brain ranking. Proceedings of the 19th Annual Meeting of the 
Organization for Human Brain Mapping. Seattle, USA. 
(2013). Development of automatic, voxel–based brain ranking. Anne Rowling 
Regenerative Neurology Clinic launch meeting. Edinburgh, UK. 
(2013). Brain Images of Normal Subjects (BRAINS) Bank. NHS Lothian Annual 
Research Conference. Edinburgh, UK. Poster Competition First Prize. 
(2012). Distinguishing normal and pathological ageing brain structures with data not 
statistics. CCACE 5th Annual Research Day. Edinburgh, UK. Young Scientist 
Poster Award. 
(2012). A databank, rather than statistical, model of normal ageing brain structure to 
indicate pathology. Proceedings of the 18th Annual Meeting of the Organization 
for Human Brain Mapping. Beijing, China. 
(2012). Do brain image databanks support understanding of normal ageing brain 
structure? A systematic review. Eur Radiol. 22 (7), 1385–1394. Received 
editorial: Barkhof, F. (2012). Making better use of our brain MRI research 
data. 
 
Valdés Hernández, M. C., …, DICKIE, D.A., et al.: 
(2013). Differentiation of Calcified Regions and Iron Deposits in the Ageing Brain on 
Conventional Structural MR Images. J. Magn. Reson. Imaging. 
(2012). Close correlation between quantitative and qualitative assessments of white 
matter lesions. Neuroepidemiology. 40 (1), 13–22. 
(2012). Comparison of ageing–related white matter lesion quantification by volume 
and visual rating scores. American Stroke Association International Stroke 
Conference. New Orleans, Louisiana, USA. 
 
 
AIII.2 List of funding awards 
Anne Rowling Regenerative Neurology Clinic, April 2013, 250 GBP. 
Postdoctoral and Early Career Researcher Exchange Fund, Scottish Funding 
Council, July 2012, 5,000 GBP.  
Travel grant, Guarantors of Brain, April 2012, 800 GBP. 
 
 












































































And so we came forth, and once again beheld the stars 
       Dante, Styron 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
